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Abstract 
 
This thesis is divided into three chapters. 
 
Chapter 1 provides brief reviews on the subjects of previous total syntheses of suaveoline, 
alstonerine and cytisine. In addition, a review concerning the Pictet–Spengler reaction 
mechanism and its application to the total syntheses of isoquinoline containing natural 
products has been included as well. 
 
Chapter 2 focuses on the research findings in the past three years. Two routes were 
investigated towards the total synthesis of (±)-suaveoline involving the decarboxylative 
Claisen rearrangement (dCr), N-sulfonylaziridine chemistry and subsequent nucleophilic ring-
opening of the latter by various sulfone-anions. Route A focused on the use of oxo-lithio 
chelation during aziridine ring-opening while route B employed selective weakening of the 
aziridine C–N bond proximal to the olefin by piC–C → σ*C–N overlap (Scheme 0.1). 
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Scheme 0.1 
 
Attempts towards total synthesis of (±)-alstonerine involved the preparation and subsequent 
screening of various sulfone-anions against the indolic hydroxy aziridine, followed by an 
interesting E1cB / Michael addition, cis-Pictet–Spengler cyclization and an ambitious global 
reduction step.  
 
Furthermore progress towards total synthesis of (–)-cytisine involved investigation towards 
the application of regioselective sulfone-anion hydroxy-aziridine opening mediated by oxo-
lithio-chelation.  
 
Chapter 3 provides the experimental details and characterization data. 
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List of Abbreviations 
 
Å     angstrom 
Ac    acetyl 
AcOH    acetic acid 
AIBN    azobisisobutyronitrile 
Anh.    anhydrous 
Ar    aromatic 
aq.    aqueous 
9-BBN    9-borabicyclo [3.3.1] nonane 
Bn    benzyl 
Boc    tert-butoxycarbonyl 
BOP    benzotriazole-1-yl-oxy-tris-(dimethylamino)-phosphonium  
bp    boiling point 
Bu    butyl 
Bz    benzoyl 
˚C    degree Celsius 
cat.    catalytic 
CAN    ceric(IV)ammonium nitrate 
Cbz    carbobenzyloxy 
CDI    N,N'-carbonyldiimidazole 
CI    chemical ionisation 
Cp    cyclopentadienyl 
CSA    10-camphorsulfonic acid 
d    doublet 
DBN    1,5-Diazabicyclo[4.3.0]non-5-ene 
DBU    1,8-Diazabicyclo[5.4.0]undec-7-ene 
dCr    decarboxylative Claisen rearrangement 
dd    doublet of doublet 
DDC    N,N’-dicyclohexylcarbodiimide  
ddd    doublet of doublet of doublet 
DDQ    2,3-dicyano-5,6-dichloro-para-benzoquinone 
ddt    doublet of doublet of triplet 
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d.e.    diastereoisomeric excess 
DEAD    Diethyl azodicarboxylate 
DIAD    Diisopropyl azodicarboxylate 
DIBAL   diisobutylammonium hydride 
DIC    diisopropylcarbodiimide 
DIPEA   N,N-diisopropylethylamine 
DMAP    4-dimethylaminopyridine 
DMDO   dimethyldioxirane 
DME    dimethyl ether 
DMF    N,N-dimethylformamide 
DMP    Dess–Martin periodinane 
DMS    dimethyl sulfide 
DMSO    dimethyl sulfoxide  
dppa    diphenylphosphoryl azide 
dppe    1,2-bis(diphenylphosphino)ethane 
dppf    1,1'bis(diphenylphosphino)ferrocene 
d.r     diastereomeric ratio 
dt    doublet of triplet 
dq    doublet of quartet 
E1cB    elimination conjugate base 
Ed.    edition 
EDCI    1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
equiv.    equivalents 
ESI    electrospray ionisation 
Et    ethyl 
Fmoc    9-fluorenylmethyloxycarbonyl 
h    hours 
HATU    2-(7-Aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium 
    hexafluorophosphate 
HMDS    bis(trimethylsilyl)amide 
HMPA    N,N,N',N',N'',N''-hexamethylphosphoric triamide 
HOAt    1-hydroxy-7-azabenzotriazole 
Hz    Hertz 
IBX    O-iodoxybenzoic acid 
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iPr    iso-propyl 
IR    infra red 
La    lanthanide 
LA    Lewis acid 
LDA    lithium diisopropylamide 
Ln    ligand 
LTA    lead tetraacetate 
lut.    lutidine 
m    multiplet 
M    molar 
mCPBA   meta-chloroperoxybenxoic acid 
Me    methyl 
m-    meta 
min    minutes 
mmHg    millimeter of mercury 
mL    milliliter 
mol%    mole percentage 
MOM    methoxymethyl ether 
mp    melting point 
Ms    methanesulfonyl 
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m/z    mass/charge ratio 
n
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NBS    N-bromosuccinamide 
nBuLi    n-butyllithium 
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o-    ortho 
p-    para 
Ph    phenyl 
phth    phthalimide 
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PTAB    phenyltrimethylammonium tribromide 
py    pyridine 
q    quartet 
Rf     Retardation factor 
rt    room temperature 
s    singlet 
SN1    unimolecular nucleophilic substitution 
SN2    bimolecular nucleophilic substitution 
SNAr    nucleophilic aromatic substitution 
t    triplet 
TBAB    tbutylamineborane 
TBAF    tetra-n-butylammonium fluoride 
TBAI    tetra-n-butylammonium iodide 
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Stereochemical Notation 
 
Throughout this report, to aid rapid visual identification of relative and absolute 
stereochemical configurations, the Maehr1 convention has been adopted. Thus, solid and 
broken lines denote a racemate, while solid and broken wedges imply absolute configuration, 
as illustrated below.  
 
 
 
 
Racemate  Single enantiomer 
 
Relative Stereochemistry  Absolute Stereochemistry 
 
 
Macroline skeletal numbering 
 
A brief overview regarding the skeletal numbering of macroline according to LeMen and 
Taylor2 has been depicted below (Figure 0.1) and will be used throughout this report. 
 
10
11
12 13
8
9
N1
2
7
3
N4
5
6
14
15
16
17
20
21
19H
H
OH
H
H
18 O
 
 
Figure 0.1 
 
 
1.  Maehr, H. J. Chem. Ed. 1985, 62, 114. 
2.  LeMen, J.; Taylor, W. I. Experientia 1965, 21, 508. 
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1.  Introduction 
 
This chapter provides brief reviews regarding the total syntheses of suaveoline, alstonerine 
and cytisine as represented in the literature. In addition, a review concerning the Pictet–
Spengler reaction mechanism and application to the total syntheses of isoquinoline containing 
natural products has been included as well.  
 
1.1.  Suaveoline 
 
1.1.1.  Background 
 
This report will cover the progress towards the total synthesis of the macroline-related natural 
products suaveoline 3 (Figure 1.1), alstonerine and the lupin alkaloid cytisine. The two former 
natural compounds are part of a much larger array of alkaloids isolated from the Alstonia 
genus of plants, commonly found in tropical regions. In these regions several species of 
Alstonia have found use in traditional medicine against malaria and dysentery.1,2  
 
N
N
H
OH
N
N
OH
O
H
H
macroline  1 sarpagine  2 suaveoline  3
H
H
H
H N
HN
H
H
N
 
Figure 1.1 
 
Suaveoline 3 was first isolated in 1972 by Potier1 from the trunk bark of Rauvolfia 
suaveolens, and has since also been isolated from other species of the Rauvolfia family. Cook 
was the first to complete the total synthesis of racemic suaveoline in 1989.2 Since then, three 
laboratories have reported total syntheses in either racemic or optically pure form. 
Structurally, suaveoline 3 and macroline 1 compounds are very alike, containing the 
characteristic azabicyclo [3.3.1] motif. Furthermore the absence of a N4–C21 linkage, 
commonly found in the sarpagine-related compounds is a key feature, as is the 3,4,5-
trisubstituted pyridine moiety.3 In contrast to sarpagine 2, macroline 1 has not been isolated 
from nature. It is widely believed that macroline is a common precursor to sarpagine 
alkaloids.3  
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1.1.2.  Previous Total Syntheses of Suaveoline 
 
1.1.2.1. Cook’s Total Synthesis 
 
In 1989 Cook et al. reported the first total synthesis of (±)-suaveoline.2 Subsequently the 
synthesis was refined, culminating in the enantioselective total synthesis of (–)-suaveoline.4 
 
Key to Cook’s synthesis was the use of the tetracyclic ketone intermediate 13,5 obtained from 
D-tryptophan using an improved modification of the Yoneda protocol6 (Scheme 1.1). 
Protection of D-tryptophan gave 5; care had to be taken during the reductive amination since 
prolonged reaction times resulted in erosion of enantiomeric excess.  
 
D-Trp
N
CO2CH3
NH2 N
CO2CH3
NHBn
a) Na / NH3
b) HCl, CH3OH PhCHO, NaBH4
80%, 2 steps 88%
4 5
 
Scheme 1.1: Protection of D-tryptophan. 
 
Synthesis of tetrahydro-β-carboline 8 had previously been achieved by Yoneda6 in 59% yield 
using Pictet–Spengler condensation of the hydrochloride salt of 5 with methyl 3-
formylpropionate in aqueous methanol. A 2 : 1 mixture of benzene and dioxane significantly 
improved the condensation reaction due to improved solubility of ketoglutaric acid. However, 
under these reaction conditions decarboxylation of 5 was observed and diester 8 obtained 
(Scheme 1.2). In this decarboxylation step, the diastereomeric ratio is determined by 
protonation of 7, occurring after decarboxylation, thus resulting in formation of both cis- and 
trans-isomers of 8.   
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N
CO2CH3
NHBn
HO2C
O
CO2H
a) C6H6 / Dioxane, ∆
N
NBn
CO2CH3
CO2CH3
OO
H
H
N
NBn
CO2CH3
CO2CH3
H
H
N
NBn
CO2CH3
CO2CH3
b) HCl / MeOH, ∆
80%, 2 steps
6
7 8
5
 
Scheme 1.2: Protonation of decarboxylated intermediate 8. 
 
Pure trans-isomer 11 was obtained by employing an acid-catalyzed isomerization step (9 to 
10) in which the latter isomer is favored due to diminished steric buttressing between the ester 
groups (Scheme 1.3). The isomerization process is thought to occur via C3–N4 bond cleavage 
and C3 cation formation due to delocalization of the positive charge over the indole ring.7 
Formation of 10 was proven through isolation of both a vinyloguous C3–C14 intermediate of 
10 and corresponding C3 methyl ether of 10. Both intermediates proved the C3–C4 bond 
fragmentation of cis-8 due to 1,2-allylic strain to occur, therefore adopting a more relaxed 
trans-conformation 10, resulting in formation of trans-11.7  
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N H
CO2CH3
CO2CH3
PhN
N
Ph
H
CO2CH3
H3CO2C
N
HCl / MeOH
NH
Ph
H
CO2CH3
H3CO2C
N NH
Ph
H
CO2CH3
N
CO2CH3
N
NBn
CO2CH3
CO2CH3
-H
8 8
9 10
11
2
3
4
 
Scheme 1.3: Acid-induced epimerization to the 3,5-trans tetrahydro-β-carboline. 
 
Dieckmann condensation of the diester 11 generated the β-keto ester 12 in 92% yield as 
reported by Yoneda.6 Acid-catalyzed C15 decarboxylation subsequently gave the desired 
tetracyclic ketone 13 (Scheme 1.4).  
 
N
NBn
CO2CH3
CO2CH3
N
BnN
O
H
H
N
BnN
O
H
H
CO2CH3
NaH, CH3OH,
Toluene, ∆
AcOH / HCl / 
H2O, ∆
11
92% 91%
12 13
 
Scheme 1.4: Tetracyclic ketone 13 formation. 
 
As the trans-isomer is unable to attain the configuration needed for cyclization, the base 
conditions involved in the Dieckmann condensation results in epimerization at the C5 position 
prior to cyclization (Scheme 1.5). The initial incorrect configuration at C5 induces the correct 
configuration at C3 which in turn induces the correct and complete epimerization at C5 and 
thus results in formation of 13.  
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N
NBn
CO2CH3
CO2CH3
N
BnN
O
H
H
N
BnN
O
H
H
CO2CH3
NaOCH3
N
NBn
CO2CH3
CO2CH3
H3O
∆
5
11
1213
14
3
 
Scheme 1.5: Epimerization of 11. 
 
With tetracyclic ketone 13 in hand, the subsequent formation of α,β-unsaturated aldehyde 15 
was achieved via rearrangement of the epoxide obtained from 13 and the anion of 
ClCH2SOPh (Scheme 1.6). Addition of the Grignard reagent generated from 1-bromo-2-
pentene resulted in undesired alcohol formation due to allylic rearrangement. This problem 
was circumvented by the use of a pseudosymmetric secondary Grignard reagent which gave a 
mixture of 1 : 1, 1,2-16 and 1,4-17 addition products, after which 16 was converted into 17 by 
anionic oxy-Cope rearrangement.  
Attempts to cleave the olefinic bond oxidatively using ozone were unsuccessful; this was due 
to the reactivity of the 2,3-indole double bond. In order to prevent the formation of a 
hemiacetal, the aldehyde 17 was protected in the form of oxime 18, osmylated and 
subsequently hydrolyzed reductively with NaHSO3. The diol obtained was subjected to 
oxidative cleavage mediated by sodium periodate to provide 19. Regeneration of the C16 
aldehyde is believed to be induced by oxidative hydrolysis of the oxime function with sodium 
periodate.4 Dialdehyde 19 was then exposed to hydroxylamine hydrochloride to furnish 3. A 
change of protecting groups at the N4-function was achieved by using Pd/C in methanol to 
give (–)-suaveoline 3 in seven steps.4  
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N
NH
H
H
N
N
BnN
O
H
H
N
BnN
H
H
CHO
N
BnN
H
H
CHO
N
BnN
H
H
HO
+
N
BnN
H
H
NOH
N
BnN
H
H
CHO
CHO
a) LDA / ClCH2SOPh
b) KOH
c) LiClO4 / nBu3PO
    Toluene, ∆
MgBr
KH, dioxane / cumene
NH2OH⋅HCl, 
EtOH, ∆
a) OsO4 / py
    NaHSO3
b) NaIO4
a) NH2OH⋅HCl, 
    EtOH, ∆
b) Pd/C, H2, CH3OH
13 15
16 17 18
19 3
87%, 3 steps
90% 88% 95%
80%, 2 steps 67%, 2 steps
 
Scheme 1.6: Total synthesis of (–)-suaveoline 3 according to Cook. 
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1.1.2.2. Bailey’s Approach  
 
Bailey and co-workers have made major contributions to the synthesis of indole alkaloids.8 
Their total synthesis of (–)-suaveoline used a Pictet–Spengler reaction, and began with the 
synthesis of cyanomethyltryptamine 21 from L-tryptophan (Scheme 1.7). Synthesis of 21 
involved reduction of the carboxylic acid, tosylation of both terminal amine and newly 
formed alcohol, substitution of the O-tosyl by a cyano nucleophile and subsequent 
detosylation of the amine. Piperidine 22, was obtained after the Pictet–Spengler cyclization 
gave only cis-C3–C5 tetrahydro-β-carboline. This was achieved after extensive optimization 
within the Bailey group as the need for a masked aldehyde was required at the C3 position.9 
Incorporation of the hydroxyaldehyde in conjunction with the cyanomethyl substituent proved 
to be both synthetically useful and cis-specific. The absence of protecting groups at both 
nitrogen atoms might explain this selective outcome as Cook reported the presence of a bulky 
substituent at the N4 position to enhance trans-C3–C5 selectivity.10 In addition, both the 
reported use of kinetically controlled reaction conditions8 and TBDPS instead of TBS might 
also provide an explanation regarding the observed cis specificity, the latter due to pi-stacking. 
Deprotection of the alcohol and Swern oxidation gave the aldehyde 23. 
  
N
H
NHTs
OTs
L-Trp
N
H
NH2
CN
N
H
NH
OTBDPS
CN
N
NBn
O
CN
a) BnBr
b) CH3I, Na
c) TBAF 
d) Swern
a) LiAlH4 
b) TsCl, py
c) KCN
d) Na / NH3,
i) 3Å mol sieves
ii) 2 equiv. TFA
OHC OTBDPS
20 21
22 23
80%, 4 steps
80% 65%, 4 steps
 
Scheme 1.7: Synthesis of cyano-aldehyde 23. 
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In more recent publications,8 Bailey has employed the Horner–Wadsworth–Emmons reaction 
(23→24) followed by vinylogous Thorpe cyclization to give tetracyclic intermediate 25 
(Scheme 1.8). The mixture of diastereoisomers was reduced using DIBAL and exposed to 
hydroxylamine hydrochloride to give 3,4,5-trisubstituted pyridine 26. Results obtained later 
showed that an acid work-up after the DIBAL reduction was sufficient to form the pyridine 
ring. Debenzylation of N4 finally resulted in (–)-suaveoline 3 formation in an overall yield of 
14%.   
EtO P
O
EtO
CN
N
NBn
O
CN
N
NBn
CN
CN
N
BnN
H
H
CN
H CN
KOtBu, THF
N
BnN
H
H
N
N
NH
H
H
N
i) HCl, EtOH 
ii) Pd/C, H2, EtOH
generated in situ
a) DIBAL
b) NH2OH·HCl, EtOH
23 24 25
26 3
83%, 2 steps 67%
53%, 2 steps 66%
 
 
Scheme 1.8: Total synthesis of (–)-suaveoline 3 according to Bailey. 
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1.1.2.3. Ohba’s Approach 
 
Ohba’s ongoing interest in annulated pyridine systems and exploitation of oxazole-olefin 
Diels–Alder reactions have recently culminated in the publication of a new total synthesis of 
(–)-suaveoline.3,11 In this article Ohba and co-workers start from N-protected amino ester 27 
which gave the oxazole 28 without erosion of ee according to their previously reported 
methodology.12 Deprotection of the amine allowed amide formation 29 which was necessary 
for the formation of the C ring. A Bischler–Napieralski reaction,13 initiated by POCl3, gave 
30. Stereoselective hydrogenation using Pearlman’s catalyst and hydrogen gave only the cis-
1,3-disubstituted tetrahydro-β-carboline, which upon Boc-protection of the free amine 
provided 31 (Scheme 1.9).      
N
H
CO2CH3
NHBoc
N
H
NHBoc
O
N
N
H
HN
O
N
O
EtO2C
N
H
NH
CO2Et
O
N
N
H
NBoc
CO2Et
O
N
i) POCl3
ii) Na2CO3
nBuLi, MeNC
a) CF3CO2H
b) EtO2CCH2CO2H,
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Scheme 1.9: Synthesis of THBC 31. 
 
With the C-ring successfully constructed, employment of the oxazoline-olefin in an 
intramolecular Diels–Alder cyclization would result in simultaneous formation of rings D and 
E to provide 35 (Scheme 1.10). Reduction of the ester using DIBAL to provide aldehyde 33 
and Wittig reaction gave olefin 34. Finally, the intramolecular Diels–Alder reaction was 
performed in boiling xylene using DBN, which acted as a water scavenger and promoted the 
conversion of the Diels–Alder adduct into pyridine 35. Methylation of the indole nitrogen 
resulted in the formation of (–)-suaveoline 3 in an overall yield of 10%.  
 
  
  Introduction 
 
   23 
N
H
NBoc
O
N
N
H
N
H
H
N
Boc
N
NH
H
H
N
a) MeI, NaH 
b) CF3CO2H
N
H
NBoc
CO2Et
O
N
Ph3P+(CH2)2MeBr- 
tBuOKDIBAL
N
H
NBoc
CHO
O
N
Xylene / DBN, ∆
32 33 34
35 3
95% 73%
69% 80%, 2 steps
 
 
Scheme 1.10: Total synthesis of (–)-suaveoline 3 by Ohba. 
 
The total synthesis of (–)-suaveoline 3 as published by Ohba11 is radically different from 
Bailey’s8 as it does not involve use of the Pictet–Spengler cyclization to yield the crucial 
tetrahydro-β-carboline, instead utilizing an intramolecular Diels–Alder reaction to form both 
D- and pyridine E-rings in 35. 
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1.2  Alstonerine 
 
1.2.1.  Background 
 
Alstonerine 36 was isolated in 1959 by Eldersfield and Gilman14 as the major alkaloid in the 
bark of Alstonia mycrophylla and has since also been isolated from other family members.15 
Le Quesne et al.,16 assigned the structure in 1969, yet the absolute configuration was 
uncertain until 1978 when the first biomimetic synthesis strongly suggested it to be similar to 
macroline. Biogenetic considerations suggest that (–)-alstonerine 36 may serve as a precursor 
to alstonine 37, an oxindole alkaloid (Figure 1.2). However, as with suaveoline 3, a full 
biological profile has not yet been established. In 1990 Cook and coworkers published the 
first total synthesis of alstonerine17 starting from D-tryptophan. 
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O
H
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sarpagine  2                                         alstonerine  36                                  alstonine  37
N
N
H
H
O
O
H
H
 
Figure 1.2 
 
Structurally very similar to suaveoline, alstonerine contains the characteristic azabicyclo 
[3.3.1] core. In addition, the absence of the N4–C21 linkage commonly found in the sarpagine-
related compounds is a key feature. 
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1.2.2.  Previous Total Syntheses of Alstonerine 
 
1.2.2.1. Cook’s Total Synthesis 
 
Cook et al., reported the first total synthesis of (–)-alstonerine in 1990, using the tetracyclic 
ketone 13.17 The synthesis of the latter will not be discussed in this section, please see section 
1.1.2.1. 
 
Tetracyclic ketone 13 was prepared in seven steps from D-tryptophan, and converted into α,β-
unsaturated aldehyde 38 via elimination of the spiroepoxide followed by oxidation17 (Scheme 
1.11). Chemoselective reduction of the aldehyde resulted in alcohol formation, which 
subsequently underwent oxo-Michael addition with butyn-3-one 18 to give desired enone 39. 
Exposing the enol ether 39 to classical Claisen condensation conditions gave β-dicarbonyl 40 
as a single diastereomer, probably due to α-face rearrangement of the double bond via a chair-
like transition state.19 This method had important implications since the correct C15 
stereochemistry would induce the absolute configuration needed for the macroline / sarpagine 
/ ajmaline alkaloids. Reduction of the β-dicarbonyl with sodium borohydride gave the 
corresponding triol 41. Stereoselective hydroboration at the β-face of the exocyclic methylene 
function (C16) with 9-BBN followed by oxidative work-up gave triol 41 stereoselectivity as a 
result of 1,3-steric repulsion between axial N4-methyl function and the incoming borane. 
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ii) 9-BBN then NaOH
13 38
39
40 41
60%, 4 steps
89%, 2 steps
66% 86%
15
16
 
 
Scheme 1.11: Synthesis of triol 41.  
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Finally, cyclization of the triol 41 by tosylation and base treatment gave 42, which after 
exposure to Swern oxidation conditions gave (–)-alstonerine 36 and the alstonerine derivative 
43 (Scheme 1.12). 
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Scheme 1.12: First total synthesis of (–)-alstonerine 36 by Cook. 
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1.2.2.2. Cook’s Second Approach 
 
In 2005, Cook et al.20 reported an improved total synthesis of (–)-alstonerine, once again 
using the tetracyclic ketone 132 as their starting point (Scheme 1.13). Earlier attempts to 
provide the sarpagine skeleton via Michael addition had failed probably due to the relative 
acidity of the γ-position (C14) of the α,β-unsaturated aldehyde system 45.21 Radical 
cyclization mediated by AIBN provided a mixture of 46 and 47,21 yet due to the moderate 
yield a Heck reaction was later employed, utilizing reaction conditions reported by Muratake 
and Natsume.22  
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b) i) 
     ∆
    ii) K2CO3 N
N
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H
H I
 
Scheme 1.13: Synthesis of the α,β-unsaturated aldehyde system 46 and 47. 
 
The Heck reaction is initiated by oxidative addition of the Pd(0)L2 to the vinyl iodide 47, 
followed by an equilibrium between ketone 47 and its enolate 48 resulting in Pd(II) formation 
(Scheme 1.14). Enolate coordination with the Pd-complex gives 49 which finally undergoes 
reductive elimination to regenerate Pd(0) and provide 46A.21  
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Scheme 1.14: Formation of 46A. 
 
When exchanging the vinyl iodide for the less reactive vinyl bromide only starting material 
was observed. This was probably due to the coordination of the palladium to the electron-rich 
indole which removes it from the reaction cycle. Subjecting ketone 46A to Wittig reaction 
conditions provided the corresponding enol ether which was subsequently hydrolyzed to the 
corresponding aldehyde 46. Reduction of 46 followed by silyl-ether formation gave protected 
alcohol 51, (Scheme 1.15). This was followed by hydroboration–oxidation to provide alcohol 
52, which was oxidized to give ketone 53. Subsequent N-methylation and spontaneous 
elimination of the quaternary ammonium salt gave 54.20  
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Scheme 1.15: Synthesis of 54. 
 
Finally, a modified intramolecular Tsuji–Wacker oxidation gave (–)-alstonerine 36 as a result 
of a one-pot domino process (Scheme 1.16). This process involves the deprotection of a silyl 
ether and carbon–oxygen bond formation under acidic conditions. The modified Wacker 
oxidation proved to be more successful than the traditional Wacker reaction in which case no 
reaction was observed due to the presence of a substituent adjacent to the carbonyl group. 
Carbon–oxygen bond formation is achieved via a palladium cycle, starting from Pd(II) 
coordination to the olefin as 55 in a reversible manner. This is followed by cleavage of the 
silyl ether 56 providing the nucleophilic oxygen, attacking the palladium and forming 57. 
Then, β-hydride elimination 58, followed by reductive elimination provides 36; the Pd(0) is 
reoxidized by tBuOOH, re-entering the catalytic cycle.20   
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Scheme 1.16: Wacker Oxidation mechanism to produce (–)-alstonerine 36. 
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1.2.2.3. Martin’s Approach 
 
The Martin lab reported the first application of the Pauson–Khand reaction to the synthesis of 
azabridged bicyclic structures, culminating in the total synthesis of (–)-alstonerine.23 Their 
route started with the conversion of L-tryptophan into the dihydrocarboline 59 via acetylation 
and cyclization as described by Previero et al (Scheme 1.17).24,25 Further modification of 
carboline 59 into the diastereomeric mixture of aminal 60 was followed by installation of the 
terminal olefin by use of BF3-mediated alkylation to give the adduct 61. DIBAL reduction of 
the ester moiety in 61 resulted in the formation of the intermediate aldehyde, which was 
subsequently exposed to Ohira–Bestmann reagent, in the presence of NaOCH3, to give enyne 
62. 26  
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Scheme 1.17: Synthesis of enyne 62. 
 
Enyne 62 was exposed to Pauson–Khand reaction conditions to afford in excellent yield the 
cyclopentenone 63 as a single diastereomer (Scheme 1.18).23 A stepwise approach was 
employed, in which cyclopentenol 63 was converted into the silyl-enol ether 64, followed by 
oxidative cleavage, resulting in an aldehyde / carboxylic acid intermediate. Upon treatment 
with sodium borohydride followed by acid-induced cyclization lactone 65 was formed. With 
the δ-lactone in hand the next step involved the formation of tetrahydropyran 66 by use of 
DIBAL.23  
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Scheme 1.18: Synthesis of 66. 
 
Attempted conversion of both the N-Boc and N-Cbz moieties in 66 to N-methyl groups, 
followed by Friedel–Crafts acylation offered a complex mixture of products, probably due to 
the use of forcing conditions, in which competing C5 acetylation of the indolic ring-system 
was observed (Scheme 1.19).27 Further optimization of the acylation reaction involved use of 
milder reaction conditions; trichloroacetylation in the absence of a Lewis acid, similarly did 
not yield the required product. Applying the same trichloroacetylation reaction conditions to 
66 showed ready acetylation towards 67. Subsequent reduction of the latter using Zn / HOAc 
furnished 68, this together with the removal of the protecting groups, followed by N-indole 
methyl installation gave (–)-alstonerine 36 via 69.         
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Scheme 1.19: Total synthesis of (–)-alstonerine 36 according to Martin. 
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1.3.  Cytisine 
 
 1.3.1.  Background  
 
(–)-Cytisine (Figure 1.3) is a member of the lupin alkaloid family, and can be found in the 
seeds of the Leguminosae genus of plants.28 After its isolation in 1862 it took another 70 years 
until the correct structure was elucidated by Ing in 1932.29 Chemically, (–)-cytisine is a 
quinolizidine alkaloid with a tricyclic skeleton, consisting of a bicyclic piperidine fused to a 
2-pyridone moiety. The two stereogenic centers were determined to be 7R,9S. 
 
N
H
N
O
70
 
 
     Figure 1.3: (–)-cytisine 70  
 
The first total synthesis of this molecule was achieved by van Tamelen in 1955, 30 closely 
followed by Bohlmann31 and Govindachari.32 Recently, after a 50 year gap, both academia 
and industry have renewed their mutual interest in cytisine and analogue synthesis due to its 
biological activity.33 Multi-gram isolation of (–)-cytisine is easily obtained by simple 
extraction of the seeds of Leguminosae anagyroides using an aqueous mixture of ammonia in 
methanol and DCM, which provides a cheap resource of (–)-cytisine. 
 
(–)-Cytisine has shown significant biological activity, specifically in the field of neuronal 
nicotine acetylcholine receptors. It has been shown to act as a partial agonist towards these 
receptors, resulting in the release of dopamine thus making it a useful starting point in the 
development of a smoking cessation drug. Despite its high affinity towards the nicotine 
binding receptors in vitro, in vivo tests showed poor efficacy due to its poor absorption and 
the inability to pass through the blood-brain barrier because of its protonated nitrogen atom at 
physiological pH.33   
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1.3.2.  Previous Total Syntheses of Cytisine  
 
Since the first successful total synthesis of (±)-cytisine by van Tamelen a total of 10 total 
syntheses have been reported; these are discussed in a recent review by O’Brien.33 A 
summary of the first synthesis of (±)-cytisine by van Tamelen,30 the O’Neill approach34 and 
the only reported total synthesis of (–)-cytisine by Lesma35 are highlighted due to their 
relevance to the project involved.  
 
1.3.2.1. Van Tamelen’s First Total Synthesis 
 
Van Tamelen published a seven-step route to (±)-cytisine in 1955 (Scheme 1.20). Formation 
of malonate 72 was achieved by substitution of acetate 71 with diethylmalonate, presumably 
via an allyl cation intermediate or a conjugate addition-elimination pathway.33 A Mannich 
reaction between the enolate of 72 and the Mannich base of benzylamine and formaldehyde 
was followed by decarboxylation of one of the acid groups as indicated by the evolution of 
CO2 which provided 73. Intramolecular conjugate addition onto the vinylpyridine 
functionality in 72 to form the piperidine ring in 73 was reported to require at least 4 h. 
Isolation of ester 73 showed a high amount of trans-73 instead of cis-73.30 Thus the need for 
epimerization which gave the thermodynamically more stable cis isomer (both substituents in 
equatorial position) was required. Reduction of cis-73 and cyclization using SN2 displacement 
with bromine under thermal conditions gave biazocycle [3.3.1] 74. Finally, low-yielding 
formation of pyridone 75, followed by debenzylation furnished (±)-cytisine 70. 
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Scheme 1.20: Total synthesis of (±)-cytisine 70 by van Tamelen. 
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1.3.2.2. O’Neill’s Approach 
 
Recent publications by O’Neill have reported a shortened, five-step total synthesis of (±)-
cytisine,34 applying palladium chemistry. The presence of methoxypyridine 77 removed the 
need for late-stage oxidation of the pyridine to pyridone and was one of the key differences 
compared to the earlier van Tamelen approach. Aryl–aryl bond formation between 76 and 80 
either via Suzuki or Stille cross-coupling reactions was investigated (Scheme 1.21). Although 
boranes 77 and 79 proved to be particularly efficient Suzuki-coupling partners (80%),36 
trapping of the latter proved difficult (20–30%). The in situ generation of the borate ester 
79,37 followed by coupling with bromopyridine 76 gave a higher overall yield (50%).  
N
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(CH3O)3B
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OCH3
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N
Br
OCH3
i) nBuLi, Et2O
ii) B(OCH3)3
76 77 78
76 79 78
20 - 30% 80%
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Scheme 1.21: Suzuki coupling reactions. 
 
Stille coupling by preparation of stannane 81,38 followed by cross-coupling with 76 gave a 
similar low overall yield (Scheme 1.22). Application of the one-pot synthesis of stannane, 
prepared in situ and subsequently coupled to bromopyridine 76, gave a similar yield 
compared to the Suzuki reaction mentioned earlier, without detection of the expected 
homodimers. Despite several optimization attempts, 78 could not be provided in a high yield. 
The one-pot strategy applied to both the Suzuki and Stille coupling reactions proved most 
successful.  
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Scheme 1.22: Stille coupling reactions. 
 
Reduction of ester moiety 78 was followed by chemoselective benzylation of the less 
hindered pyridine nitrogen to give pyridine salt 82 (Scheme 1.23). Selective reduction of the 
benzylpyridinium salt gave a mixture of cis / trans (85 : 15) regarding the 3,5-substituents. 
This selective reduction is believed to be linked to the oxidation level of the 3,5-substituents 
when compared to the inertness of the methoxypyridine. Cyclization of the biazacyclo [3.3.1] 
nonane ring was carried out by activation of the alcohol by mesylation and, subsequent 
chemoselective hydrogenolysis of the N-benzyl group to give (±)-cytisine 70. 
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Scheme 1.23: Total synthesis of  (±)-cytisine 70. 
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1.3.2.3. Lesma’s Approach 
 
The Lesma approach to (–)-cytisine featured a ruthenium-catalyzed RCM, relying on the 
readily available cis-piperidine-3,5-dimethanol monoacetate 84 as the chiral building block 
(Scheme 1.24). This building block could be obtained in both enantiomeric forms by use of 
enzymatic asymmetrization of the appropriate σ-symmetrical dimethyl piperidine-3,5-
dicarboxylate 83.39 Use of PFL (Pseudomonas fluorescence lipase) in combination with vinyl 
acetate gave 84 with >98 ee. 
 
N
Cbz
CO2MeMeO2C
N
Cbz
HO OAc
78%, 2 steps
a) Reduction
b) PFL
83 84
 
 
Scheme 1.24: Synthesis of cis-piperidine-3,5-dimethanol monoacetate 84 building block. 
 
Swern oxidation of 84 generated the corresponding aldehyde, which after allyl addition using 
Brown’s (–)-allyldiisopinocampheylborane reagent gave a 10 : 1 mixture of alcohol 80 
(Scheme 1.25). Although the stereogenic center at C6 does not have any significant value in 
the total synthesis of (–)-cytisine, as it will be incorporated into the pyridone structure later 
on, the ease of working with a single diastereomer was advantageous. Formation of the 
mesylate was followed by azide displacement, which on exposure to Staudinger reduction 
conditions gave acryloyl amide 87 upon treatment with acryloyl chloride. Despite the 
presence of a free NH amide group, ring-closure of the diolefinic substructure 87 was 
achieved in high yield. It was rationalized that the neighboring piperidine ring sterically 
blocked the NH group, thus preventing formation of chelate complexes with ruthenium. 
Deprotection of the acetate in 88 was followed by mesylation after which base-induced 
intramolecular alkylation gave the tricyclic skeleton of (–)-cytisine, 89. Dehydrogenation of 
dihydropyridone using DDQ provided the corresponding pyridine. Last, Cbz-deprotection 
furnished (–)-cytisine 70. 
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Scheme 1.25: Lesma’s total synthesis of (–)-cytisine 70.  
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1.4 The Pictet–Spengler Cyclization 
 
The Pictet–Spengler reaction has proven to be a very powerful tool in indole and isoquinoline 
alkaloid synthesis. It was conceived in 1911 by Ame Pictet and Theodor Spengler, who 
successfully condensed β-arylethylamines with carbonyl compounds in an acidic environment 
as was already known to occur in plants.40   
 
Increased interest in the synthesis of tetrahydro-β-carbolines, due to their biological 
activity,41,42 provided the basis of further research into applying the Pictet–Spengler reaction 
towards the preparation of these substrates, this being a common motive in indole alkaloids. 
Tatsui43 was the first to report the successful application of this method to give tetrahydro-β-
carbolines using indole bases instead of phenylethylamine (Scheme 1.26). These carbolines 
91 were prepared by condensation of tryptamine derivatives 90 and aldehydes. In addition to 
aldehydes, other carbonyl containing compounds were tested, such as α-keto acids, that 
undergo facile decarboxylation, and β-keto-aldehydes both of which would yield carbolines.44  
 
N
NH
R
N
NH2 RCHO
- H2O
+
90 91
 
 
Scheme 1.26: Tetrahydro-β-carboline formation through Pictet–Spengler reaction. 
 
Two mechanisms for the Pictet–Spengler cyclization reaction have been proposed and 
thoroughly investigated by Jackson and co-workers45 (Scheme 1.27). However, regardless of 
which path is followed, it is the electrophilic nature of the imine double bond which is the 
driving force in this cyclization.  
The first proposed mechanism involves formation of the spiroindolenine, as proposed by 
Woodward46 in 1948, via electrophilic attack of the 3-position of the indole by the Schiff base 
(Route A). Subsequent 1,2-alkyl shift followed by deprotonation would give the carboline. 
The other mechanism would involve a much simpler route namely via direct attack at the 2-
position of the indole, which would give rise to the cationic intermediate (Route B).47  
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Scheme 1.27: Two proposed mechanisms for the Pictet–Spengler reaction. Route A (via C3) & route B (via C2). 
 
Jackson45 illustrated the differences between both of the proposed mechanisms in an energy 
diagram (Figure 1.4 and Scheme 1.28). They reasoned that disruption of the pi-electron system 
of the benzene ring (I → IV) would require more energy when compared to the indolenine (I 
→ II), both of which would provide the same intermediate. Therefore, attack at the C3-
position would be favored over the C2-position. The following step, which involves 
deprotonation to reform the indole ring (V), would not be affected by either pathway.  
 
 
Figure 1.4: Energy diagram, route A and B.45  
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Scheme 1.28: Illustrated compounds belonging to Figure 1.4. 
 
An interesting experiment in order to further investigate the viability of the proposed 
mechanisms involved labeling of indolyl-3-butanol 97 with tritium on the methylene group 
adjacent to the indole ring (Scheme 1.29). Treatment of the latter with BF3 triggered 
cyclization (with all tritium labels in place) after which oxidation revealed loss of half of the 
labels which could only have occurred via spiroindolenine formation.44  
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Scheme 1.29: Tritium (*) labeled experiment. 
 
Another example44 of strong evidence towards the former was obtained when an experiment 
to reduce the molecule’s carboxylic acid functionality 100 to alcohol 101 instead resulted in 
spiroindolenine 104 formation (Scheme 1.30), probably through intermediates 102 and 103. 
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Scheme 1.30: Unexpected spiroindolinene formation. 
 
Casnati47 has shown that changes in reaction conditions and / or substituents might induce 
attack at the C2-position in competition with the indolenine mechanism (Scheme 1.31).  
N
R1
HO
R2
E
N
R1
O
R2
E
106105
 
Scheme 1.31: C2 favoring conditions. 
 
It seems reasonable that formation of the indolenine is kinetically controlled while the 
rearranged 2,3-disubstituted indole requires more energy to rearrange to a tetrahydro-β-
carboline thus being thermodynamically controlled. While the spiroindolinene mechanism has 
been widely accepted, the direct C2 coupling cannot be ruled out and both mechanisms result 
in general poor cis / trans selectivity.9  
 
Pitchard9 reported the cis-specific Pictet–Spengler reaction of benzaldehyde and an allyl ester 
of tryptophan (Scheme 1.32). Complete cis selectivity was observed when allyl esters 107 
were used, using propyl esters 109 usually yielded 4 : 1 cis / trans mixtures as previously 
reported by this group. In addition to this finding, only aryl aldehydes were able to condense 
in a cis-specific way. This was explained by the possibility of pi-stacking between the allyl / 
aryl groups, which would allow cyclization to proceed through a diaxial intermediate.  
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Scheme 1.32: Cis-specific Pictet–Spengler when using allyl esters. 
 
The trans-specific Pictet–Spengler reaction was reported in detail by Cook et al.10 They first 
looked at the possibility of both stereoisomers and concluded that one would clearly be 
favored (E isomer 111) over the other (Z isomer 112), due to steric interference between the 
1,3-substituents during the transition state (Scheme 1.33). Initial attack of the indole double 
bond whether via the C2 or C3-position would be under stereoelectronic control, similar to 
attack of a hydroxide ion on imidate salt (periplanar) reported by Delongchamps.48  
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Scheme 1.33: Steric interference in the Z isomer 111 when compared to the E isomer 112. 
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When considering the spiroindolenine (C3) mechanism, the indole double bond could either 
attack at the bottom 113 or top face 114 of the imine. Bond formation via the top face 
addition would result in cis configuration with substituents C1, C2  and C3 very close to each 
other (eclipsed) when compared to trans. In the case of structure 113 attack has taken place 
opposite to the ester function, which has also minimized interactions of these groups. The 
stereospecificity becomes more obvious when illustrated in Scheme 1.34.10  
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Scheme 1.34: Bottom (left, less crowded) and top face (right, crowded) after nucleophilic attack from the C3 
indole, 113 being less crowded due to the eclipsed conformation of the substituents in 114. 
 
Even though the spiroindolenine is the most accepted mechanism, as stated before, one cannot 
rule out direct attack at C2 (Scheme 1.34). When considering this mechanism, attack from the 
bottom face of C=N+ gives the benzyl group in an equatorial position while the phenyl at C1 
occupies an axial position. The product of this attack yields a molecule with two equatorial 
and one C1-axial position. In a similar sense attack at the top face would give a more crowded 
cis-molecule, giving rise to a less favorable equatorial 1-substituent along with the NH of the 
indole, and an axial 2-benzyl position during the transition state. In both mechanisms the 
trans-molecule is favored, which can be confirmed by NMR analysis.49  
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Scheme 1.35: Nucleophilic attack from the C2-position of the indole from the top or bottom face. 
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1.5.  Recent Progress in Pictet–Spengler Mediated Total Syntheses of  
  Isoquinoline Alkaloids. 
 
The tetrahydroisoquinoline (THIQ) ring system forms the core of a vast array of biologically 
active natural and unnatural products (Figure 1.5). These alkaloids have sparked the interest 
of both academic as well as industrial communities due to their exhibited medicinal 
bioactivities, physiological and pharmaceutical effects.50 Recent methods applied towards the 
synthesis of these isoquinolines involve stereochemical modifications of sequential Bischler–
Napieralski cyclization / reduction, the Pictet–Spengler and various Pomeranz–Fritsch 
cyclizations. In addition, the introduction of electrophilic / nucleophilic carbon units at the C1 
position via the C1–Cα connectivity approach provides an alternative in regard to the more 
classical approaches that have been reported.51 The overwhelming amount of reviews 
published in regard to Pictet–Spengler52 / oxa-Pictet–Spengler cyclizations,53 total syntheses 
of indole alkaloids54 and recent progress towards β-carbolines55 revealed the absence of an 
updated review regarding the progress in Pictet–Spengler mediated total syntheses of THIQ 
alkaloids. As such this review provides an updated overview from 2004 onwards51 and has 
been organized into the alkaloid families of the THIQ natural products involved. In addition, 
besides highlighting the application of the Pictet–Spengler cyclization in the synthesis of the 
core scaffolds, key conversions in the total syntheses of these natural products will be 
examined as well. 
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Figure 1.5: General THIQ structure. 
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1.5.1.  Small THIQ-derived Natural-occuring Alkaloids  
 
The THIQ structure is a common core structure in biologically active natural compounds 
(Figure 1.6). In addition to the complicated natural compounds, smaller congeners are known 
and relatively common. Jung,56 Cuny58 and Ruchirawat61 have recently reported the total 
synthesis of a couple of these structurally simple THIQ natural products in order to show the 
general applicability of their methodologies. 
 
N
R
R
R R
R
A B
R
 
Figure 1.6: Characteristic THIQ core structure. 
 
1.5.1.1.  (±)-Calycotomine  
 
Jung56 reported a total synthesis of (±)-calycotomine 121 in 2007 that utilized their N,O-acetal 
TMS ether methodology57 as an excellent means of generating acyliminium ions which are 
susceptible to various electrophilic reactions. The chief aim of their study was gaining rapid 
access to 1-substituted THIQs using the N,O-acetal TMS ether approach. This method proved 
to be superior to most other N-acyliminium ion precursors in terms of preparation, functional 
group compatibility and facile conversion.56  
 
Condensation of phenylethyl amine 117 with (benzyloxy)acetic acid gave amide 118 (Scheme 
1.36). Amide protection followed by reductive silylation gave the N,O-acetal TMS ether57 
119. Various reaction conditions were investigated to facilitate the intramolecular amido-
alkylation of 119 via Pictet–Spengler cyclization, of which BF3 proved to be the most 
effective, giving 120 in an 80% yield. Full deprotection of THIQ 120 furnished calycotomine 
121. Due to the lack of a set stereocenter in the THIQ, the Pictet–Spengler gives a 
diastereomeric C1 mixture of (±)-calycotomine 121 after removal of both N- and O-protecting 
groups. Despite this drawback a fast and versatile route to small THIQ libraries had been 
achieved.  
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Scheme 1.36: Jung’s total synthesis of (±)-calycotomine 121. 
 
1.5.1.2.  (±)-Aporphine 
 
Cuny58 reported the synthesis of (±)-aporphine 127 utilizing a Pictet–Spengler cyclization, 
followed by an ortho-arylation and an unusual dehydroxylation step (Scheme 1.37). Initially 
application of the Bischler–Napieralski cyclization was proposed yet the absence of an alkoxy 
moiety para to the site of cyclization caused this reaction to fail.58 Barn59 had reported the 
possibility of a Pictet–Spengler cyclization despite the absence of an electron-donating moiety 
in the aryl-ring. Therefore, synthesis starting with 4-methoxyphenylethylamine 122 would 
utilize a tosylamide. 122 was readily converted into 123, which upon treatment with TFA and 
an aldehyde prepared Pictet-Spengler adduct 124 via iminium formation. Intramolecular 
ortho-arylation was attempted using previously developed palladium-catalyzed coupling 
conditions to give 125 in a moderate yield of 56%.60 Next, phenol activation by triflic 
anhydride was followed by palladium-induced dehydroxylation, providing intermediate 126.58 
Subsequent N-detosylation by sodium naphthalide followed by reductive amination provided 
(±)-aporphine 127 in seven steps. While successfully applying transition-metal mediated 
intramolecular ortho-arylation to aporphine class alkaloids, the moderate yields obtained 
severely limits the general applicability of this strategy. 
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Scheme 1.37: Cuny’s total synthesis of (±)-aporphine 127. 
 
1.5.1.3. General Strategy Towards THIQ Synthesis  
 
A simple but effective use of the Pictet–Spengler reaction was reported by Ruchirawat,61 in 
which they developed a general procedure to synthesize a common intermediate 129. From 
129; (+)-xylopinine 130, (+)-laudanosine 131, (+)-8-oxo-O-methylbharatamine 132 and (+)-
isoindoloisoquinoline 133 were prepared. Treatment of 2-(3,4-dimethoxyphenyl)ethylamine 
117 with the corresponding acid chloride provided the mono-amide using a biphasic system 
(Scheme 1.38). Subsequently, N-acylcarbamates 128 were obtained by nBuLi deprotonation 
followed by treatment with ethyl chloroformate. Diamides 128 were next reduced using 
DIBAL and Lewis acid-induced Pictet–Spengler cyclization using BF3 gave THIQs 129 in 
good to excellent yields. However, when a non-activated aryl system was employed Pictet–
Spengler cyclization did not take place, showing the limitation of this method in regard to 
THIQ formation.61 Further manipulations of intermediates 129 were required to provide all 
four natural products 130 / 133.  
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Scheme 1.38: Ruchirawat’s total syntheses via common intermediate 129. 
 
1.5.1.4. Summary 
 
When comparing all three methodologies described above, several limitations became 
apparent in terms of stereoselectivity (due to the lack of a set stereocenter), general reactivity 
and overall yield. Jungs’s N,O-acetal TMS ether method, aside from the lack of 
stereoselectivity, provided a useful tool towards fast and high yielding synthesis of THIQ 
libraries. Cuny’s intramolecular ortho-arylation for THIQ scaffold synthesis gave only 
moderate yields. Ruchirawat’s syntheses subsequently failed to facilitate similar Pictet–
Spengler cyclizations when using non-activated aryl systems, therefore severely limiting the 
general application of this strategy.    
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1.5.2.  Asclepiadaceae Alkaloids 
 
A structurally more interesting class of THIQs are the phenanthroindolizidine alkaloids 
(Figure 1.7). Part of the Asclepiadaceae family, these pentacyclic THIQs can be easily 
distinguished from other THIQ alkaloids by the phenanthrene core (C, A, D-rings). Synthesis 
of the C-A-D-core was first described by Pschorr62 in 1896 via an arenediazonium salt, but a 
low yield and long linear sequence severely restricted this approach. Wang64 and Fürstner65 
recently published alternatives to overcome these problems.  
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Figure 1.7: Phenanthroindolizidine-core of asclepiadaceae alkaloids. 
 
1.5.2.1. Iron (III)-mediated Phenanthrene Synthesis 
 
Various modifications of the Pschorr method have been reported but never broadly applied 
due to toxicity issues and low yields.64 Iron (III) chloride, on the other hand, has been widely 
used in organic chemistry due to its inexpensive nature, environmentally benign and strong 
oxidizing character. Aryl–aryl coupling reactions using iron (III) have been reported, but have 
found limited application due to unwanted side-reactions.63   
 
The total syntheses of tylophorine, deoxytylophorinine and antofine have been reported by 
Wang.64 The Perkin condensation of benzeneacetic acid 134 and corresponding aromatic 
aldehydes 135 gave products 136 in good yields (Scheme 1.39).64 A preference for the E-
isomer was observed. Both E- and Z-isomers of 136 could be obtained separately by 
precipitation at different pH. The para-para coupling reaction was performed by treatment 
with iron (III), which gave the phenanthrene core 137. Interestingly, in contrast to the Pschorr 
reaction, both the E- and Z-isomers were fully consumed to give corresponding 137. 
Intermolecular tin tetrachloride-catalyzed Friedel–Crafts acylation of electron-rich pyrrole 
and the acid chloride corresponding to 137, furnished 138. Carbonyl reduction and pyrrole 
hydrogenation provided 139, which upon acid-catalyzed Pictet–Spengler cyclization gave 
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THIQ 140. Tylophorine, deoxytylophorinine and antofine were thus synthesized in 48%, 44% 
and 46% overall yield over six steps, utilizing mild and simple reaction conditions.    
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Scheme 1.39: Wang’s total syntheses of tylophorine, deoxytolyphorine and antofine. 
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1.5.2.2. Phenanthrene Synthesis by Cycloisomerization  
 
A different approach was reported by Fürstner65 in the synthesis of phenanthrene-related 
alkaloids. Biaryl derivatives bearing an ortho-alkyne-substituent were observed to undergo 
cycloisomerization when exposed to various carbophilic Lewis acids.66 Synthesis of biaryl 
143 could easily be achieved via cross-coupling techniques, which are tolerant to various 
functional groups.  
 
The total synthesis of cryptopleurin 147 would be the prototype required for the total 
syntheses of the three other phenanthrene-containing alkaloids. Bromination of arene 141 
gave the dihalide as the Suzuki electrophile (Scheme 1.40). Subsequently, a Suzuki cross-
coupling reaction of 141 with the boronic acid of 142 furnished 143.  
I
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OCH3
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H3CO
H3CO
I
57%, 2 steps
141 143
+
142
 
Scheme 1.40: Synthesis of phenanthrene precursor 143. 
 
Suzuki reaction conditions were once again employed, this time by reacting 9-CH3O-9-BBN67 
with the alkynylmetal species of alkyne 144 (Scheme 1.41). The coupling strategy involved 
showed the ready transfer of alkynyl from the borate-complex to aryl halides or triflates under 
palladium catalysis.67 With the aryl–alkyne adduct set for cycloisomerization, exposure to 
PtCl2 gave the phenanthrene scaffold 146.66 Key to the success of this reaction proved to be 
the correct dilution due to competing oligomerization reactions of the substrate. Finally, one-
pot deprotection and Pictet–Spengler cyclization provided cryptopleurin 147 in six steps.  
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Scheme 1.41: Total synthesis of cryptopleurin 147. 
 
A similar reaction sequence was applied in the syntheses of (–)-antofine 149, (–)-tylophorine 
151 and (–)-ficuseptine C 153 (Scheme 1.42). In contrast to cryptopleurin 147, all three latter 
compounds were constructed using a proline-derived alkyne 148; all gave comparable overall 
yields.  
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Scheme 1.42: Total synthesis of (–)-antofine 149, (–)-tylophorine 151 and (–)-ficuseptine 153. 
 
1.5.2.3. Summary 
 
Wang’s strategy provided the phenanthrene ring-system in an overall higher yield but did not 
proceed with any stereoselectivity when compared to Fürstner’s protocol. Both strategies 
approached the phenanthrene ring synthesis using transition metal catalysis, either by using 
iron (III)-mediated cyclization in which both E- and Z-isomers are consumed, or by platinum-
induced cycloisomerization.  
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1.5.3.  Amarylidaceae Alkaloids 
 
Originally isolated from the Amaryllidaceae plant family, multiple synthetic studies have 
been reported since the first total synthesis by Brossi68 in 1970, although this early work 
involved multiple steps and gave generally low yields. The amarylidaceae alkaloids are 
structurally more complex than the THIQ-scaffolds discussed earlier, possessing a common α-
C2 bridge embedded in an azabicyclo [4.3.0] nonane skeleton (Figure 1.8). Cho,71 Chida,78 
Sha79 and Banwell82 have all recently reported total syntheses of amarylidaceae natural 
products.      
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Figure 1.8: Amarylidaceae alkaloid structure. 
 
1.5.3.1. (±)-Crinine and (±)-Crinamine by Diels–Alder  
 
Crinine alkaloids are closely related to lycorane- and galanthamine-type alkaloids due to a 
common precursor, norbelladine.69 As part of their continuing interest in applying 3,5-
dibromo-2-pyrone 15470 and its derivatives as novel enophile synthons, Cho et al. reported 
the total synthesis of (±)-crinine and (±)-crinamine.71 Previous efforts to incorporate the 
pyrone methodology had already culminated in the total synthesis of (±)–trans-
dihydroarciclasine and (±)-joubertinamine,72 though not including the Pictet–Spengler 
cyclization. 
 
3,5-Dibromo-2-pyrone 154 was obtained from a Hunsdiecker reaction of 2-pyrone-carboxylic 
acid73 (Scheme 1.43). Diene 154 proved to be more reactive than its mono-brominated 
counterpart in both normal- and inverse-electron-demand Diels–Alder reaction conditions 
applied to a series of electronically and sterically distinct dienophiles.70 C3 selective Stille 
coupling of pyrone 154 with aryltin substrate 155 gave 156. Diels–Alder cycloaddition with 
TBS-protected vinyl ether produced the bicyclolactone 157 and 158 with moderate endo-
selectivity due to the bulky C3 substituent. Earlier studies had shown a high endo-preference 
when using 156 and other dienophiles as the steric bulk destabilizes the endo-transition 
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state.70 Resolution gave the endo-compound 157, which was further manipulated for the 
synthesis of 159 over 10 steps.  
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Scheme 1.43: Synthesis towards Pictet–Spengler precursor 159. 
 
The Pictet–Spengler cyclization was achieved upon heating 159 with paraformaldehyde in the 
presence of HCl as reported by Pearson (Scheme 1.44).74 Molecular modeling had shown the 
Z-conformation of the diene to exert a strong influence on the reactivity of the cyclization 
precursors. Steric interactions between the alkoxy group and the aromatic moiety become 
evident in 160. However, 161 does not exhibit such a clash being therefore preferred and 
resulting in 162 formation. Epimerization of the latter provides 163. The analysis assumed a 
concerted [pi4s + pi2s] cycloaddition to take place thus providing a cis-conformation, Pearson 
had already observed similar results in earlier cycloadditions.74    
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Scheme 1.44: 2-Aza-allyl anion cycloaddition according to Pearson. 
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Reductive removal of the vinylogous bromide (164) was followed by a one-pot process as 
described by Pearson74 to give (±)-crinine 165 (Scheme 1.45).  
Bu3SnH, AIBN
O
O N
Br
OH
O
O N
OH
i) Ms2O
ii) CsOAc
iii) K2CO3
O
O N
OH
163 164 165
73% 72% 70%
 
Scheme 1.45: Total synthesis of (±)-crinine 165. 
 
The same Diels–Alder strategy was also applied to the total synthesis of (±)-crinamine 172 
and structurally related (±)-6a-epi-crinamine 171. The stereoselective α-C2 hydroxide moiety 
present in both compounds, in contrast to (±)-crinine 165, would require a slightly different 
approach.  
 
Formation of epoxides 167 and 168 was achieved by treating aldehyde 166 (obtained from 
endo-157) with diiodomethane and methyllithium to give a 6 : 1 mixture of two diastereomers 
167 and 168 (Scheme 1.46).75 Earlier attempts using Wittig olefination of aldehyde 166 
followed by osmium-mediated dihydroxylation had been non-selective, probably due to the 
sterically-congested environment. Resolution of both diastereomers via column 
chromatography was possible after ring-opening of the epoxides 167 and 168 with sodium 
azide. 169 Was obtained from 167 after six steps and exposed to Pictet–Spengler reaction 
conditions. THIQ 170 was treated with paraformaldehyde in the presence of HCl. Finally, 
debromination of 170 resulted in formation of (±)-6a-epi-crinamine 171. Unfortunately, the 
conversion of 171 into (±)-crinamine 172 proved to be low yielding even after optimization 
attempts. 
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Scheme 1.46: Synthesis of 6a-epi-crinamine 171. 
 
In light of these problems, (±)-crinamine was prepared using epoxide mixture 167 and 168 
followed by azide-mediated ring-opening to provide the corresponding azido-alcohol 173. 
Exposure to Dess–Martin / NaBH4 prior to the formation of the THIQ resulted in isolation of 
the correct isomer 175. The same reaction procedure ultimately gave (±)-crinamine 172 
(Scheme 1.47). The reaction sequence as described by Cho revealed an interesting, albeit 
moderately successful Diels–Alder cycloaddition in combination with a very efficient Pictet–
Spengler cyclization providing both crinine and crinamine in moderate overall yields.71 
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Scheme 1.47: Total synthesis (±)-crinamine 172. 
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1.5.3.2. (+)-Vittatine and (+)-Haemanthamine by Claisen Rearrangement 
 
Compared to their relatives, both crinine-type family members vittatine and haemanthamine 
have received only limited attention. Harboring the same ethanophenanthridine core skeleton 
as observed in all family members, Chida reported in 2007 the first enantioselective total 
synthesis of both (+)-vittatine and (+)-haemanthamine, starting from D-glucose.76 Their 
approach included a stereoselective Claisen rearrangement, intramolecular aminomercuration-
demercuration and Chugaev reaction as key-features. 
 
Both natural compounds were constructed using a common intermediate 178. Commercially 
available methyl 4,6-O-benzylidene-α-D-glucopyranoside 176 was converted into chiral 
cyclohexenol 177 in 11 steps (Scheme 1.48). The conventional Johnson–Claisen 
rearrangement gave the rearranged product 178. In order to improve the irreproducible result 
during this rearrangement 2-nitrophenol was added as an acid catalyst as described by 
Fukazawa.77 Interestingly, application of 2,4-dinitrophenol instead of 2-nitrophenol resulted 
in substrate decomposition.  
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Scheme 1.48: Johnson–Claisen rearrangement of 177 into 178.   
 
The N-Boc protection was found to be necessary for the mercury-induced intramolecular 
perhydroindole skeleton formation (180), since use of the free amine did not result in 
cyclization. Chugaev reaction provided the xanthate ester from perhydroindole 180 which was 
removed under base conditions to provide hexene 181 (Scheme 1.49). Similar sulfone-
induced eliminations proved to be unsuccessful and decomposition of the starting material 
was observed.76 Finally, BF3-induced deprotection was followed by Pictet–Spengler 
cyclization using acidified formalin, providing (+)-vittatine 182.   
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Scheme 1.49: Total synthesis of  (+)-vittatine 182.  
 
In the same article,76 the total synthesis of (+)-haemanthamine was reported using common 
intermediate 178. The key difference between the target alkaloid and (+)-vittatine is the 
introduction of a hydroxy moiety at the C2’ position (Scheme 1.50). The Davis reagent was 
effective in this transformation and gave the corresponding hydroxy moiety 185. A study 
revealed the need for LiHMDS at 0 oC in order to form the ester enolate in combination with 
the Davis reagent.78 Regardless of the oxidant used, a diastereomeric mixture was obtained in 
all cases. Preferential formation of 185 was thought to be induced by steric factors. In the 
transition structures illustrated (Scheme 1.50), three out of four substituents are in an 
equatorial position therefore electrophilic attack would occur at the upper face of the enolate 
as the back face is hindered by the presence of the benzyloxy moiety. In 184 a non-bonding 
interaction between an axial C6 hydrogen and enolate oxygen C1’ would be unfavourable, thus 
resulting in 183 (185) being the major product.  
  Introduction 
 
   62 
TBSO
BnO
CO 2Et
O
O i) LiHMDS
ii) (+)-Davis reagent
TBSO
BnO
O
O
CO2Et
OH
38% 4%
+
TBSO
BnO
O
O
CO2Et
OH
185 186
178
H
O
Ar
TBSO
H CH2Ph
H
OEt
OLi2' 1'
"O"
H
O
Ar
TBSO
H
H
CH2Ph
2'
1'
1'1'
2' 2'
OLi
EtO
"O"
183 184
 
Scheme 1.50: Transition state structures for 185 and 186. 
 
After converting ester 185 into Boc-protected amine 187, mercuration was applied to provide 
perhydroindole 188 (Scheme 1.51). Selective TES protection of the less sterically hindered 
hydroxy was followed by xanthate formation and Chugaev elimination to give xanthate ester 
189. As due to the removal of the Boc-group during the Chugaev reaction, the amine of 189 
had to be Boc-protected in order to solve purification issues. Finally, treatment with 
paraformaldehyde in an acidic environment effected quantitative Pictet–Spengler cyclization 
to give (+)-haemanthamine 191.  
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Scheme 1.51: Total synthesis of (+)-haemanthamine 191.  
 
Application of the Claisen rearrangement successfully provided rearranged product 178 in a 
moderately high yield when exposed to 2-nitrophenol. This in combination with mercury-
induced cyclization and a Chugaev elimination step provided both (+)-vittatine and (+)-
haemanthamine.  
 
1.5.3.3. (–)-Manthine 
 
(–)-Manthine 201 contains a core skeleton similar to that in the natural products described 
earlier with the key difference being the inversion of the C3 configuration.79 The total 
synthesis was initiated by converting (–)-quinic acid 192 into enone 193 by applying a 
protocol according to Elliott80 (Scheme 1.52). 194 Was subsequently obtained in eight steps 
from enone 193. 194 Underwent protecting group exchange give ketal intermediate 195. 
Selective protection of the axial hydroxy-moiety would allow manipulation of the 
stereocenter at the C3 C–O bond. Complexation of DIBAL gave 198 due to steric hindrance at 
the axial hydro-moiety, thus preferably coordinating to the equatorial oxygen.81 199 
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Underwent Pictet–Spengler cyclization resulting in formation of the core structure 200. 
Further manipulation of this structure by treatment with BF3 followed by methylation finally 
provided (–)-mantine 201. 
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Scheme 1.52: Total synthesis of (–)-mantine 201. 
 
Although the subtlety in converting the C3 position in mantine from a cis to a trans 
relationship by use of DIBAL is noteworthy, the low Pictet–Spengler cyclization yields 
severely limits the reaction sequence.   
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1.5.3.4.  (+)-Nangustine 
 
(+)-Nangustine was completed by Banwell82 in order to exploit the enantiomerically pure cis-
1,2-dihydrocatechol derivative 202. Synthesis of this compound involved whole cell-mediated 
transformation starting from chlorobenzene, using genetically engineered organisms that 
over-express toluene dioxygenase.83  
 
Having successfully obtained 203 after 8 steps from catechol acetal 202, Schotten–Baumann 
conditions were applied to couple 203 with 204 (Scheme 1.53). Tin-mediated radical addition 
/ elimination reaction resulted in the formation of the tetrahydro-oxindole 206. A study on the 
mechanism in this cyclization is ongoing.82 Reduction of the oxindole to the corresponding 
amine was followed by triphosgene cleavage of N-PMB. 207 Underwent acid-hydrolysis and 
was immediately exposed to conventional acid catalyzed Pictet–Spengler reaction conditions 
which gave (+)-nangustine 208. 
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Scheme 1.53: Total synthesis of (+)-nangustine 208. 
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1.5.3.5. Summary  
 
Cho’s total synthesis of crinine and crinamine provides an excellent example of using the 
Pictet–Spengler cyclization to obtain the corresponding THIQ in a highly stereoselective 
manner and high yield. Their sequence, applying a Diels–Alder approach provides an 
interesting reaction sequence although hampered by the moderate selectivity and yield.    
 
Chida’s approach towards vittatine and haemanthamine by Claisen rearrangement, 
mercuration and classic Pictet–Spengler conditions yielded both natural products in very high 
yields. The only drawback to this sequence was the inherent toxicity of mercury.  
 
Sha’s DIBAL-mediated conversion of the C3 conformation of molecule 194, from cis to trans 
using steric factors within manthine, provided an interesting example of simple yet effective 
conformational changes.  
 
The synthesis of nangustine by Bandwell involved the use of catechol acetal 202 which was 
derived from chlorobenzene and converted into 202 by use of genetically engineered micro-
organisms. Subsequent straight forward synthesis provided the natural compound in a good 
overall yield. 
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1.5.4.  Schulzeine A, B and C 
 
Schulzeine A, B and C belong to the schulzei class of THIQ alkaloids. These marine alkaloids 
were isolated from the sponge Penares schulzei by Fusetani;84 they exhibit intriguing 
bioactivity and contain a unique chemical structure (Figure 1.9). This has led two research 
groups to explore the total synthesis of these natural compounds.  
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Figure 1.9: Schulzeine-class of alkaloids.  
 
1.5.4.1. Corey–Link in Schulzeine B, C 
 
Romo85 reported the total synthesis of schulzeines B and C due to his interest into utilization 
of optically active trichloromethyl-β-lactone 209, which was previously reported86 to serve as 
a useful masked α-azido acid via the Corey–Link process.87  
 
Commercially available β-lactone 209 was converted into enol ether 210 in four steps which 
gave a 3 : 2 mixture of E / Z-isomers of 210 (Scheme 1.54). A 1 : 1 mixture of diastereomers 
was obtained by treating 210 and 211 with glacial acetic acid facilitating in situ hydrolysis of 
the vinyl ether and simultaneously triggering Pictet–Spengler cyclization to give 212 and 213. 
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Scheme 1.54: Synthesis of masked THIQ 212 and 213. 
 
Initial attempts to utilize the Corey–Link process to obtain δ-lactam 216 were unsuccessful.85 
Although Corey–Link processes have rarely been described for amino-containing substrates, 
the expected formation of dichlorooxirane intermediate 214 has been reported (Scheme 
1.55).88 Oxirane 214 cleavage by azide would have yielded azide intermediate 215 which 
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would cyclize to δ-lactam 216. When DBU was used as base, premature epoxide ring-opening 
/ cyclization of 214 gave 217.  
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Scheme 1.55: One-pot tricyclic core synthesis attempt. 
 
In order to avoid the unwanted cyclization the THIQ amine 212 was Boc-protected and 
subjected to Corey–Link conditions, which upon Boc-deprotection and DPPA-induced δ-
lactam formation provided 219. Staudinger azide reduction furnished amine 220 (Scheme 
1.56).  
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Scheme 1.56: Core structure synthesis and total synthesis of schulzeine B using 220 (ii). 
 
A modified strategy in order to simplify the final catechol deprotection utilized a benzyl 
protected catechol 212 (ii, R = Bn, Scheme 1.56), which underwent a similar reaction 
sequence to give a benzyl protected catechol 220 (ii). Lowering of the reaction concentration 
solved initial solubility issues due to the increased hydrophobic nature of the substrate during 
Corey–Link transformation and 220 (ii) (CH3O = BnO) was obtained in a high yield.85 
Subsequent peptide coupling of the corresponding fragments gave 221 which, after protecting 
group conversion provided schulzeine B 222. Similarly, schulzeine C was prepared following 
the same reaction sequence starting from the other diastereomer 213 in order to obtain the 
correct stereochemistry. This reaction sequence utilized an α-amino acid aldehyde synthon 
derived from β-lactone 209 and a Corey–Link process in order to obtain both natural products 
thus showing the applicability of α-amino acid aldehyde synthons to natural product 
synthesis.85  
 
1.5.4.2. Pictet–Spengler Issues Towards Schulzeine A, B, C 
 
Wardrop89 recently reported the synthesis of schulzeines A, B and C using L-glutamic acid γ-
methyl ester 224 (Scheme 1.57). 224 Was first coupled with 223 via the mixed anhydride 
followed by chemoselective reduction of the methyl ester to the corresponding alcohol 225. 
The Pictet–Spengler condensation could not be performed due to Boc-group interference; 
therefore, conversion of the carbamate into the more robust phthalamide was required.90 
Swern oxidation provided 226, followed by treatment with acetic acid, gave lactams 227 and 
228 were isolated. Exposure of 226 to BF3, TFA or acetic acid facilitated the Pictet–Spengler 
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cyclization in varying degrees of cis / trans selectivity. Lee91 and others92 had already 
demonstrated the γ- and β-substituents of hydroxy lactams to be able to affect 
stereoselectivity at the C1 ring conjunction. While both cis and trans products could not be 
separated, subsequent hydrazinolysis of the phthalimide group followed by carbamate 
formation made separation of both cis and trans products 229 and 230 possible, and thus 
provided the core substrates for the formation of schulzeine A, C and B respectively.  
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Scheme 1.57: Synthesis of THIQ core. 
 
Having prepared the core THIQ structures 231 and 232, the synthesis of the aliphatic chain 
234 starting with hydroxy ester 23393 was achieved in eight steps. A peptide coupling reagent 
afforded amide 236 from 234 and 235. A 4 : 1 mixture of 236 was obtained from the 
Sharpless dihydroxylation in the presence of (DHQ)2PHAL ligand. Finally, installation of the 
sulfates using SO3-pyridine complex and deprotection,94 provided schulzeine A, B or C 
depending on the R1 and R2 substituents 237 (Scheme 1.58). Schulzeine A: C11 = 237, R1 = 
CH3, R2 = H. Schulzeine B: C11 = 237 diastereomer, R1 = R2 = H. Schulzeine C: C11 = 237,  
R1 = H, R2 = H.  
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Scheme 1.58: Total syntheses of schulzeine A, B and C 237. 
 
1.5.4.3. Summary 
 
Romo’s approach towards schulzeine B and C using a Corey–Link process together with 
Noyori hydrogenation and Sharpless dihydroxylation shows the applicability of α-amino acid 
aldehyde synthons starting from β-lactone 209. Similar to Wardrop’s synthesis of schulzeine 
A, B and C, the Pictet–Spengler reaction proved complicated, unable to significantly 
distinguish between cis- and trans-conformations. This is probably due to the α- and β-
substituents at the hydroxy lactam affecting C1 stereocontrol.   
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1.5.5.  Quinocarcin Family 
 
Quinocarcin was originally isolated from a Streptomyces melunovinuceus culture broth by 
Takahashi and Tomita in 1983.95 Recently Zhu reported a 22-step total synthesis of 
enantiomerically pure (–)-quinocarcin in 16% overall yield.96 Quinocarcin family members 
incorporate a pentacyclic structure containing a bridge bicycle D / E as depicted in Figure 
1.10. 
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Figure 1.10: Quinocarcin alkaloids 
 
1.5.5.1. Mannich Reaction in (–)-Quinocarcin 
 
Pictet–Spengler precursor 239 was obtained in seven steps by, among other conversions, 
applying an enantioselective alkylation using Corey’s procedure in the presence of Corey–
Lygo’s phase transfer catalyst97 starting from 238 (Scheme 1.59). Application of 239 to 
Pictet–Spengler cyclization provided THIQ 240, and it was observed that slow addition of the 
aminoester to the acidic solution containing molecular sieves was pivotal to ensure a good 
yield.96 Reduction of ester 241 and Swern oxidation furnished tricyclic hemiaminal 242.  
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Scheme 1.59: Synthesis of tricyclic 242. 
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In order to provide 245, attempts to convert the hemiaminal 242 into either an amino ether or 
aminonitrile using methanol or TMSCN in the presence of various Lewis and Brønsted acids 
either gave no product or resulted in decomposition. Oxophilic hafnium98 in combination with 
ethanethiol provided the solution to this problem and furnished amino thioether 245. Removal 
of the silyl ether during this step prepared the molecule for the subsequent oxidation step 
(Scheme 1.60). Ethanethiol is crucial to the success of this conversion due to the formation of 
cyclic aminoether 243 when applying benzenethiol. A strong external nucleophile is needed 
to trap the N-acyliminium intermediate 244. When a weaker nucleophile is used formation of 
243 is observed due to nucleophilic attack of the tethered alcohol prevailing over the 
nucleophile. Although this side-reaction was observed using benzenethiol, the intermediate 
could be converted into the correct cyclic aminoether 245 by exposure to the same reaction 
conditions applied to 243 to give 245 in a single step. It is hypothesized that the equilibrium 
between N-acyliminium 244 and 1,3-oxazepine 243 was disturbed by use of the poorly 
thiophilic hafnium, thus forming the stable amino thioether 245. When applying different 
Lewis and Brønsted acids, amino thioether 245 underwent rapid equilibrium with N-
acyliminium 244. This can be explained by looking at the structural conformation of N-
acyliminium, adopting a pseudoaxial position and therefore favoring the formation of 1,3-
oxazepine due to A1,3 allylic interaction.99 
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Scheme 1.60: Synthesis of amino thioether 245. 
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Oxidation was followed by silyl protection of the enolate, providing silyl enol ether 246 
(Scheme 1.61). The silver tetrafluoroborate-mediated Mannich reaction furnished the 
tetracycle 247 containing an exo-oriented aldehyde function.100 Silver activates both 
electrophile and nucleophile in this reaction enabling a disfavored 5-endo-trig cyclization. 
Jones oxidation furnished the carboxylic acid and was followed by a Pd/C-induced one-pot 
removal of the aryl-bromide, benzyl and Cbz moieties. Subsequent reductive amination 
provided quinocarciamide 248. Partial lactam reduction in liquid ammonia was followed by 
slow sequential addition of methanol and ammonium chloride to provide (–)-quinocarcin 249.  
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Scheme 1.61: Total synthesis of (–)-quinocarcin 249. 
 
1.5.5.2. Summary  
 
The synthetic sequence towards the total synthesis of quinocarcin by Zhu96 contains some 
very interesting chemical conversions, such as use of hafnium and ethanethiol in order to 
produce the Mannich precursor. Subsequently, application of the silver-mediated Mannich 
reaction provides ring-cyclization and giving rise to an exo-oriented aldehyde functionality.  
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1.5.6.  Ecteinascidin Alkaloids 
 
The ecteinascidins were first isolated from Ecteinascidia turbinate and are structurally 
composed out of two THIQs and an additional two bridged ring systems, to give in total a six 
membered ring-system (Figure 1.11).101 Total synthesis of ecteinascidin 743 have recently 
been described by Danishefsky102 and Zhu.103 
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Figure 1.11: Ecteinascidin alkaloids. 
 
1.5.6.1. Pictet–Spengler Cyclization Towards Et-743  
 
Danishefsky had earlier reported his intention towards the use of a cascade-like reaction 
initiated by cleavage of a urethane function of the type 250 yet proven utilization of a linchpin 
Mannich cyclization (250 to 251) to be unattainable (Scheme 1.62).104  
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Scheme 1.62: Proposed Mannich reaction. 
 
This cyclization would have been readily incorporated into the total synthesis of Et-743. 
However, this route was abandoned due to formation of the wrong anti-isomer of 254 and the 
need for a difficult late stage epimerization at the C1 position. Therefore a new pathway was 
devised in which key intermediate 254 would be obtained via a 3,4-dehydro system. In an 
attempt to simplify the latter approach and gain access to a broad range of THIQ-related 
alkaloids, direct cyclization of ortho-hydroxystyrene 257 was proposed due to a sense of 
regiochemical discrimination by the hydroxy phenol (Scheme 1.63).   
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Key-steps in the formal total synthesis of Et-743 are: 1) the application of the aforementioned 
ortho-hydroxystyrene moiety to Pictet–Spengler cyclization, 2) Exploitation of an unusual 
enamide epoxide for hydration at the C3–C4 double bond through reductive treatment of 262 
(Scheme 1.65, next page). 
 
Danishefsky started his proposed route towards the total synthesis of Et-743 with the regio-
stereospecific bromination of Borchardt catechol 252105 to provide 253. Bobbitt-modified 
Pomeranz–Fritsch reaction conditions106 subsequently furnished the THIQ core 254 (Scheme 
1.63). Coupling of THIQ 254 with L-tyrosine derivative 255107 afforded amide 256 after 
which the Pictet–Spengler precursor 257 was obtained in 4 steps. Condensation with various 
acids provided 258 in moderate yields.  
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Scheme 1.63: Synthesis of 258. 
 
Selective functionalization of the C3–C4 double bond in 258 by epoxide formation proved to 
be rather complicated. A large variety of reagents were investigated but only dihydroxylation 
of 259 could be obtained (Scheme 1.64). The need of a strong oxidizing agent in combination 
with a more reactive double bond led to N-protecting group exchange using McCluskey 
reaction conditions108 to afford the N-Troc urethane. Only DMDO was able to facilitate the 
epoxide formation. Selective epoxide opening using NaCNBH3 afforded 260 and 261.102  
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Scheme 1.64: DMDO / NaCNBH3 mediated epoxide formation and selective opening. 
 
A small amount of ketone 261 was obtained during the epoxide ring-cleavage which led to the 
proposal of a new mechanism involved in the ring-cleavage. Formation of ketone 261 could 
be induced due to a concerted rearrangement of epoxide 262, providing the ketone and 
hydride shift from C4 to C3 (Scheme 1.65). Formation of imine 263 could also be followed by 
external hydride donation to give 260. 263 can either undergo the aforementioned external 
hydride addition pathway or 1,2-hydride migration to 262.  
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Scheme 1.65: Mechanistic proposal for the reduction of the epoxide of 262 into 260 and 261. 
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The advanced Fukayama intermediate 265109 was obtained after several deprotection / 
protection steps and could be converted into Et-743 by following the latters procedure 
(Scheme 1.66).  
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Scheme 1.66: Advanced intermediate towards Et-743. 
 
1.5.6.2. Zhu’s Approach Towards Et-743 
 
Zhu reported another total synthesis regarding Et-743 in 31 steps using simple reaction 
conditions.103 Three key steps are; 1) the rapid and diastereoselective construction of the D-E 
segments by Pictet–Spengler cyclization of phenylalanol 269 and Garner’s aldehyde 268, 2) 
diastereoselective N-alkylation of racemic benzyl bromide 267 by use of enantiomerically 
pure 271 and 3) an one-pot deprotection / cyclization leading to formation of a 1,4-bridged 
10-membered ring. 
 
The synthesis started by converting sesamol 266 into α-bromo-α-aryl substituted ethyl acetate 
267 (Scheme 1.67).  
O
O
OH
6 Steps
O
O
OMOM
Br
CO2Et
266 267
 
Scheme 1.67: Ethyl acetate 267 synthesis. 
 
Intermolecular Pictet–Spengler condensation of Garner’s aldehyde 268, obtained in 8 steps 
from catechol,110 and amine 269 gave 270 (Scheme 1.68). Interestingly, C11 stereochemistry 
during the Pictet–Spengler is solely controlled by the configuration of amino alcohol 269, 
providing cis-C11–C13. Pseudoequatorial positioning of both C11 and C13 is presumed and 
results in cis-270 formation after ring-closure.103  
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Scheme 1.68: Synthesis of the THIQ 271.  
 
Coupling of amino alcohol 271 was achieved by use of TEA in combination with 
bromobenzene 267 to furnish amines 272 and 273 (Scheme 1.69). A 2 : 1 stereoselectivity 
was observed. The SN1 mechanism involved in the coupling reaction forms a tentative 
explanation to the lack of stereochemical control in the formation of 272 and 273 via ortho-
quinone methide intermediate.111 After 7 steps, aldehyde 274 was obtained and applied to 
Pomerantz–Fritsch-type cyclization106 affording alcohol 275. The A-B-C-D-E ring system 
was constructed under mildly acid conditions.  
AllylO
OCH3
AllocN
HO
H2N
AcO
+
O
O
OM OM
Br
CO 2Et
TEA
MOMO
O
O
NH
CO 2Et
N
OCH3
AllylO
HO
OAc
MOM O
O
O
NH
CO2Et
N
OCH3
AllylO
HO
OAc
+
MOMO
O
O
N
OAc
N
OCH3
AllocO
O
CN
a) TFA
b) K2CO3
MOMO
O
O
N
OH
N
OCH3
AllocO
OH
CN
H
271 267 272 273
274 275
91%, 2 : 1
94%, 2 steps
Alloc Alloc
Alloc Alloc7 Steps
 
Scheme 1.69: Synthesis of 275. 
 
Synthesis of the bridged ring-system in 277 involved selective ester formation of 276 after 
deprotection of the primary alcohol and phenol acetate formation using standard acid 
conditions (Scheme 1.70). This transformation involved a (PMB)3CS deprotection / 
cyclization to form the 1,4-bridged 10-membered ring via C–S formation, 1,4-β-elimination to 
an ortho-quinone methide and macrocyclization. Guibé’s conditions112 simultaneously 
removed the N-Alloc and O-allyl functional groups and subsequent reductive N-methylation 
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provided intermediate 278. Lastly, Corey’s protocol provided Et-743 in four steps starting 
with removal of N-Troc group by reductive conditions followed by amino ester oxidation to 
ketoester 279. Pictet–Spengler reaction gave 280, which upon treatment with AgNO3 
provided Et-743 280.103  
HO
O
O
N
OH
N
OCH3
AllocO
OH
CN
H EDCI, DMAP
HO
O
O
N
O
N
OCH3
AllocO
OH
CN
H
O
NHTroc
(PMB)3CS
i)  Ac2O, pyridine
ii) TFA
AcO
O
O
N
O
N
OCH3
AllocO
CN
H
O
NHTroc
S
a) nBu3SnH, PdCl2(PPh3)2 AcOH
b) NaCNBH3, HCHO, AcOH
AcO
O
O
N
O
N
OCH3
AllocO
CN
H
O
NHTroc
S
a) AcOH, Zn
b) DBU, 4-formyl-1-
methylpyridinium 
benzenesulfonate
AcO
O
O
N
O
N
OCH3
AllocO
CN
H
O
O
S
H3CO
HO
NH2
AcO
O
O
N
O
N
OCH3
AllocO
X
H
O
S
X = CN
X = OH
AgNO3
92%
NH
H3CO
HO
275 276
277 278
279 280
95%
77% 84%, 2 steps
49%, 2 steps 97%
NaOAc
Alloc
Alloc
Alloc
OH
O
NHTroc
(PMB)3CS
 
Scheme 1.70: Total synthesis of Et770 and Et743. 
 
  Introduction 
 
   81 
1.5.6.3. Stereoselective Aldol Applied to Et-583 and Et-597 
 
Total syntheses of different relatives of Et-743, namely Et-597 and Et-583 were reported by 
Zhu.113 Their syntheses featured; 1) a stereoselective aldol reaction to couple the A-ring with 
the D-E unit, 2) highly stereoselective Pictet–Spengler B-ring formation and 3) TMSBr-
promoted macrocyclization of thiol 287 to afford the 1,4-bridged 10 membered ring system.  
 
In order to obtain pentacyclic 285, a highly diastereoselective Pictet–Spengler condensation 
was applied between 268 and the Garner aldehyde (synthesis of 281 has already been 
discussed on page 79 regarding the total synthesis of Et-743). Selective hydrolysis of 
oxazolidine 281 afforded alcohol 282 which via Swern oxidation provided the corresponding 
aminoaldehyde (Scheme 1.71). Aldol condensation with magnesium phenolate provided syn-
283 exclusively.114 Protecting group manipulation gave mono-THIQ 284 which underwent a 
second Pictet–Spengler cyclization when exposed to TrocOCH2CHO affording bis-THIQ 285 
as a single enantiomer in a high yield. Swern oxidation followed by a zinc-mediated catalytic 
intramolecular Strecker reaction provided the adduct as a single diastereomer. The selectivity 
observed during the reaction sequence shows a highly efficient route towards construction of 
the pentacycle 285.  
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Scheme 1.71:  Synthesis of 285. 
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The trans-configuration of the iminium intermediate of 285 with regard to the 
pseudoequatorial C3 and C4 substituents, explains the diastereoselectivity observed (Scheme 
1.72).113 Mechanistically however, an alternative phenolic aldol condensation and β-
elimination resulting in orthoquinone methide and intramolecular Michael addition of the 
tethered amine cannot be disregarded. Protecting group manipulation was followed by ester 
formation to provide 286. Removal of the S-protecting group resulted in formation of a thiol 
which upon exposure to TMSBr afforded the bridged macrocycle. C–S formation had been 
achieved in a single step which involved O-MOM deprotection, 1,4-elimination to provide the 
orthoquinone methide intermediate and macrocyclization via Michael addition. Guibe’s 
procedure112 removed the allyl and alloc moieties and this provided intermediate 287. N-Troc 
deprotection and conversion of aminonitrile 287 into a secondary alcohol gave hemiaminal 
Et-583 288. Similar manipulations provided Et-597 289.  
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 Scheme 1.72: Total synthesis of Et 583 288 and Et 597 289. 
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1.5.6.4. Summary 
 
Danishefsky’s104 and Zhu’s103 research in the field of Ecteinascidin alkaloids has revealed 
some very interesting complex chemical conversions. Danishefsky utilized an ortho-hydroxy 
styrene moiety to undergo Pictet–Spengler cyclization. Albeit progressing in a relative 
moderate yield, this ambitious cyclization provided the desired THIQ intermediate. Further 
manipulation involved formation of an unusual enamide epoxide 262 obtained from 259 C3–
C4 double bond epoxidation, which through reductive treatment provided alcohol 260 in 
moderate yield.   
 
Zhu’s103 reaction sequence involved a more straightforward approach and was able to obtain 
higher yields, providing a more preferable strategy towards total synthesis of Et-743. The D-E 
segments were constructed in a rapid and diastereoselective manner by Pictet–Spengler 
cyclization of phenylalanol 269 and Garner’s aldehyde 268. Diastereoselective N-alkylation 
of racemic benzyl bromide 267 by use of enantiomerically pure 271 and finally a one-pot 
deprotection / cyclization led to the formation of an 1,4-bridged 10-membered ring required 
for Et-743 in high yield. 
In addition to Zhu’s synthesis of Et-743,113 the same intermediate was applied to the 
construction of Et-583 and Et-597. A stereoselective aldol reaction was utilized to couple the 
A-ring with the D-E unit together with a highly stereoselective Pictet–Spengler B-ring 
formation and TMSBr-promoted macrocyclization of thiol 287 to afford the 1,4-bridged 10 
membered ring system.  
 
Although Danishefsky developed some interesting chemistry, the relatively low yield of his 
synthesis hampers any scale-up endeavors when compared to Zhu’s approach which utilizes 
more robust and higher-yielding chemical conversions.  
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1.5.7.  Renieramycin Family 
 
Four members of the renieramycin family of alkaloids were first isolated from the Reniera 
sponge by Frincke and Faulkner in 1982.50 Over the years more family members were 
isolated from different sponges yet proved to be unstable.50 Although structurally closely 
related to saframycins, the main difference can be observed when looking at the side chain 
revealing the presence of an angelic ester side chain in renieramycins in contrast to the 
pyruvamide in saframycins (Figure 1.12). Recently Williams,115,124 Liao119 and Zhu121 have 
reported the total synthesis of renieramycin related natural products.  
  
O
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R1 = CN / =O / OH
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E
 
Figure 1.12: Renieramycin alkaloid general structure. 
 
1.5.7.1. Total Syntheses of (–)-Jorumycin and (–)-Renieramycin G 
 
Williams115 reported the total synthesis of (–)-jorumycin and (–)-renieramycin G in 25 and 23 
steps respectively. During their attempt to prepare both natural compounds stereoselectivity 
issues were encountered when applying the Pictet–Spengler cyclization to 290 providing an 
anti-relationship between the C1–C3 moieties in 291. This problem was solved by treating the 
substrate with DBU,116 providing a 3.3 : 1 relationship in favour of the syn-conformation 
(Scheme 1.73).  
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Scheme 1.73: Synthesis of THIQ 293. 
 
After isolating the syn-product 292, further conversions yielded 297 which interestingly 
provided C3-epimerized 297 (Scheme 1.74). Such observations had already been reported by 
Danishefky117 and were reported to complicate the total syntheses of both natural products.  
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Scheme 1.74: Unwanted epimerization of 297. 
  
A hypothesis based upon earlier research by Corey118 in which acidic conditions were used in 
the synthesis of the second THIQ 297 suggested that the unwanted epimerization is induced 
under basic conditions. Therefore, acidic conditions were applied and 297 obtained which 
contained the correct C3 stereoconfiguration (Scheme 1.75). Protecting group manipulation 
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followed by oxidation and base-induced cyclization furnished 301 from 300. Removal of the 
Boc-protecting group and reductive amination resulted in the formation of the THIQ core 
system NC of (–)-jorumycin and (–)-renieramycin 304. 
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Scheme 1.75: Synthesis of pentacycle 302. 
 
(–)-Jorumycin 303 was obtained by installation of a cyanide moiety followed by protecting 
group manipulation, oxidation and cyanide reduction (Scheme 1.76). 
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Scheme 1.76: Total synthesis of (–)-jorumycin 303. 
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(–)-Renieramycin G 304 utilized the same advanced intermediate 302, in which protecting 
group manipulation and esterification provided the latter in three steps (Scheme 1.77). 
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Scheme 1.77: Total synthesis of (–)-renieramycin G 304. 
 
1.5.7.2. (–)-Renieramycin G by Liao 
 
Total synthesis of (–)-renieramycin G was reported by Liao119 in 21 steps with an overall 
yield of 8.5% starting from L-tyrosine. This reaction sequence would involve a highly 
selective Pictet–Spengler cyclization for the construction of the pentacyclic ring-system.  
 
The synthesis started from L-tyrosine120 305 which after manipulation and Pictet–Spengler 
cyclization furnished THIQ 307 diastereoselectively (Scheme 1.78). This cyclization was 
extremely susceptible to temperature change; at rt a 5 : 4 cis : trans ratio of 307 was observed 
while at 0 oC the reaction proceeded selectively and only the cis-isomer was obtained. The 
same reaction did not facilitate any THIQ 307 formation at –10 oC.119  
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Scheme 1.78: THIQ western core synthesis. 
 
After silyl protecting 307, peptide coupling of both 308 and 309 fragments gave 310 without 
racemization. Hemiaminal 311 was subsequently obtained as a single diastereomer (Scheme 
1.79). Removal of the secondary silyl ether moiety prior to DMP oxidation resulted in 
decomposition of the starting material, and therefore the latter was removed after oxidation.119 
Attempts to effect intramolecular Pictet–Spengler cyclization with HCOOH and TFA, BF3 or 
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MeSO3H did not provide the pentacyclic product 313. Fortunately exposure to CF3SO3H at 
room temperature provided the pentacyclic core and simultaneously removed both Boc and 
benzyl protecting groups. It was suggested that the presence of a bromide atom para to the 
phenolic hydroxyl group would retard electrophilic aromatic substitution. When TFA was 
used cyclic enamine 312 was obtained, being favored over electrophilic aromatic 
substitution.119 Formation of a dication in the formation of 313 from 311 acted as a stronger 
electrophile in the intramolecular electrophilic substitution when compared to formation of 
312. The latter involved formation of a single monocationic enamine by favoring elimination 
over electrophilic substitution.116 Finally, total synthesis of (–)-renieramycin G 314 was 
achieved in four steps from 313. 
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Scheme 1.79: Synthesis of (–)-renieramycin G 314. 
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1.5.7.3. Aziridine-Mediated Total Syntheses of (–)-Renieramycin M, G and (–)-
  Jorumycin  
 
Zhu reported the total synthesis of (–)-renieramycin M, G and (–)-jorumycin using aziridine 
chemistry as the linchpin in their total synthesis.121 The aziridines 315 and 317 were derived 
from N-trityl-L-serine methyl ester 316 (Scheme 1.80).  
 
HO
CO 2CH3
NHTr
4 Steps5 Steps
TrN
CO2tBu
TrN
O
316 317315
 
Scheme 1.80: Aziridine synthesis. 
 
Synthesis of the core structure 323 would involve application of the aziridine moieties and 
started with the conversion of 318 into 319. Arylmagnesium formation was achieved utilizing 
Knochel’s conditions122 and 320 was obtained by reacting the Grignard reagent of 319 with 
aziridine 317 (Scheme 1.81). O- and N-deprotection using acid conditions was followed by an 
intermolecular Pictet–Spengler reaction between aziridinal 315 and 320. Classic reaction 
conditions proved complicated in inducing Pictet–Spengler cyclization, a catalytic amount of 
diphenylphosphoric acid was needed in order to provide THIQ 321.121 Benzylation of 321 
was followed by exposure to aryl Grignard which fascilitated ring-opening of the aziridine 
providing amine 322. Tandem Boc-deprotection and exposure to benzyloxyacetaldehyde 
furnished the Pictet–Spengler cyclized bisTHIQ 323. Having constructed the core for all three 
natural products, separate manipulation of the bisTHIQ 323 would provide all three alkaloids.  
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Scheme 1.81: Synthesis of core THIQ 323. 
 
(–)-Renieramycin M and (–)-jorumycin were prepared using a similar route which involved 
ester reduction, alcohol oxidation (providing the cyclized product) and cyanide installment by 
a Strecker reaction to furnish pentacyclic 324 (Scheme 1.82). O-Debenzylation by BCl3 
followed by oxidation provided (–)-jorunnamycin A 325. This alkaloid could either provide 
(–)-renieramycin M 326 via angelic acid123 installment or by acetylation and cyanide 
hydrolysis to provide (–)-jorumycin 327.  
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Scheme 1.82: Total syntheses of (–)-renieramycin M 326 and (–)-jorumycin 327. 
 
Finally, total synthesis of (–)-renieramycin G 330 was achieved by ester saponification and 
peptide coupling to give pentacyclic 328 (Scheme 1.83). Debenzylation, esterification with 
angelic acid and phenol oxidation gave (–)-renieramycin G 330. 
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Scheme 1.83: Total synthesis of (–)-renieramycin G 330. 
 
1.5.7.4. (–)-Cribostatin 4 
 
The Williams group124 reported the total synthesis of (–)-cribostatin 4 (renieramycin H) 
utilizing previously reported strategies126 for formation of the THIQ core and the eastern half 
of the molecule. The strategy involved built on methodology developed for the formation of 
the THIQ 334 C3=C4 present in cribostatin 4.125 Key elements in the total synthesis of this 
compound being the reductive opening / elimination of the C3–C4 β-lactam present in 333, 
and the Pictet–Spengler cyclization in order to obtain the pentacyclic skeleton.  
 
The synthesis was initiated by acid chloride formation of 332 which subsequently afforded 
333 following Fmoc-deprotection. Reduction of the β-lactam into the C3=C4 alkene was 
achieved by use of LiEt3BH to provide 334 (Scheme 1.84).  
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Scheme 1.84: Synthesis of pentacyclic 334. 
 
Two pathways towards formation of this benzylic alkene in 334 were proposed. The first of 
these involved β-elimination of the benzylamine residue at C4 via the incipient aldehyde 
which would undergo Pictet–Spengler cyclization by an α,β-unsaturated iminium 
intermediate. An alternative pathway involved C4 elimination of the benzylic amine after 
formation of the pentacyclic core via an ortho-quinone methide intermediate. Preliminary 
investigations support the latter.124 Debenzylation of 334 was followed by oxidation to form 
the phenol moieties while preventing hydrogenation of the C3–C4 moiety (Scheme 1.85). 
Installation of the angelic acid chloride at the primary alcohol was followed by selenium 
induced oxidation of the C14 position to furnish the alcohol precursor of 334 in a chemo-, 
regio- and diastereoselective manner. Subsequent use of DMP oxidized this alcohol while 
addition of sodium thiosulfate reduced the quinine into hydroquinone thus concluding the 
total synthesis of (–)-cribostatin 4 335. 
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Scheme 1.85: Total synthesis of (–)-cribrostatin 4. 
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1.5.7.5. Summary 
 
All four articles discussed regarding the total syntheses of renieramycin natural alkaloids 
provided an interesting view on the use of recently developed methodology / different 
strategies in the field of complex natural compounds synthesis.  
 
Williams115 reported the total syntheses of (–)-jorumycin and (–)-renieramycin G after 
successfully solving a base induced C3-epimerization of one of the advanced intermediates. 
Application of acidic conditions prevented this unwanted conversion from taking place, thus 
allowing the reaction sequence to continue towards completion using a rather straightforward 
approach.  
 
Liao119 never observed any epimerization in his total synthesis and was able to report a very 
highly selective Pictet–Spengler cyclization using commercially available L-tyrosine as the 
starting material. This Pictet–Spengler cyclization was achieved by using superacidic 
conditions and relying on the p-bromine substituent on retarding electrophilic aromatic 
substitution.    
 
Aziridine-mediated total synthesis by Zhu121 described an interesting use of these moieties in 
the field of natural product synthesis. Successful application of these aziridines combined 
with two highly selective Pictet–Spengler cyclizations and no observed epimerization 
provides a very straightforward and efficient strategy. 
 
Lastly, the second approach by Williams124 utilized a very interesting β-lactam intermediate 
in order to construct the C3=C4 alkene, this in combination with a chemo-, regio- and 
diastereoselective manner of constructing this alkaloid makes for a very interesting approach.   
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1.5.8.  Cyanocycline A and Bioxalomycin-β2 
 
In order to utilize their [C+NC+CC] coupling reactions on a more complex scale, Garner126 
reported the total synthesis of cyanocycline A and bioxalomycin-β2. This methodology 
provided the formation of a highly functionalized pyrrolidine by means of a metal-mediated, 
multicomponent [3+2] cycloaddition. Previous total syntheses by both Evans (35 linear steps) 
and Fukuyama (32 linear steps) had already been reported.126 In order to test Garner’s 
methodology, aldehyde 336 was constructed, combined with L-glycylsultam by using AgOAc 
thus furnishing syn-pyrrolidine 337 (Scheme 1.86).  
 
BocN
CHO
N
CbzBnO
H3CO
OCH3
Bn
BocN
N
CbzBnO
H3CO
OCH3
Bn
HN
H
COXL
CO2CH3
AgOAc
H2NCH2COXL
CH2=CHCO 2CH3
336 337
74%
 
Scheme 1.86: Key [C+NC+CC] coupling reaction. 
 
On the basis of earlier studies revealing the endo-si preference for this [3+2] cycloaddition it 
was assumed the latter had been formed due to the steric hindrance created by urethane 
functionalities, NMR observation would later prove this assumption to be correct (Scheme 
1.87).126  
CO2Me
NHBoc
ArBnCbzN
H
N Ag
O
H
N
S
OO
via:
Endo-Si
 
Scheme 1.87 Key [C+NC+CC] coupling reaction approach hypothesis. 
 
After the successful synthesis of 337, the latter was converted into 338 which underwent 
Pictet–Spengler cyclization to afford THIQ 339 in a stereoselective manner (Scheme 1.88). 
Benzyl protection was followed by LiAlH4 reduction to give primary alcohol 340. This 
reaction involved cleavage of the chiral auxiliary together with the conversion of the urethane 
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moiety to N-methyl. Swern oxidation and aminonitrile exposure furnished 341. Formation of 
the F-oxazilidine 343 was obtained by use of Pelletier’s process127 via imine 342. 
Debenzylation using BCl3 finally gave 343, which is an advanced intermediate reported by 
Fukayama.128 In addition, as cyanocycline A can readily be converted into bioxalomycin-β2 
through the use of Ag(I),129 both natural compounds could be prepared using this advanced 
intermediate. 
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H
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Scheme 1.88: Garners total synthesis towards cyanocycline A. 
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1.5.8.1. Summary  
 
The formal total synthesis of cyanocycline A and bioxalomycin-β2 involved utilization of a 
[3+2] cycloaddition providing a highly functionalized pyrrolidine via [C+NC+CC]-
methodology. Application of their methodology to these complex molecules reduced the 
amount of steps involved from 35 or 32 steps to 22. The methodology described therefore 
provided an interesting application to the field of natural product total synthesis due to the 
fast, efficient and stereoselective manner in which it allows [3+2] cycloadditions to take place 
starting from small molecules.   
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2.  Results and Discussion 
 
In this part of the report our efforts towards the total synthesis of (±)-suaveoline,  
(±)-alstonerine, and (–)-cytisine will be discussed. A summary of earlier studies conducted 
within the Craig group will be included in order to provide a more detailed background to our 
work. 
 
2.1.  Suaveoline 
 
2.1.1.  Prior Work within the Craig Group 
 
The total synthesis of (–)-suaveoline was proposed1 with the aim of incorporating the newly 
developed decarboxylative Claisen rearrangement (dCr)2 as well as the de novo pyridine3 
methodology.  
 
In addition to both the dCr and de novo pyridine methodologies, synthesis of 1,3-cis-bridged 
piperidine 3 via Pictet–Spengler cyclization was to be employed (Figure 2.1). Previous 
research had shown that when the cyclization occurred intramolecularly, complete selectivity 
for the 1,3-cis-bridged piperidine ring was observed.4 Preparation of the 3,4,5-trisubstituted 
pyridine ring would involve oxidative cleavage of cyclopentene 346 followed by treatment 
with an ammonia source. The use of cyclopentene 346 instead of the bis-olefin was proposed 
to aid both α-alkylation at the tosyl-C4 position as well as increase the yield of the 1,5-
dicarbonyl-containing product of oxidative cleavage.5 Dual-dCr of 349 would provide 4-
tosyl-1,6-heptadiene 348.  
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Figure 2.1: Retrosynthesis of (–)-suaveoline. 
 
Synthesis of malonate 349 started from N-methyl-L-tryptophan and involved Weinreb amide 
synthesis, ester reduction and Horner–Wadsworth–Emmons olefination to provide vinylogous 
ester 350 (Scheme 2.1). Subsequent DIBAL reduction of the α,β-unsaturated ester 350 gave 
the corresponding alcohol, which upon esterification with tosylacetic acid gave 351.  
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Scheme 2.1: Synthesis of dCr intermediate 351. 
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Amine protection was necessary due to competition between the highly acidic amine proton 
and the desired α-tosyl position in the carboxylation step. Malonate 353 was subsequently 
obtained in moderate yield (Scheme 2.2).  
 
NNBoc
O
O
Ts
Ts
O2N
O O
O
NNBoc
O
O
TsTs
O
O
+
NaH
DMF
45%
351
352
353
 
Scheme 2.2: Synthesis of malonate 353. 
 
Malonate 353 underwent dCr reaction (discussed in detail on page 117) to give terminal olefin 
354 regioselectively (Scheme 2.3). However, the desired dual-dCr rearrangement was not 
observed and thought to be inhibited by the electron-withdrawing, sterically demanding 
tosamide moiety next to the more substituted end of the diene. 
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Scheme 2.3: Regioselective dCr product 354. 
 
The analogous substrate possessing the less electron-withdrawing PMB moiety similarly gave 
only the mono-dCr product. It was therefore hypothesized that even the tosyl-protecting group 
might also be too electron-withdrawing and so both protecting groups were to be converted to 
furnish the corresponding chemically inert, electron-rich, dibenzyl amine. However, 
subsequent microwave-assisted dCr of the dibenzyl amine malonate failed to furnish the dual-
dCr rearranged product. Installation of a second ester moiety at the α-tosyl position of 
malonate 355 simultaneously provided a more reactive dCr substrate and an activating group 
which it was hoped would enable incorporation of the second olefin α to the tosylate. In 
addition, this could potentially be used in chain homologation / piperidinium formation 
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required to form cis-bridged piperidine 3 at a later stage. Olefin 357 was subsequently 
obtained in a high yield under dCr conditions (Scheme 2.4). 
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Scheme 2.4: Synthesis of 357. 
 
With mono-olefin 357 in hand, two strategies were investigated for the insertion of the second 
olefinic moiety (Scheme 2.5). pi-Allyl palladium chemistry was to be employed as, besides 
being highly demanding, formation of a quaternary center with α-branching on two of the 
substituents would vastly simplify the final approach towards (–)-suaveoline.  
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Scheme 2.5: Transition-metal approach. 
 
The use of rhodium, as described by Evans6, was also investigated for the required allylation 
reaction. Unfortunately, no product formation was observed using either palladium or 
rhodium catalysts. In addition to the unsuccessful transition-metal induced α-tosyl alkylation, 
transesterification of 357 proved equally disappointing. Therefore, removal of the methyl 
ester moiety was followed by nBuLi-induced deprotonation and carboxylation to give 359 
(Scheme 2.6). Subsequent microwave-assisted dCr gave diene 360 in low yield, together with 
starting material 360. Attempts to preserve the α-ester moiety in 360 by inhibiting the 
decarboxylation step proved ineffective. 
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Scheme 2.6: Stepwise access to 2nd dCr substrate. 
 
With the desired dual dCr product in hand, the following Grubbs II-mediated RCM met with 
little complications and the corresponding cyclopentene 361 was isolated in moderate yield 
(Scheme 2.7).  
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Scheme 2.7: RCM. 
 
Attempts to alkylate the α-tosyl position proved unsuccessful. It was suggested that although 
formation of the anion was a viable process, alkylation at that same position with anything 
more sterically hindered than a proton was not and only epimerization was observed.1 
Furthermore, reductive α-desulfonylation followed by attempted in situ alkylation using a 
variety of electrophiles provided only α-desulfonylated product.  
 
It was therefore necessary to find an alternative method for cyclopentene alkylation, and the 
use of tosyl pyridine N-oxide 365 was investigated (Scheme 2.8). It was thought that the 4-
position of the pyridyl moiety would be susceptible to SNAr reaction via a Birch intermediate7 
363, through reductive desulfonylation–alkylation. SNAr reactions of 4-sulfonylpyridine 364 
with cyanide are known.8  
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Scheme 2.8: Possible products from use of hydroxylamine. 
 
Formation of a pyridine N-oxide model system showed loss of the C4 tosyl-moiety, resulting 
in a 53 % yield of pyridine-N-oxide 365 (R1,2 = H). A better leaving group at the N-position, 
formed by treating diketene with hydroxylamine-O-sulfonic acid was speculated to prevent 
the loss of the tosyl moiety, to no avail. However, selective C4 functionalization of the 
pyridine-N-oxide 365 could still be achieved, as described by Saito9i and Taylor.9ii  
 
Attempting to utilize the pyridine-N-oxide method in the total synthesis approach towards (–)-
suaveoline required mild oxidative cleavage of the cyclopentene via the vicinal diol.4 This is 
due to the oxidatively sensitive electron-rich indole 2,3-pi system which undergoes facile 
cleavage, especially under ozonolytic conditions.10 Several attempts to cleave the 
cyclopentene oxidatively via the vicinal diol proved unsuccessful.    
  
 Results and Discussion 
 
  109 
The failure to dihydroxylate the cyclopentene was thought to be caused by competing 
oxidation of the indole, and therefore attempts were made to convert the electron-rich 2,3-pi 
system into an oxindole (Scheme 2.9). Use of DMDO as reported by Zhang,11 provided 
oxindole 366 in moderate yield. Subsequent RCM using Grubbs II catalyst gave cyclopentene 
367 and OsO4 mediated Upjohn dihydroxylation12 provided the vicinal diol 368. However, 
oxidative cleavage of the diol 368 did not result in the isolation of the corresponding 
dialdehyde 369 due to the instability of the latter. A similar result was observed when 
attempting direct ozonolytic cleavage of 367. Although one-pot treatment of the crude 
dialdehyde mixture with NH2OH·HCl gave some pyridine-N-oxide according to mass 
spectrometric analysis, no product was isolated.   
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Scheme 2.9: Oxidative cleavage of 367. 
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2.1.2.  Current Progress Towards (±)-Suaveoline  
 
The retrosynthesis of (±)-suaveoline was based upon previous research involving attempts to 
facilitate a double intramolecular dCr, as discussed in section 2.1.1. Problems arose due to the 
application of a dual-dCr to a system which already contained a sterically demanding 
tosamide moiety positioned adjacent to a significantly electron-depleted alkene.3  
 
In order to circumvent these chemically demanding rearrangements, the proposed key step in 
this project involved the installment of dCr adducts 370 as sulfone-stabilized anions, which 
nucleophilically ring-open N-sulfonylaziridines 371 (Scheme 2.10). Results from the 
alkylation of aziridines 371 with the nucleophiles of type 370 would then be assessed in order 
to identify the best outcome with respect to yield and regioselectivity. Recent studies13,14 
carried out in our group have shown that vinylaziridines related to 371 are attacked by 
sulfone-stabilized carbanions at the ring carbon adjacent to the double bond if the nucleophile 
is not excessively hindered. We interpret the observed selectivity in terms of selective 
weakening of the aziridine C–N bond proximal to the olefin by piC=C → σ*C–N overlap.15,16 
Sterically more demanding nucleophiles were found to attack these vinyl aziridines at the 
terminus of the double bond, where this would be the case, utilizing the directing effect of the 
hydroxy moiety would ensure the correct regioselectivity through lithium chelation.17 
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Scheme 2.10: Sulfone-anion mediated N-sulfonylaziridine opening. 
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Retrosynthetic analysis revealed the synthesis of the characteristic azabicyclo [3.3.1] 
substructure in suaveoline 3, prevalent in all ajmaline / sarpagine related alkaloids,18 via 
pyridine C4 side chain homologation (Scheme 2.11). Reducing the ester functionality at this 
newly expanded carbon chain to an aldehyde followed by acid treatment would trigger the 
formation of tetrahydropyridinium 374, which in turn would undergo intramolecular Pictet–
Spengler cyclization. Reactions of this type have been thoroughly investigated within our 
group and have been proven to be highly regio- and stereoselective.4  In the example outlined 
below, deprotection of protected aldehyde 373 with an acid catalyst gave the 
tetrahydropyridinium intermediate 374, which was converted spontaneously into 375 via 
Pictet–Spengler cyclization. 
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Scheme 2.11: Lewis acid mediated Pictet–Spengler cyclization. 
 
The proposed synthesis of the 3,4,5-trisubstituted pyridine motif in 3 involved our recently 
developed method for the synthesis of polysubstituted pyridines from dicarbonyls,2 such as 
dialdehyde 377 (Figure 2.2). Obtaining this dialdehyde containing compound would either be 
achieved via oxidative cleavage of the corresponding terminal olefins (R2 = CH=CH2) or 
involve a combination of oxidative cleavage and alcohol oxidation (where R1 = CH2OH) 
depending on the type of aziridine used.  
 
As stated earlier, adduct 378 would, be obtained by combination of lithiated dCr products 380 
with the N-sulfonylaziridine 379. Use of the less substituted congener would require an 
additional α-tosyl carboxylation step to ensure pyridine C4 alkylation. Synthesis of the dCr 
products 380 would involve exposure of sulfonyl esters 382 to established dCr reaction 
conditions,2 the synthesis of the requisite N-sulfonylaziridine electrophiles would start from 
cis-2-butene-1,4-diol 381.19 
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Figure 2.2: Retrosynthesis of (±)-suaveoline 3. 
 Results and Discussion 
 
  113 
2.1.2.1. Preparation of Hydroxy Aziridine 388 
 
The synthetic routes towards (±)-suaveoline and (±)-alstonerine were initiated by mono 
protection of cis-2-butene-1,4-diol 381 using TBSCl to give 383. Subsequent hydroxy-
assisted aziridination20 of the alkene via the Sharpless method provided the corresponding 
hydroxy aziridine 384 (Scheme 2.12).  
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TsNOTBS
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Scheme 2.12: a) i) NaH, THF, rt, 16 h; ii) TBSCl, rt, 15 min, 90%; b) Chloramine-T, PTAB, CH3CN, rt, 72 h, 
93%. 
 
The proposed mechanism, depicted in Scheme 2.13, is initiated by insertion of a bromonium 
species following treatment of alkene 383 with PTAB to give I. Nucleophilic ring opening 
mediated by ionic chloramine-T results in formation of II, after which chloride displacement 
by either a bromide ion or another chloramine-T anion generates a Br–X species and forms 
III. Aziridine formation and subsequent bromide expulsion gives rise to 384 and a bromide 
ion which in turn can re-enter the catalytic cycle by regenerating a new Br–X species.  
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Scheme 2.13: Sharpless aziridination mechanism. 
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Following the Sharpless aziridination of 383 the corresponding epoxide 385 was obtained 
following a base-induced aza-Payne rearrangement (Scheme 2.14). Studies by Fuji et al.21 
have shown that NaH as well as KH can be used in order to trigger inversion of the 
configuration at the C2 carbon via a SN2 mechanism. Use of other bases such as nBuLi, LDA 
or DBU were ineffective. Furthermore, the substrate used needs to be an “activated” aziridine 
(such as the electronically deficient N-tosyl aziridine 384) in order to facilitate this 
rearrangement due to failure when utilizing non-activating protecting groups. The solvent of 
choice was found to be THF, alternatives such as toluene, dimethoxyethane and DCM either 
would not facilitate complete product formation or required excessively long reaction times. 
The ideal temperature for complete aza-Payne rearrangement was determined to be between 0 
°C and room temperature. Below 0 °C the equilibrium is pushed towards the aziridine due to 
the fact that the aza-anion formed after rearrangement is slightly higher in energy when 
compared to its oxa-counterpart.21  
 
Lewis-acid mediated Friedel–Crafts type alkylation of N-methylindole using epoxide 38519 
resulted in the formation of indolic amino-alcohol 386 in a moderate yield of 50%. 
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Scheme 2.14: a) NaH, THF, 0 °C, 4 h, 93%; b) N-methyl indole, anh. NaHCO3, BF3·Et2O, DCM, rt, 16 h, 50%. 
 
Ring-opening of epoxides using indoles and pyrroles has been reported using different 
methods such as acid catalysis,22 application of high pressure,23 lanthanides24 and HBF4-
SiO2.25 The yields reported are usually unsatisfactory, especially with aliphatic epoxides.   
 
Due to the low yield of the initial nucleophilic ring-opening of epoxide 385, attempts were 
made to optimize this reaction (Table 2.1) using different “mild” Lewis acids.  
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Table 2.1: Lewis acid mediated Friedel–Crafts indole alkylation. 
 
Entry Lewis Acid Conditions Yield 
1 Yb(OTf)3 DCE, 1.5 M, rt, 2.5 h 0% 
2 Yb(OTf)3 DCE, 1.5 M, µW, 
80 oC, 2 x 0.5 h 
0% 
3 Yb(OTf)3 DCE, 1.5 M, µW, 
100 oC, 2 x 0.5 h 
0% 
4 In(OTf)3 DCE, 1.5 M,  rt, 16 h 0% 
5 In(OTf)3 DCE, 1.5 M, µW, 
100 oC, 2 x 0.5 h 
0% 
6 Cu(BF4)2 DCM, 1.0 M, rt, 16 h 65% 
7 Cu(BF4)2 DCM, 1.0 M, µW, 
80 oC, 2 x 0.5 h 
84% 
8 ZnCl2 DCM, 1.0 M, rt, 16 h 66% 
9 ZnCl2 DCM, 1.0 M, µW, 
80 oC, 2 x 0.5 h 
92% 
 
Although rare, the use of lanthanides as Lewis acids in epoxide ring-opening reactions has 
been documented.23 Ytterbium (III) is reported to facilitate epoxide ring-opening when using 
primary amines, resulting in high yields of aminoalcohols.23 Applying ytterbium (III) to a 
mixture of our epoxide 385 and N-methylindole at rt in DCE (to increase overall solubility) 
did not yield any product (entry 1, 2 and 3). Umani-Ronchi26 reported that indium (III), 
facilitated Friedel–Crafts type addition of indole to optically active styrene oxide. Various 
mild Lewis acids were applied, giving the following order of reactivity: In (III) > Zn (II) > 
BF3 > Sc (III) > Cu (II). Indium (III) was found to be the most reactive without significant 
erosion of ee. Application of indium (III) to our structurally more complex epoxide 385 in 
combination with the less reactive N-methylindole resulted in the recovery of starting material 
(entry 4 and 5).  
Despite being reported to be less reactive than indium (III) in promoting Friedel–Crafts-type 
addition of indole to 2-phenyloxirane, the use of zinc (II)27 and copper (II)28 gave promising 
results. Consumption of starting material was observed together with product formation (entry 
6). No further conversion was detected after 16 hours and attempts to further increase the 
consumption of starting material resulted in application of the microwave29 (entry 7). High 
yields of the amino alcohol 386 were obtained when applying the microwave irradiation at  
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10 mol% catalyst loading, but the use of increased catalyst loadings did not improve the 
overall conversion. Friedel–Crafts addition of N-methylindole to epoxide 385 using sub-
stoichiometirc zinc(II) chloride gave amino alcohol 386 in 92% yield (entry 9). No ring-
opening of the epoxide by chloride nor any other side products were observed; this clean 
method seems limited only by the size of the microwave reactor. 
 
Due to the restriction on reaction scale imposed by use of the microwave, several attempts to 
optimize the initial BF3-mediated reaction were investigated concurrently with the screen of 
alternative Lewis acidic additives. Earlier results had shown that reaction at rt reached 
completion within 30 min, and it was considered that this rapid formation and subsequent 
decomposition of material was likely to be reduced by lowering the reaction temperature. It 
was hoped that slowing the reaction down would subsequently inhibit the decomposition. 
Lowering the temperature to –40 °C gave an increase in isolated product while the reaction 
time slowed down to 2.5 h. A further decrease in temperature to –78 °C showed total 
conversion of starting material 385 to amine alcohol 386 with no sign of decomposition with 
the reaction reaching completion after 4 h (95% yield). Large scale reactions (17 g-scale) 
could be carried out without erosion of the yield, this in combination with the high increase in 
yield (50% → 95%) turned this reaction from being a chocking-point into a very successful 
indole-mediated epoxide alkylation. 
 
Mitsunobu-type reaction conditions were applied in order to facilitate ring closure of amino-
alcohol adduct 386, resulting in formation of aziridine 387 (Scheme 2.15). Subsequent 
fluoride-mediated desilylation using TBAF resulted in an 80% yield of hydroxy aziridine 
388.19  
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Scheme 2.15: a) DIAD, PPh3, THF, rt, 1 h, 86%; b) TBAF, THF, 0 °C, 15 min, 80%. 
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2.1.2.2. Decarboxylative Claisen Rearrangement  
 
The discovery of the Claisen rearrangement30 in 1912 provided a new chemical tool to 
generate highly stereoselective products via [3,3]-sigmatropic rearrangements. Its frequent use 
is due to various factors, such as the ease of substrate synthesis, high levels of 
stereoselectivity based on well-established trends, compatibility with a wide range of 
functionalities and the ability to form new carbon–carbon bonds with regioselective 
transposition from simple derivatives of alcohol precursors.31    
Various adaptations of this type of rearrangement have been developed, further enhancing it 
as a powerful carbon–carbon bond-forming tool in organic synthesis. One of these adaptations 
is the Ireland–Claisen rearrangement (Scheme 2.16)32 in which silyl ketene acetals 389 
derived from allylic carboxylic esters yield carboxylic acids 390 upon hydrolysis of the initial 
silyl ester products. 
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Scheme 2.16: The Ireland–Claisen rearrangement 
 
The failure in our own laboratory of Ireland–Claisen type rearrangements previously reported 
by Davidson and co-workers, involving tosylacetate substrates, lithium diisopropylamide and 
chlorosilanes resulted in the development of milder conditions in which a weak base and a 
silylating agent were used.2(i) This provided an intermediate silyl ketene acetal which 
underwent [3,3] sigmatropic rearrangement followed by spontaneous decarboxylation, leading 
to the term decarboxylative Claisen rearrangement (dCr).  
Over time several important features of the dCr reaction have become apparent; the tolerance 
towards oxygen and nitrogen substituents, provided that they are fully masked; complete 
regioselectivity; transformation takes place regardless of the substrate structure (ester derived 
from primary or secondary alcohols), and irrespective of the level of substitution on the 
olefinic carbon.2(iv)  
 
The proposed mechanism for the dCr reaction (Scheme 2.17) starts with the reversible 
combination of KOAc and BSA to give the conjugate base of N-trimethylsilylacetamide and 
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TMSOAc. Deprotonation of 391 by the former results in enolate formation, which is silylated 
to generate the silyl ketene acetal 392 and potassium acetate. [3,3] Sigmatropic rearrangement 
of 392 yields the γ,δ unsaturated silyl ester 393, followed by reversible desilylation mediated 
by the acetate ion which regenerates TMSOAc. Spontaneous decarboxylation of the 
desilylated product gives the conjugate base of 394 which abstracts a proton from N-
trimethylsilylacetamide formed in the initial deprotonation. The regenerated conjugate base of 
N-trimethylsilylacetamide re-enters the cycle, thus generating new nucleophilic enolates.2 (iv)  
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Scheme 2.17:  Proposed mechanism of the dCr. 
 
Support for the proposed mechanism was provided by the following observations:2(i) heating 
of toluene solutions of substrate with potassium acetate alone led to full recovery of starting 
material; substitution of BSA with other silylating agents, such as TMSOAc, TMSOTMS or 
(TMS)2NH, likewise resulted in complete starting material recovery. Reactions in which 
KOAc was substituted with TEA, DBU or pyrrolidine together with BSA resulted in 
rearrangement not decarboxylation, giving carboxylic acid products. Treatment of the 
substrate with BSA alone in toluene at reflux likewise resulted in the formation of rearranged 
product, which again did not decarboxylate. This indicated the key, catalytic role of the 
acetate ion in the silyl transfer step.  
Finally, exposure to a mixture of tBuLi, N-trimethylacetamide and TMSOAc gave a moderate 
yield of dCr product, and when tBuLi was substituted with KH the same result was observed. 
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These results suggesting that despite the key catalytic role it fulfills, the mode of generation of 
acetate ion is of less importance.  
 
The synthesis of malonate 397 was initiated by treating Meldrum’s acid 395 with methanol at 
reflux, to yield methyl malonate 396 quantitatively (Scheme 2.18). Esterification of 396 using 
a standard DCC / DMAP condensation reaction with trans-2-penten-1-ol gave compound 397. 
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Scheme 2.18: a) CH3OH, ∆, 16 h, 92%; b) trans-2-penten-1-ol, DCC, DMAP, DCM, rt, 16h, 65%. 
 
Subsequent tosylation using tBuOK–TsF in DMSO gave 398. Four equivalents of the anion of 
397 were generally required to gain acceptable levels of conversion; unconsumed malonate 
was usually recovered in good yields. Exposing 398 to dCr reaction conditions gave in 
modest yield the product of formal regiospecific allylation of methyl tosylacetate 399 2(ii) 
(Scheme 2.19).  
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Scheme 2.19: a) tBuOK, TsF, DMSO, rt, 16h, 64%; b) DBU, TBDMSOTf, DCM, rt, 1.5h, 64%.  
 
The tosylacetate ester 401 was prepared in a similar manner, by DCC / DMAP-mediated 
esterification of commercially available tosyl acetic acid with allyl alcohol. Exposure of 401 
to dCr reaction conditions gave 402 in good yield (Scheme 2.20). 
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Scheme 2.20: a) DCC, DMAP, tosyl acetic acid, DCM, rt, 16 h, 92%; b) BSA, KOAc, toluene, ∆, 16 h, 91%. 
 
As discussed earlier, the dCr reaction was attempted using DBU and TBDMSOTf (as in the 
case of formation of 399). However, this did not result in any product formation and clean 
starting material 401 was recovered (Scheme 2.21). Therefore the original dCr procedure was 
used, involving BSA as the silylating agent and KOAc as the base.2 (i) The inability of the 
DBU–TBDMSOTf procedure to successfully rearrange 401 to 402, when compared to BSA–
KOAc, is because acetate ion is required in order to facilitate the silyl transfer step, resulting 
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in decarboxylation of 401.2(i) However, when using DBU in the dCr of 398 an alternative dCr 
mechanism becomes apparent (Scheme 33), which does not require acetate assisted 
desilylation-decarboxylation. In this case, after [3,3]-sigmatropic rearrangement, 
decarboxylation is achieved via silatropic rearrangement in a formal retro-ene reaction.2(iv)
 
 
H3CO
O
O
O
Ts
H3CO
O
O
O
Ts
SiR3
H3CO
O
O
O
Ts
R3Si
[3,3]
H3CO
O
O
O
Ts
R3Si
H3CO
O
Ts
SiR3
-CO2
H3CO
O
Ts
398
399
 
 
Scheme 2.21: Proposed alternative dCr reaction. 
 
Alternatively, treating 402 with 2 equivalents of nBuLi followed by methyl formate treatment 
provided 399 in a high (81%) yield. Excess base is needed due to the high acidity of the 
newly formed α-proton in 399, which results in the consumption of one equivalent of 
additional base in the carboxylation reaction. 
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2.1.2.3. Regioselective Ring-Opening of Aziridines 
 
Aziridines are invaluable intermediates for nitrogen-containing molecules and have become 
increasingly popular in recent decades with respect to their use as building blocks in synthetic 
chemistry,33,34 especially for nitrogen-containing bioactive natural compounds.35 
Regioselective ring-opening depends on the nature of both the aziridine and incoming 
nucleophile. In general, 1,2-disubstituted aziridines mirror similarly substituted epoxides, in 
that they suffer attack at the less substituted end. Where both carbon atoms are substituted, 
competing steric and electronic effects may be such that regioselectivity of nucleophilic ring-
opening is eroded. For example, this changes when the C–N bonds are polarized unequally, 
thus favoring one over the other by the increased formation of a positive charge at the more 
substituted carbon atom.16 It is widely accepted that aziridines containing an electron-
withdrawing group at the N-position, such as sulfonyl, phosphoryl and carbonyl, are more 
reactive with regard to ring-opening than their N-alkyl or N-unsubstituted counterparts.36 
 
Previous studies have demonstrated regioselective ring-opening of 1,2,3-trisubstituted 
aziridines by use of sulfone-stabilized carbanions using both terminal lithiated methylhydroxy 
and vinyl moieties at the ring carbon adjacent to the double bond if the nucleophile is not 
excessively hindered.14,16,17 For example, initial test reactions with (2R,3R) aziridine 404 and 
the lithio anion of 403 gave a single regioselective product  405 (Scheme 2.22).16  
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Scheme 2.22: Regioselective sulfone-aziridine ring-opening. 
 
In a similar fashion, the conjugate base of acetal 406 gave a single regioisomer which could 
be cyclized into tetrahydropyridine 409 upon treatment with BF3 (Scheme 2.23).37  
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Scheme 2.23: Regioselective opening of sulfone-aziridine 404 with acetal 406, and subsequent cyclization. 
 
More complex sulfone-stabilized anions showed a similar trend upon exposure to comparable 
reaction conditions. Treatment of methyl 2-phenylsulfonylacetate 410 with KH formed the 
potassium enolate of 410. Upon nucleophilic aziridine ring-opening of 404 at the less 
hindered carbon, γ-lactam 411 was isolated following in situ cyclization (Scheme 2.24).16 
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Scheme 2.24:  KH induced γ-lactam formation. 
 
These results show a powerful directing effect of the vinyl moiety towards regioselective 
aziridine ring-opening. This may be attributed to selective weakening of the aziridine C–N 
bond proximal to the olefin by piC–C → σ*C–N overlap. Exposure of vinyl aziridines to 
organomagnesium38 and organocopper39 reagents predominantly give the SN2’ products, as do 
the more sterically hindered organolithium reagents.16 In addition, ring-opening experiments 
were carried out using both hydroxy aziridine 413 and 388 in order to probe regioselectivity. 
Exposure of these hydroxyaziridines to the lithio-anions of 412 and 406 gave the 
corresponding regiochemical adducts 414 and 415. It seems likely that the lithiated oxygen 
moiety interacts with both the electrophile and the nucleophile, thus directing the incoming 
nucleophile towards the proximal aziridine carbon (Scheme 2.25).15,16 Protection of the 
hydroxy moiety by MOM gave a mixture of regioisomers as expected, further supporting this 
assumption. 
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Scheme 2.25: Regioselective sulfone-aziridine opening using sulfone-anions of 412 and 406. 
 
Alkylation reactions40,41 of this type have been known to work by deprotonating the α-acidic 
proton of sulfone-anions with nBuLi prior to addition to the O-lithiated hydroxyaziridine. As 
discussed earlier, lithium-chelation control should enable correct regioselectivity regarding 
the aziridine ring-opening (Scheme 2.26). When considering lithium chelation between the N-
aziridine hydroxy and sulfone-stabilized anion intermolecular ring-opening at the less 
hindered carbon is induced as illustrated in model 416.  
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Scheme 2.26: Sulfone-anion mediated opening of hydroxy-aziridine. 
 
Following the successful preparation of dCr adducts 380 and indolic hydroxy aziridine 388, 
attempts to regioselectively ring-open 388 to provide 417 were investigated (Scheme 2.27).  
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Scheme 2.27: Sulfone-anion mediated aziridine ring-opening reactions. 
 
Experiments involving the nucleophilic ring-opening of aziridine 388 with the sulfone-
stabilized lithio-enolate of 380 (R1 = CO2CH3) did not result in the formation of the desired 
product 417. The prospect of producing a quaternary center, together with the high level of 
steric interference already present within this nucleophile might have proved too demanding 
for reaction of the subsequent lithio-enolate.  
 
In light of the unsuccessful attempts described above, application of the lower homologue to 
the nucleophilic ring-opening of aziridinol 388 was investigated (R1 = H). As stated earlier, 
the use of secondary sulfone-stabilized lithio-anions in aziridine ring-opening reactions 
proven had to be reliable.16 Addition of nBuLi to 380 (R1 = H) showed an immediate colour 
change, which has previously been reported as evidence for the formation of the sulfone-
stabilized lithio-anion.13,14 However, in none of the experiments was the aziridine ring-opened 
product 417 obtained, or consumption of hydroxyaziridine 388 observed. TMEDA, a well 
known nBuLi co-solvent responsible for increasing the nucleophilicity of lithio-anions by 
complexation with the lithium counter-ion, was also used, yet proved equally unsuccessful. 
Increased concentrations, variations of temperature, reversal of addition, application of nBuLi 
to both reagents and use of an excess of nBuLi all failed to contribute to the formation of 417. 
Interestingly no consumption of hydroxyaziridine nor the sulfone-stabilized anion was 
observed. 
 
Use of 1,10-phenanthroline42 (nBuLi indicator) did detect an excess of nBuLi in the reaction 
mixture. The carbanion used simply did not seem to be sufficiently nucleophilic to react with 
the N-sulfonyl activated aziridine.  
 
More demanding reaction conditions were therefore required in order to facilitate the ring-
opening of aziridine 388. It was thought that conversion of the hydroxy moiety into the 
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corresponding terminal olefin, as suggested in the retrosynthesis, would allow harsher 
reaction conditions to be employed without risk of aza-Payne rearrangement (occurs at rt 
when utilizing nBuli and 0 oC for NaH). 
 
2.1.2.4.  Towards Vinylogous Aziridine 419  
 
Conversion of alcohol 388 into the corresponding olefinic aziridine 419 could be achieved by 
conversion of the alcohol into the aldehyde followed by Wittig olefination.43 Prolonged 
exposure to air resulted in extensive decomposition of the unstable aldehyde, and therefore 
the oxidation method used had to deliver a quantitative yield of the aldehyde following facile 
work-up.  
 
From four different oxidation techniques, IBX, Dess–Martin, Parikh–Doering and Swern 
oxidation, IBX was selected due to its ease of application and subsequent work-up in 
combination with a high yield of crude aldehyde 418 (Scheme 2.28).  
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Scheme 2.28: a) IBX, DMSO, rt,16 h, 75%;  b) Ph3P+CH3Br-, NaHMDS, THF, rt, 1.5 h, 12%. 
 
Subsequent olefination of the aldehyde using the Wittig reaction43 gave 419 in low yield on a 
small scale but decreased even more dramatically when on a larger scale with the olefin being 
isolated in only 12% yield13,44 in contrast to earlier results published by Hyland.14 Changes in 
the phosphonium species (iodide instead of bromide) and the base used to generate 
methylenetriphenylphosphorane (commercially available sodium hexadimethylsilazide was 
more concentrated than the potassium analogue: 2 M vs 0.1 M) did not increase the yield.44 
These conversions had already been described by previous group members who had shown 
the ready decomposition of α,β-aziridinoaldehydes to give complex mixtures.16  
Alternative pathways for the synthesis of the vinyl aziridine 419 using hydroxy aziridine 388 
were therefore investigated. It was considered that Julia–Lythgoe olefination could provide 
the vinyl aziridine 419 via sulfone-aziridine acetate 420 (Scheme 2.29).  
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Scheme 2.29: Proposed Julia–Lythgoe olefination of 420.  
 
The Julia–Lythgoe olefination incorporates the use of methanol and sodium amalgam in order 
to facilitate the formation of an alkene.45 This procedure was first reported by Julia46 in 1973 
and has since proven to be a valuable tool in the synthesis of alkenes. In most cases sodium 
phosphate buffers are used in order to control the pH of the reaction and prevent any 
unwanted alkoxide-induced side-reactions from taking place.47 The reaction is believed to be 
initiated by the formation of methoxide, from reaction of sodium and methanol (Scheme 
2.30). Deprotonation at the α-carbon to the sulfone in A results in alkene formation and 
acetate expulsion to give B. A radical reaction then reduces the vinyl sulfone to a vinyl radical 
D and subsequent single electron donation gives the ionic species E with sodium acting as the 
counterion. Quenching of the ionic species finally results in formation of the desired terminal 
olefin F. 
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Scheme 2.30: Julia-Lythgoe mechanism. 
 
Synthesis of 420 from 388 involved use of IBX oxidation to give the aldehyde 418 (Scheme 
2.31). Nucleophilic attack of the lithio-anion of methyl phenyl sulfone at the aldehyde and 
subsequent acetic anhydride quench of the oxanion adduct gave 420. 
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Scheme 2.31: a) IBX, DMSO, rt, 16 h; b) i) Phenylsulfonyl methane, nBuLi, THF,  –78 °C → –40 °C, over 3 h; 
ii) Ac2O, rt, 15 min, 74%. 
 
Julia olefination of 420 using the classic Na/Hg reagent would inevitably produce a 
methoxide-mediated aziridine ring-opened side product. This in combination with the use of 
substantial amounts of mercury severely limited this conversion. On the other hand, Julia 
olefination mediated by SmI247 provided an attractive alternative, since no alkoxides are 
involved, thereby providing a different pathway compared to sodium amalgam (Scheme 
2.32). 
 
This pathway is initiated by a radical reaction at the aromatic sulfone A. This is followed by 
expulsion of the phenylsulfinate ion, resulting in formation of alkyl radical D. Donation of a 
second electron from SmI2 to radical D then affords the intermediate organosamarium 
derivate E, which undergoes β-elimination to yield the olefin F.  
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Scheme 2.32: Alternative Julia–Lythgoe mechanism. 
 
Use of freshly prepared SmI2 was vital to the success of this reaction and therefore was 
prepared in situ.48 Addition of HMPA or DMPU has commonly been reported to increase the 
overall reactivity of the reagent in these processes.49 
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Experiments involving 420, SmI2 and DMPU did not result in any product formation and only 
starting material was observed (Scheme 2.33).  
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Scheme 2.33: SmI2 mediated Julia olefination attempt. 
 
During the experiment a color change was observed from purple to grey indicating 
decomposition of the SmI2 reagent. 
 
Examples of both acetate and benzoate esters used in the Julia olefination are known in the 
literature.50 Using a similar reaction pattern to that of the Julia acetate substrate, but 
quenching the sulfone-alkoxide intermediate with benzoyl chloride instead of acetic 
anhydride, resulted in formation of the benzoate ester in 40% yield. Subsequent experiments 
involving 421, SmI2 and DMPU resulted in formation of 422 (Scheme 2.34).  
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Scheme 2.34: a) SmI2, DMPU, THF, rt, 30 min, 40%. 
 
An explanation for the formation of this unusual side-product can be found when examining 
the radical reaction involved. Markó reported a similar observation when using β-benzyloxy 
sulfone esters instead of the corresponding β-hydroxy sulfones.51 He reported a change in 
mechanism when applying the SmI2 protocol to benzyloxy containing compounds (Scheme 
2.35). When applying this protocol to benzyloxy sulfone ester A, single electron transfer takes 
place at the benzoate moiety B. A process described as being much easier and taking place 
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very rapidly even at very low temperatures (–84 oC), when compared to the β-hydroxy 
sulfones. Expulsion of the benzoate to give C, followed by donation of a second electron from 
SmI2 to radical C then affords the intermediate organosamarium derivate D, which undergoes 
elimination towards the tosyl-activated aziridine. Subsequent removal of the aromatic sulfone 
in E takes place as described earlier and ultimately results in the formation of olefin F.  
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Scheme 2.35: Alternative Julia–Lythgoe mechanism. 
 
A different olefination reaction, the Peterson reaction52 (Scheme 2.36), was investigated in 
order to gain access to vinyl aziridine 419. The intermediate β-hydroxy silane A can be 
isolated from the corresponding aldehyde, and the subsequent Peterson elimination step, can 
be performed separately. Both acid and base conditions can be used to trigger the elimination 
step, yet the outcome results in different stereoisomers. In our case, base was believed to lead 
to aza-Payne rearrangement prior to elimination and thus was not an option. Aqueous acid 
treatment of the hydroxysilane would trigger a similar β-elimination to that described for the 
Julia–Lythgoe olefination and should result in the formation of olefin C.  
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Scheme 2.36: Acid-induced Peterson olefination. 
 
Attempts to isolate Peterson precursor 423 proved unsuccessful due to the unstable nature of 
the product (Scheme 2.37). An one-pot strategy towards vinyl aziridine 419 involved 
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exposing crude 423 to acid, to no effect and only decomposition was observed. Further 
investigations into this type of olefination reaction were abandoned. 
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Scheme 2.37: a) IBX, DMSO, rt, 16 h.  
 
2.1.2.5.  Tryptophan-Based Approach Towards 419 
 
All α,β-aziridinoaldehyde-based olefination approaches had proven to be unsuccessful in 
providing the vinyl aziridine, and a major factor had been the instability of the aldehyde 
involved.16 Therefore, a new strategy using L-tryptophan was proposed. In this strategy, we 
envisaged the successful synthesis of vinyl aziridine 419 by application of the Mitsunobu 
condensation of tosylamino-alcohol 424 (Figure 2.3). This compound would be constructed 
using a Wittig reaction followed by an in situ Brook rearrangement53 to give the 
corresponding syn-vinylogous hydroxy-amine 424 upon desilylation. Direct addition of vinyl 
Grignard to 425 was suspected to provide a mixture of syn- / anti-vinylogous 424. Synthesis 
of the presumed unstable aldehyde 425 would involve selective DIBAL ester reduction of the 
fully protected L-tryptophan derivative 426. 
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Figure 2.3: Revised synthesis of vinyl aziridine 419. 
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Attempts to optimize the full protection of L-tryptophan had already been thoroughly 
investigated by previous group members Ioannidis and Rahn.54 Methylation of the indole 
amine was achieved by use of NaNH2–CH3I in liquid ammonia (Scheme 2.38). Initial 
addition of excess CH3I severely complicated the work-up of the reaction and proved to be 
unnecessary. Equally, a decrease in reaction concentration from 0.5 M to 0.1 M further 
increased the yield and simplified the purification of the product considerably. Esterification 
of the N-methylindole 427 with methanol in the presence of SOCl2 afforded 428 and was 
followed by N4-tosylation to furnish 426 as reported.54     
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Scheme 2.38: a) CH3I, cat. FeCl3, NH3, –78 °C, 5 h, 91 %; b) SOCl2, CH3OH, ∆, 4 h, 99 %; c) TsCl, TEA, 
DCM, rt, 16 h, 80%. 
 
Synthesis of syn-vinylogous amino alcohol 424 was more desirable as earlier investigations 
using similar systems revealed the difficulty of ring-opening trans-vinyl aziridines, with a 
preference for SN2’ at the vinyl-position instead. When comparing both conformations of cis- 
and trans-vinyl aziridines, it becomes obvious that the cis-product is more strained due to 
steric hindrance at both aziridine positions, making it more susceptible to ring-opening. In 
contrast the trans-isomer is less constrained and as a result far less reactive.13  
 
Depending on the stability of aldehyde 425, DIBAL reduction of ester 426 would either be 
exposed immediately to the Wittig reaction and Brook rearrangement or, purified prior to 
exposure. The application of the required Wittig reagent has been reported by Taddei et al,53 
whereby simple α-amino aldehydes are used in order to obtain high quantities of syn-
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vinylogous amino alcohols in a Cram-selective fashion. Based upon the work of 
Tokoroyama,55 β-silylphosphorous ylides B prepared in situ react with α-alkyl- or α-alkoxy 
aldehydes A to give the vinylogous products D via silyl group migration towards the oxygen 
with expulsion of triphenylphosphine (C) (Scheme 2.39).  
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Scheme 2.39: Wittig reaction followed by Brook rearrangement. 
 
The transition state during these reactions favors chelation-controlled si attack (Figure 2.4). In 
the same article a substantial reduction of selectivity was observed when using compounds 
with a trisubstituted amine in which case undesired re attack is significantly increased (Figure 
2.4).53,55  
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Figure 2.4: Chelation control, si versus non-chelation control, re attack. 
 
Optimization of the in situ ester reduction followed by the one pot Wittig / Brook 
rearrangement proved to be impossible (Scheme 2.40). Over-reduction of 426 by DIBAL to 
the corresponding alcohol (80% yield) severely hampered the reaction. Lowering the amount 
of the reducing agent to one equivalents from two equivalents did not result in any aldehyde 
425 formation at –78 oC, instead resulting in partial alcohol formation as soon as the 
temperature reached –40 oC. In order to circumvent this problem, a new route was proposed 
which involved the re-oxidation of the alcohol to aldehyde 425 prior to the Wittig treatment.  
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Scheme 2.40: a) DIBAL, THF, 0 oC, 30 min; b) i) Ph3P=CHCH2Si(CH3)3, nBuLi, THF, –78 oC; ii) TBAF, THF, 
rt, 30 min, 23% (3 steps).  
 
Although the reduction of ester 426 to the corresponding alcohol was achieved in high yield 
using LiAlH4, aldehyde 425 proved to be unstable during work-up and would start to readily 
decompose, resulting in a low yield (Scheme 2.41). Although NMR analysis showed 
complete selectivity towards the syn-diastereomer of the alcohol this route was deemed 
unviable due to the low yield of 424.  
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Scheme 2.41: a) LiAlH4, THF, 0 oC, 16 h, 80%; b) IBX, DMSO, rt, 16 h, 95%; c) i) Ph3P=CHCH2Si(CH3)3, 
nBuLi, THF; ii) TBAF, THF, rt, 30 min, 33% (2 steps).  
 
An article by Jurczak et al.56 reports a DIBAL reduction of an N-monoprotected α-amino ester 
followed by in situ treatment with vinyl Grignard to obtain the corresponding vinylogous 
amino alcohol. Initial reactions involving the addition of vinyl Grignard to amino aldehydes at 
room temperature showed moderate selectivity (3 : 2) towards the syn-product. Reduction of 
the temperature to –78 oC showed a preference towards anti (30 : 70). As in the case of the 
Wittig / Brook protocol, the same Cram chelation-control model is proposed. A similar 
preference for syn-selectivity was observed by Ibuka,57 and this was ascribed to the enhanced 
chelation of the aldehyde by aluminium (ratio syn : anti 90 : 10). Both groups reported 
problems regarding the reproducibility of the yields involved  (30 – 50%).  
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When using this protocol for the olefination of 425, a mixture of both diastereomers of 424 
(41%; 80 : 20 in favor of syn) together with the corresponding alcohol of 426 (40%) was 
obtained. Attempts to optimize this reaction failed to give increased yield or selectivity 
(Scheme 2.42). 
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Scheme 2.42: a) DIBAL, THF, 0 oC; b) vinyl Grignard, THF, 0 oC → rt, 2 h, 41% (2 steps). 
 
In a similar article by Ali,58 using the Ireland–Norbeck protocol,59 Swern oxidation of an α-
amino alcohol was followed by in situ treatment with vinyl Grignard to give the 
corresponding vinylogous syn-α-amino alcohol as a single isomer. However, applying the 
same oxidation protocol to our amino alcohol 429 followed by vinyl Grignard treatment 
resulted in complete decomposition (Scheme 2.43). 
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Scheme 2.43: a) IBX, DMSO, rt, 16 h. 
 
As conversion of ester 426 into the corresponding vinylogous amino alcohol 424 via aldehyde 
425 had been unsuccessful, we envisaged an alternative route from 426 which would include 
the use of Weinreb amide 430 (Scheme 2.44). Treatment with vinyl Grignard would result in 
the formation of vinyl ketone 431,60 which via selective reduction of the vinyl ketone to the 
syn-amino alcohol 424, followed by Mitsunobu condensation would provide 
diastereoselective vinyl aziridine 419. 
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Scheme 2.44: Anticipated route towards vinyl aziridine 419. 
 
Following the original Weinreb amide synthesis route using amidation of a carboxylic acid 
with the hydrochloric salt of (methoxy)methyl amine, an alternative was reported by 
Shimizu61 using Me2AlCl. While this procedure, using Me2AlCl, had already been reported 
by Weinreb, Shimizu observed unsatisfactory results in the case of sterically crowded 
lactones. The reactive species formed in situ during this process is Cl2Al-NCH3(OCH3) with 
the evolution of two equivalents of methane using 2–5 equivalents of the aluminium source. 
A number of variations have since been reported, all using strong Lewis acid / nucleophilic 
reagents such as (OCH3)NCH3-MgCl62 and (OCH3)NCH3-SnCl.63 
Application of the Shimizu protocol to our ester 426 did not provide the corresponding 
Weinreb amide 430, with decomposition being observed. Failure of this reaction might be due 
to the presence of a tosamide moiety in close proximity to the carbonyl group (Scheme 2.45). 
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Scheme 2.45: Application of Shimizu protocol to 426. 
 
Synthesis of the Weinreb amide was achieved by saponification of ester 426 with LiOH, 
followed by amidation using a peptide coupling agent and the hydrochloride salt of 
(methoxy)methyl amine (Scheme 2.46). Use of EDCI as the coupling agent led to moderate 
conversion of carboxylic acid 432; changing the coupling agent to DIC in combination with 
TEA and a catalytic amount of DMAP increased the yield to 95% of Weinreb amide 430.  
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Scheme 2.46: a) LiOH, DME, H2O, rt, 2 h, 95%; b) (Methoxy)methyl amine, DIC, DMAP, TEA, DCM, rt, 16 h, 
95%. 
 
Exposure of the Weinreb amide 430 to vinyl Grignard gave the corresponding vinyl ketone 
431 after acidic work-up (Scheme 2.47).60 With the vinyl ketone in hand, subsequent selective 
reduction experiments were carried out in order to generate the desired syn-stereoselective 
vinylogous amino alcohol. 
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Scheme 2.47: a) Vinyl Grignard, THF, rt , 16 h, 95%. 
 
Several methods for the stereoselective reduction of ketones into alcohols have been reported 
in the literature. A selection was made and applied to our vinyl ketone 431; the results are 
collected in Table 2.2. 
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Scheme 2.48 and Table 2.2. Attempts to stereoselectively reduce ketone 431 to amino alcohol 424. 
 
Entry Conditions Ratio (syn : anti) Yield 
1 CeCl3 / NaBH4, rt, 5 min 1 : 1 95% 
2 CBS / BH3·THF, rt, 16 h n / a SM 
3 TiCl4 / BH3·pyridine, –78 oC, 2 h n / a Decomposition 
4 Selectride / CeCl3, –78 oC, 2 h n / a Decomposition 
5 NaBH4 / LiCl, rt, 5 min 1 : 1 80% 
6 LiBH4, rt, 30 min 1 : 1 90% 
7 Zn(BH4)2, rt, 16 h  n / a SM 
8 DIBAL, –78 oC → rt, 30 min 1 : 2.8 96% 
 
The Luche reduction has been reported by Spaltenstein64 to give the vinylogous syn-α-amino 
alcohol with moderate stereoselectivity when applied to its vinylogous ketone counterpart (3 : 
1, syn : anti). While this method can be applied without the requirement for moisture / air 
exclusion and includes easy work-up, high yields and fast reaction times, no selectivity was 
observed either at rt or at T = –78 oC (entry 1).  
 
Stereoselective reduction of vinylogous alcohols has been thoroughly described by Corey et 
al.65 and has led to the development of the Corey–Bakshi–Shibata catalyst. 
Prepared in situ from (S)-diphenylprolinol and BH3·THF, the CBS catalyst is reported to react 
rapidly with a large variety of ketones, with easy recovery of the dipenylprolinol ligand. The 
method uses very low catalyst loadings (typical 0.6 equivalents BH3 : 0.05 equivalents 
diphenylprolinol) (Scheme 2.49).  
 
 Results and Discussion 
 
  138 
N
B
O
H
H
Ph
Ph
+ BH3 NH+
B
O
H
H
Ph
Ph
H3B
RSCORL
N+
B
O
H
H
Ph
Ph
B-
H
H H ORS
RL
N+
B
O
H
H
Ph
Ph
H2B
O
RS RL
H
BH3 O
RS RL
H
BH3 N+
B
O
H
H
Ph
Ph
H3B
+
 
 
Scheme 2.49: CBS-catalyst activation and mechanism. 
 
Surprisingly, the CBS catalyst proved to be inert (entry 2). In order to ascertain the quality of 
our catalyst, a small test reaction was conducted with cyclohexanone which showed rapid 
reduction to cyclohexanol.  
 
Marcantoni66 published an article describing the use of TiCl4 / BH3 and LiEt3BH (L-
selectride) / CeCl3 on α-alkyl-β-keto sulfones. While the strongly chelating TiCl4 was 
reported to lead to the syn-product, application of L-selectride / CeCl3 protocol showed a 
strong preference for the Felkin–Ahn model resulting in anti-formation. It is unclear whether 
cerium, as stated by the author, is non-chelating.66 Use of both methods resulted in 
decomposition, probably due to the harsh reaction conditions employed in these reductions 
(entry 3 and 4).  
 
Hoping to induce some form of metal-chelation control, and thus a more stereoselective 
outcome, application of NaBH4 and LiBH4 was proposed. In both cases no stereoselectivity 
was observed, yet use of LiBH4 in contrast to NaBH4 / LiCl took considerably longer (entry 5 
and 6). 
 
Narasimhan67 reported the use of Zn(BH4)2 in reducing carboxylic acids to their 
corresponding alcohols. Experiments involving this reagent did not give the vinyl ketone, and 
further attempts were aborted (entry 7).  
 
As a last attempt to facilitate stereoselective ketone reduction, the use of DIBAL was 
proposed. Katsumura68 reported a 14 : 1 anti : syn ratio when applying DIBAL to his vinyl 
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ketone. Interestingly we observed a significantly lower stereoselectivity, though still in favor 
of the anti-product (1 : 2.8, syn : anti, entry 8). 
 
Previous research had shown a lack of reactivity when using trans-vinyl aziridines in 
combination with sulfone-anions.13 The different composition of vinylaziridine 419 in regard 
to earlier aziridine substrates would hopefully prove to increase general reactivity. Therefore, 
use of a CeCl3 / NaBH4 procedure, incorporating an easy work-up and robust application was 
used in the reduction of vinyl ketone 431 into diastereomeric vinyl amino alcohol 424. A high 
yield of the aforementioned racemate was obtained (Scheme 2.50). Subsequent Mitsunobu 
reaction gave a 1 : 1 mixture of cis and trans vinyl aziridines 419. Separation of the 
diastereomers of 424 had previously been described by S. Carballares in which he utilized 
TBSCl, significantly improving separation by column chromatography.13 However, no 
attempt to separate the aziridine mixture was undertaken in this report.   
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Scheme 2.50: a) CeCl3, NaBH4, CH3OH, rt, 5 min, 95%, b) DIAD, PPh3, THF, rt, 30 min, 96%.  
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2.1.2.6. Ring-Opening of Aziridine 419 
 
To ascertain the reactivity of diastereomeric vinyl aziridine 419, test reactions were carried 
out using the sulfone-anion of 432, in order to facilitate aziridine 419 ring-opening (Scheme 
2.51, Table 2.3). Throughout these optimization attempts, the amount of base being used 
equaled the amount of pre-nucleophile + 1 extra equivalent. 
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Scheme 2.51 and Table 2.3: Attempts to ring-open aziridine 419 using tosyl nucleophile 432. 
 
Entry Ratio 432 : 419 Reaction 
Concentration 
Reaction Conditions Yield 
1 1 : 1 0.5 M –78 oC → rt, 16 h 0% 
2 1 : 1 0.5 M –40 oC → rt,16 h 0% 
3 1 : 1 1.0 M –40 oC → rt, 16 h 48%1 
4 1 : 1 2.0 M –40 oC → rt, 16 h 47%1 
5 2 : 1 2.0 M –40 oC → rt, 16 h 48%1 
6 3 : 1 2.0 M –40 oC → rt, 16 h 89% 
7 1 : 1 3.0 M –40 oC → rt, 16 h 47%1 
8 2 : 1 3.0 M –40 oC → rt, 16 h 87% 
9 3 : 1 3.6 M –40 oC → rt, 16 h 90% 
10 1 : 1 4.0 M –40 oC → rt, 16 h 0%2 
1
 = only cis opening of aziridine 419 
2
 = decreased solubility inhibited the reaction from taking place. 
 
Initial results revealed the ineffectiveness of the nucleophile when using standard reaction 
conditions due to insolubility of the newly formed sulfone-anion (entry 1). Increasing the 
temperature did increase the solubility, but did not facilitate aziridine ring-opening (entry 2). 
Concentrating the reaction mixture indicated product formation; only the cis-diastereomer 
was consumed (entries 3, 4 and 5). Complete conversion of diastereomeric vinyl aziridine was 
achieved following further optimization; using three equivalents of sulfone anion at a 
concentration of 3.6 M gave the highest-yielding reaction (entry 8). A concentration of 3.6 M 
proved to be the upper limit, as higher concentrations (entry 10) resulted in insolubility of the 
reagents.  
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Applying mild reaction conditions to vinyl aziridine 419 using the more sterically demanding 
sulfone 402 revealed the same lack of reactivity as that described earlier. Use of the optimized 
reaction conditions resulted in total consumption of the starting material, and diolefinic amine 
434 was obtained in high yield (Scheme 2.52, Table 2.4).   
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Scheme 2.52 and Table 2.4: Attempts to ring-open aziridine 419 using tosyl nucleophile 402. 
 
Entry Ratio 402 : 419 Reaction 
Concentration 
Reaction Conditions Yield 
1 1 : 1 0.5 M –40 oC → rt, 16 h 0% 
2 1 : 1 2.0 M –40 oC → rt, 16 h 0% 
3 3 : 1 3.6 M –40 oC → rt, 16 h 94% 
 
Having successfully obtained 434, Grubbs II mediated RCM reaction could provide 
cyclopentene 435 (Scheme 2.53). Lewis had already utilized a similar cyclopentene, and had 
observed pyridine-N-oxide formation as evidenced by mass spectrometry, after several 
unsuccessful attempts at alkylation α- to the cyclopentene tosyl group (section 2.1.1, page 
103). 
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Scheme 2.53: Route towards cyclopentene 436. 
 
Attempts to open the same diastereomeric vinyl aziridine 419 with the higher homologue 399 
using the sodium enolate were investigated. A similar protocol had previously been developed 
regarding the synthesis of γ-lactams from the sulfone-enolate assisted ring-opening of vinyl 
aziridines followed by intramolecular condensation (Scheme 2.54, Table 2.5).14,16   
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Scheme 2.54 and Table 2.5: Attempts to ring–open aziridine 419 using tosyl nucleophile 399. 
 
Entry Ratio 399 : 419 Reaction 
Concentration 
Reaction Conditions Yield1 
1 1 : 1 0.3 M 60 oC, 16 h 0% 
2 1 : 1 1.0 M rt, 16 h 45% 
3 
4 
5 
1 : 1 
1 : 1 
1 : 1 
2.0 M 
3.0 M 
3.6 M 
rt, 16 h 
rt, 16 h 
rt, 16 h 
42% 
44% 
46% 
1
 = yield of trans-isomer regained. 
 
Initially, there was no evidence of product formation using standard reaction conditions, with 
complete decomposition being observed (entry 1). Decreasing the reaction temperature to 
room temperature did improve the reaction (entry 2). Further optimization led to the 
consumption of the cis-isomer, resulting in the formation of a complex mixture of products 
and isolation of the unreacted trans-diastereomer (Scheme 2.55). This trend of selective cis-
aziridine opening has been observed in previous research,13 and is thought to be due to the 
closer proximity of functional groups, and the more sterically strained nature of the aziridine 
when compared to its trans-counterpart. 
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Scheme 2.55: NaH-induced nucleophilic ring-opening of aziridine 419 using sodium enolate nucleophiles of 
399. 
 
A strategy involving utilization of a less complex, therefore more reactive sulfone-anion 
related to 399 was proposed. 
 Results and Discussion 
 
  143 
2.1.3.  Second Generation Approach 
 
In light of the problematic nucleophilic ring-opening of vinyl aziridine 419 with the sodium 
enolate of 399 described above, a second route towards the total synthesis of (±)-suaveoline 
was proposed. This strategy would utilize similar transformations, but would involve the 
aziridine ring-opening of 419 with the structurally less complex ester 443. Retrosynthetically, 
formation of the pyridine, together with the construction of the azabicyclo [3.3.1] core would 
involve chemistry already discussed in section 2.1.2, page 111, involving de novo pyridine 
synthesis3 together with cis-Pictet–Spengler cyclization (Figure 2.5).4 Pictet–Spengler adduct 
439 would be obtained by substitution of the OP functional group in 440 with a cyanide 
moiety, thus providing a masked aldehyde and simultaneously allowing C–C homologation.  
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Figure 2.5: Second route towards suaveoline. 
 
Disconnection of the cyclopentene in 440 revealed diolefin 441, which we anticipated to 
complicate RCM due to the lack of guaranteed syn-stereochemistry of the olefinic moieties. In 
our view the syn-diastereomer of 441 would undergo RCM, while the anti-diastereomer 
would not due to conformational constraints.13,44 Therefore, γ-lactam 441 would undergo N-
carbonyl cleavage facilitated by Superhydride or NaBH4 to provide a more flexible 444 
product (Scheme 2.56).  
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Scheme 2.56: Forward synthesis of cyclopentene 440. 
 
In contrast to the structurally more complex olefinic ester 399, sulfone-ester 443 does not 
contain an olefinic moiety, and therefore this had to be installed after the initial γ-lactam 
formation from vinyl aziridine 419 and the sulfone-nucleophile of 443 (Scheme 2.57). 
Enolization of lactam 443 using NaH would be followed by subsequent addition of 3-
iodopentene (prepared in situ by treatment of 3-bromopentene and TBAI). Claisen 
rearrangement would then give the corresponding [3,3]-sigmatropically rearranged diolefin 
441.2 Similar reactions on γ-lactams were previously reported to proceed in high yields.14,44  
 
2.1.3.1. γ-Lactam Formation 
 
Attempts to obtain γ-lactam 442 from the sulfone-stabilized ring-opening of vinyl aziridine 
419 with methyl phenylsulfonyl acetate 443 are listed in Table 2.6.  
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Scheme 2.57 and Table 2.6: Attempts to ring-open aziridine 419 using tosyl nucleophile 443. 
 
Entry Ratio 443 : 419 Reaction 
Concentration 
Reaction Conditions Yield1 
1 1 : 1 0.3 M 60 oC, 16 h Decomposition 
2 1 : 1 1.0 M rt, 16 h 49% 
3 
4 
5 
1 : 1 
1 : 1 
1 : 1 
2.0 M 
3.0 M 
3.6 M 
rt, 16 h 
rt, 16 h 
rt, 16 h 
23% 
0% 
Decomposition 
1
 = yield of trans-isomer regained. 
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The nucleophilic ring-opening / intramolecular condensation reaction failed to give 442. 
Initial application of the Hyland protocol14 led to the decomposition of the vinyl aziridine 419 
(entry 1). Reactions at room temperature proved to be more successful (entries 2 to 5); with 
partial consumption of the cis-diastereomer observed at 1 M. Although a subsequent increase 
in concentration led to a total consumption of vinyl aziridine 419, mass spectrometry 
indicated no product to be present in the complex mixture of products. Further increase in 
concentration led to total decomposition (entry 5). 
 
Optimization of the aziridine ring-opening reaction of 419 using the sodium enolate of 443 
might be effected by using KH as the base. This would provide a more reactive enolate 
species and therefore hopefully be more successful in forming γ-lactam 442. Due to time 
constraints, further optimization was not carried out. 
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2.2.  Alstonerine 
 
2.2.1.  Prior Work within the Craig Group  
 
The basis of the Craig group’s attempts towards alstonerine involved a previously developed 
synthetic route towards the preparation of 2,6-syn-piperidines 450 as well as 2,4-syn-THPyr 
(tetrahydropyridine) 448 from 445 (Scheme 2.57).37,69 Exposure of THPyr 445 to Lewis 
acidic conditions provided the conjugated iminium species 446, which could be attacked by a 
nucleophile at the C4 position to afford 448 or at C6 generating 449. Protonation of 445 under 
Brønsted acidic conditions generated iminium species 447 which gave 450 via nucleophilic 
attack at the C2 position.37  
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Scheme 2.57: Lewis acid / Brønsted acid conditions applied to 445. 
 
Analysis by X-ray crystallography showed the conformation of 451 to be as depicted in 
Figure 2.6. In this chair-like conformation, steric repulsion between the tosyl group and the 
C2–R moiety is minimized, and due to the N-tosyl moiety blocking β-face attack, cyclization 
(as depicted in Scheme 2.57, compound 449) can only occur on the α-face.117   
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Figure 2.6: α- and β-attack possibilities. 
 
The observed stereochemistry when using Lewis acid conditions can be attributed to the more 
accessible pi* orbital at C4 rather than C6. A model depicted as 452 shows the pi* orbital at C4 
to allow maximal overlap with the reacting pi-system in contrast to C6 (Figure 2.7).4,69 
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Figure 2.7: Accessibility of the C4 pi*-orbital. 
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2.2.1.1. The Diels–Alder Approach  
 
A key synthetic intermediate in the first strategy for the total synthesis of (–)-alstonerine 36, 
by Ioannidis,69 was ketone 455 (Figure 2.8). It was anticipated that the fifth ring would be 
formed via a regioselective aldol reaction with formaldehyde to provide β-hydroxyketone 
454. Conversion into β-ketoester 453 and subsequent Knoevenagel reaction would establish 
the fifth ring, after which oxidation level adjustment would give (–)-alstonerine 36.69  
 
The application of homochiral lithium amide bases would discriminate between both α-
positions of ketone 455 because of their quasi-enantiotopic nature.70 Furthermore, the 
approach of the formaldehyde should take place on the β-face for stereoelectronic reasons. In 
the cyclohexanone moiety the axial proton is lost due to its greater acidity as a result of 
maximum σC–H orbital overlap with the carbonyl pi*.71 It appears that attack along the α-
trajectory is both sterically hindered and stereoelectronically disfavored, leading to axial C–C 
bond formation. 
 
Ketone 455 would subsequently be formed from sulfone 456 via oxidative desulfonylation. 
456 in turn would be obtained from acid-mediated Pictet–Spengler cyclization of 457.  
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Figure 2.8: Retrosynthetic analysis of (–)-alstonerine. 
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The strategy was initiated by ring-opening of L-tryptophan-derived aziridine 458, with the 
lithio-sulfone acetal 406, obtained from acrolein (discussed in detail on page 182, Scheme 
2.117).  
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Scheme 2.58: Sulfone-anion mediated aziridine ring-opening. 
 
The diastereomeric mixture of 457 was treated with either (±)-CSA or p-TsOH to give the 
Pictet–Spengler tetracyclic product 456 (Scheme 2.59). 
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Scheme 2.59: cis-Pictet–Spengler bicyclization. 
 
Having successfully prepared the diastereomeric tetracyclic structure 456, the next step would 
involve oxidative desulfonylation (Scheme 2.60). Published reports69,72,73,74 describe these 
procedures to progress initially via α-deprotonation of the sulfone followed by reaction with 
an oxygen electrophile (peroxide), which in turn promotes the departure of the sulfonyl group 
as sulfinate anion, to form the carbonyl functionality 455.  
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Scheme 2.60: Oxidative desulfonylation mechanism. 
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In order to facilitate oxidative desulfonylation, several reagents were evaluated in 
combination with nBuLi. The molybdenum(V) reagent MoOPH72 was not tried due to its 
toxicity and instability. Despite several attempts, involving BTSP,73 chlorodimethoxyborane74 
and anhydrous lithium tbutylhydroperoxide, none of the desired ketone 455 was isolated. 
 
An alternative strategy for ketone formation involved the introduction of a thiophenyl group 
at the α-position. It was anticipated that exposure of 458 to Lewis acid would yield thionium 
ion 459, which would give ketone 455 on hydrolysis (Scheme 2.61). However, no product 
was obtained, and this was attributed to steric interference between the nucleophile and the 
indole ring, which blocks the α-face approach. 
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Scheme 2.61: Thiophenyl induced detosylation followed by α-oxidation. 
 
Following several unsuccessful attempts to obtain α-thiophenyl intermediate 458, a thioacetal 
analogue was finally obtained in unacceptably low yield.54,69  
 
A new approach to the synthesis of ketone 455 involving oxidative cleavage of terminal olefin 
460 (Scheme 2.62) proved successful when using OsO4 and NaIO4, as reported by Cook.75  
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Scheme 2.62: Oxidative cleavage of 460. 
 
However, the synthesis of 460 proved low yielding in part due to the formation of an 
inseparable mixture during alcohol oxidation and Pictet–Spengler cyclization (Scheme 2.63). 
In most cases migration of the terminal olefin into conjugation with the aldehyde was 
observed, forming conjugated enal 463.  
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Scheme 2.63: Pictet–Spengler bicyclization.  
 
Exposure of ketone 455 to Mukaiyama aldol reaction conditions76 furnished 464. However, 
attempted β-ketoester formation from 464 resulted in substrate decomposition, with 
regeneration of ketone 455 (Scheme 2.64). Earlier attempts to install the α-methanol 
substituent at ketone 455 using LDA and paraformaldehyde had revealed a retro-aldol 
reaction to take place. It was hoped that reducing the amount of base to catalytic amounts in 
the β-ketoester formation step would retard the retro-aldol reaction, to no avail.69 
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Scheme 2.64: Mukaiyama aldol reaction followed by β-ketoester formation. 
 
In light of the unsuccessful attempts described above, a second approach was pursued. The 
new strategy involved hetero-Diels–Alder reaction of diene 467 with formaldehyde to 
construct the fifth ring in 466 (Figure 2.9). The diene would be prepared from aziridine ring-
opening of 458 with the desulfonylated sulfone-anion of 471. This cyclopentene would 
provide a 1,5-dialdehyde via oxidative cleavage. Dialdehyde 469 could be used in the cis-
Pictet–Spengler cyclization via cyclic iminium formation, and subsequent desulfonylation 
would provide enal 468, which upon enolate O-silylation would provide the conjugated diene 
467.54  
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Figure 2.9: Second retrosynthetic analysis of (–)-alstonerine 36. 
  
Bis(phenylsulfonyl)cyclopentene 471 was made from thiophenol and could be prepared in 
large quantities in three steps (Scheme 2.65).69 Aziridine ring-opening of 458 was carried out 
using lithium naphthalide-mediated desulfonylation of 471, giving 470.54,77  
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Scheme 2.65: Aziridine ring-opening by desulfonylated 471. 
 
In initial studies, oxidative cleavage of the cyclopentene double bond with OsO4 and NaIO4 
gave compound 472 instead of the desired aldehyde intermediate (Scheme 2.66).  
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Scheme 2.66: Oxidative cleavage followed by acid induced Pictet–Spengler cyclization. 
 
The acidic conditions used in the reaction resulted in formation of cyclic iminium 473 in 
which the C4-sulfonyl moiety had been removed. As such an allylic carbocation 473 was 
formed which underwent Pictet–Spengler cyclization at the C4 position (Scheme 2.67). 
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Scheme 2.67: Side-product formation due to Pictet-Spengler cyclization. 
 
An alternative two-step approach involved permanganate-induced dihydroxylation78 of 470 
followed by LTA (lead tetraacetate) mediated oxidative cleavage79 afforded the unstable 
dialdehyde 469 in high yield (Scheme 2.68).  
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Scheme 2.68: Dihydroxylation / oxidative cleavage of cyclopentene. 
 
Optimization of the Pictet–Spengler cyclization by treating intermediate  
469 with TFA finally gave cyclic aldehyde 475 in 80 % yield, which was converted into the 
unsaturated aldehyde 468 using mild basic conditions (Scheme 2.69). Diene formation was 
achieved in high yield using TBDPS which was found to be hydrolytically less sensitive than 
the TIPS and TBS derivatives.54  
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Scheme 2.69: Vinyl aldehyde formation, followed by trapping of silyl enolate trapping. 
 
As in the case of the aldol-type reactions attempted earlier, it was anticipated that the required 
stereochemistry at C13 would be obtained by the preferred approach of the formaldehyde from 
the top face of the diene (Scheme 2.70). Top-face attack would give a chair-like conformation 
of the piperidine ring, while bottom face approach would give a twisted-boat conformation; in 
addition, top-face attack appears to be sterically favored.69,80  
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Scheme 2.70: Conformation analysis of 476. 
 
A test reaction using maleic anhydride as dienophile gave 477, demonstrating the reactivity of 
the diene in the Diels–Alder cycloaddition (Scheme 2.71).80  
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Scheme 2.71: Diels-Alder cycloaddition of maleic anhydride. 
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Following the successful formation of adduct 477, 476 was exposed to oligomeric/polymeric 
sources of formaldehyde (paraformaldehyde, 1,3,5-trioxane) in conjunction with a range of 
Lewis acids (BF3·Et2O, lanthanide triflates, TiCl4, Me3Al, Me2AlCl), all to no avail.54,80 Use 
of monomeric formaldehyde, obtained by a modified Schlosser treatment,80,81 in combination 
with Me2AlCl provided the pentacycle 478, but in low yield; this was due to facile retro-
Diels–Alder reaction of 478, regenerating 476 (Scheme 2.72).  
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 Scheme 2.72: Successful hetero-Diels–Alder cyclization using monomeric formaldehyde. 
 
In order to prevent retro-Diels–Alder reaction and establish the syn-C13–C18 relationship via 
hydrogen addition at the less sterically hindered bottom-face of 478, attempts to hydrogenate 
the existing double bond were made using several homo- as well as heterogeneous 
catalysts.80,82 Deprotection of the silyl-ether in 478 provided 479 after exposure to Pd/C, 
which although undesired would provide evidence regarding the nature of the C13 
stereochemistry by use of X-ray crystallography (Scheme 2.72). Analysis showed the Diels–
Alder reaction to have taken place at top face of the indole, therefore providing the correct C13 
stereochemistry.  
In all, no hydrogenation attempts led to the formation of hydrogenated 478, instead resulting 
in lactol formation due to silyl deprotection in most cases. Simultaneous efforts to oxidize the 
lactol to the corresponding lactone, using several oxidizing agents, as well as isomerization of 
the double bond, were equally unsuccessful.80  
It was considered that the piperidine N-tosyl group might be reducing the overall reactivity of 
478, and changing the N-piperidine substituent from tosyl to methyl was therefore proposed; 
this was a required structural feature in the target molecule 
Sodium naphthalide-induced detosylation gave 480, possibly due to the slightly acidic 
conditions while purifying by column chromatography using EtOAc–MeOH. Reductive 
amination83 using formaldehyde gave 481 (Scheme 2.73).  
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Scheme 2.73: N-piperidine protecting group conversion. 
 
A number of Pd/C-mediated hydrogenation attempts were made with 481, but these were 
unsuccessful. Due to lack of time, further studies into the hydrogenation / oxidation / 
isomerization of 481 were not conducted.80  
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2.2.1.2.  The Conjugated Iminium Approach 
 
A different approach towards the total synthesis of (±)-alstonerine 36 was based upon 
previous work conducted in the Craig group with regard to THPyr. These 1,4-
bis(tosyl)THPyrs readily undergo loss of the tosyl moiety to form conjugated iminium 
species,117 which may be intercepted at C6 (482) or at C4 (484), the latter generally by bulkier 
nucleophiles (Scheme 2.74).  
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Scheme 2.74: Soft nucleophile C4 attack (left); Hard nucleophile C6 attack (right). 
 
Intramolecular substitutions are also possible, as described earlier on page 146. Retrosynthetic 
analysis of (±)-alstonerine 36 reveals the reduction of a lactone which will allow the fifth 
alstonerine ring to be constructed from corresponding cyclic silyl-enol ether 485 (Figure 
2.10).  
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Figure 2.10: Retrosynthetic analysis of (±)-alstonerine 36. 
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Silyl ether 485 would be formed by three sequential cyclizations (Scheme 2.75). Treating 486 
with Lewis acid would, according to previous studies,37,69 form cyclic iminium 488 via E1cB 
desulfonylation. Michael-type addition of the β-ketoenolate forms 48919 after which addition 
of a catalytic amount of acid would be sufficient to trigger Pictet–Spengler cyclization to give 
490.  
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Scheme 2.75: Triple cyclization cascade. 
 
Although a mixture of regioisomers was obtained from the ring-opening reaction of MOM-
protected aziridine 487 with the sulfone-anion 406, combination of lithio-406 with O-lithio 
388 resulted in successful formation of 415. This marked change in selectivity is attributed to 
the directing effect of the alkoxylithium group in the conjugate base of 388 as discussed on 
page 123 (Scheme 2.76).   
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Scheme 2.76: Aziridine ring-opening by tosyl acetal 406. 
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Subsequent functionalization of the alcohol to the corresponding β-ketoester 486 gave 
unexpected results. Use of trimethyldioxinone resulted in premature Pictet–Spengler 
cyclization, thus preventing the desired sequence of sulfinate elimination and subsequent 
Michael-type addition at the iminium C4 (Scheme 2.77). Use of diketene gave 486 without 
formation of cyclized side-product 491.19  
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Scheme 2.77: β-Ketoester formation. 
 
Treatment of β-ketoester 486 with several Lewis acids gave 491, again due to premature 
Pictet–Spengler cyclization. Attempts to decrease the overall acidity of the reaction mixture 
by adding base were made as this would increase the rate of tetrahydropyridine formation and 
allow formation the β-ketoester enolate. Unfortunately, no cyclisation product was observed 
other than 491, that of Pictet–Spengler reaction.  
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2.2.2.   Current Progress Towards (±)-Alstonerine 
 
As with our proposal for the total synthesis of (±)-suaveoline, the key step in the final strategy 
evaluated for the total synthesis of (±)-alstonerine 36 involved the regioselective opening of 
hydroxyaziridine 388. In order to prevent the premature Pictet–Spengler cyclisation described 
earlier, δ-lactam 493 was identified as a key intermediate. This necessitated the use of a more 
highly oxidized sulfone anion as the key nucleophilic reactant.19  
 
Our proposal towards the total synthesis of (±)-alstonerine 36 involved a cis-selective Pictet–
Spengler cyclization in order to construct the characteristic [3.3.1]-azabicyclic system 36 from 
492. This bicyclic core would be formed by a global reduction step, which would convert the 
vinylogous carbonate into the transposed vinylogous ester and reduce the δ-lactam to the 
labile N-tosyl hemiaminal, which on acidification would undergo spontaneous Pictet–
Spengler cyclization to give 36 (Figure 2.11).  
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Figure 2.11: Retrosynthetic analysis of (±)-alstonerine 36. 
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Construction of 494 will be achieved via nucleophilic ring-opening reaction of N-
sulfonylaziridine 388 using the dianion of 495, followed by lactamization and acylation of the 
primary alcohol to furnish 493 (Figure 2.11). E1cB elimination of the tosyl moiety would be 
followed by a Michael-type addition providing tetracycle 492.   
 
Previous research had already shown the formation of a conjugated cationic system 497 
following the departure of the tosyl-moiety triggers cyclization by the aromatic ring providing 
498 (Scheme 2.78).16,37  
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Scheme 2.78: Lewis acid mediated C6 cyclization. 
 
2.2.2.1. Dianion-Mediated Aziridine Ring-Opening 
 
Preparation of hydroxyaziridine 388 involved the same sequence as described earlier, starting 
from cis-2-butene-1,4-diol 381 (page 113). The key step once again involved the aziridine 
ring-opening of 388 by the sulfone-anion mediated dianion of 495 (Scheme 2.79).  
Ts
OH
O
+
N
TsHN
HO
Ts
HO
OOH
HO
N
TsN
HO
Base
388 495 494381
 
Scheme 2.79: Proposed aziridine ring-opening by tosyl carboxylic acid.  
 
In the event that formation of the protected-ether 500 proved inefficient, alternative peptide 
coupling conditions could be employed to form δ-lactam 500 or δ-lactone 499 prior to alcohol 
protection. In this reaction formation of the δ-lactone is probably favored due to the higher 
reactivity of the alcohol when compared to the electron-deficient tosamide. Conversion of the 
δ-lactone 499 into the silyl protected δ-lactam 500 would be achieved by using acid-mediated 
δ-lactone cleavage followed by silyl protection of the alcohol, forming the acid-silyl ether 
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precursor of 500 as described by Hanquet et al (Scheme 2.80).84 Having protected the alcohol, 
peptide coupling reactions would provide lactam 500. 
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Scheme 2.80: Proposed δ-lactone formation followed by the Hanquet protocol towards silyl-protected δ-lactam. 
 
Disappointingly, no aziridine ring-opening was observed when combining the dianion of 495 
with aziridine 388. Carrying out the reaction at different temperatures, as well as using 
different modes of addition and different bases (NaH or nBuLi) failed to yield the desired 
product.  
 
2.2.2.2. Alternative Tosyl-containing Nucleophiles 
 
Due to the lack of success using the dianion of 495, four alternative strategies were proposed 
in regard to the preparation of δ-lactam 500 (Scheme 2.81). 
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Scheme 2.81: Proposed sulfone-nucleophiles for aziridine ring-opening. 
 
One of these alternatives involved a terminal olefin (R = CHCH2), which would provide 
halogen piperidine 504 via iodine-induced cyclization (Scheme 2.82). Subsequent removal of 
the halogen followed by oxidative cleavage of the cyclic enamine would furnish δ-lactam 500. 
Cyclizations similar to that of 504 have been reported in the literature by Minakata et al.86 and 
utilize a strategy not dissimilar to that of the Sharpless aziridination.20  
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Scheme 2.82: Olefin-mediated δ-lactam formation. 
 
Another alternative would utilize a rather unstable enol-ether approach (R = C(CH2)OCH3) 
which we hoped to utilize in order to obtain δ-lactam 500 (Scheme 2.83). Enol-ether 505 
would therefore either undergo cyclization followed by oxidative cleavage or subjected to the 
reverse sequence of reactions.  
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Scheme 2.83: Enol-ether approach towards lactam 500. 
 
An interesting approach towards preparation of 500 could also involve a 6-exo-dig cyclization 
of a deprotected acetylene with tosamide 509 (R = CCTMS, Scheme 2.84). Oxidative 
cleavage of this enamine would form the lactam 500. However, according to Baldwin’s rules, 
no special preference is observed when considering 6-exo-dig versus 7-endo-dig cyclisation.  
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Scheme 2.84: 6-Exo-dig approach utilizing acetylene 508. 
 
A last alternative was based upon the earlier success of tosyl acetal-induced aziridine ring-
opening (as reported on page 157). Formation of ortho-ester 510 (R = C(OCH3)3) would 
involve a similar nucleophilicity as compared to the tosyl acetal and provide a higher 
oxidation state therefore preventing any unwanted Pictet–Spengler cyclization upon 
deprotection (Scheme 2.85). 
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Scheme 2.85: Ortho-ester hydrolysis followed by δ-lactam formation. 
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2.2.2.2.1. Sulfonyl-Olefin 514 
 
Synthesis of sulfonyl-olefin 514 was described by Takahata et al.85 using 1-bromo-2-propene 
512 as electrophile and the lithio-anion of phenyl methyl sulfone 432 to give 514, 513 and 
unreacted starting material (Scheme 2.86). Deprotonation of the secondary acidic α-sulfone 
proton of 514 resulted in additional alkylation at this position by another equivalent of 1-
bromo-2-pentene to provide 513. Thus both mono-, dialkylated product and starting material 
were obtained. 
PhSO2 Br+
PhSO2 PhSO2
+
a)
432 512 513 514
 
Scheme 2.86: a) LDA, 432, THF, –78 oC, 1 h then addition of 512,  –78 oC, 30 min, 31% 513, 48% 514. 
 
Sulfonyl olefin 514 was subsequently utilized in the sulfone-aziridine ring-opening, giving the 
olefinic amino alcohol 503 in moderate yield (Scheme 2.87).  
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Scheme 2.87: a) nBuLi, 514, THF, –78 oC, 30 min, then addition of 388, –78 oC → rt, 16 h, 60%. 
 
After the aziridine ring-opening, silylether formation would be followed by iodide-mediated 
cyclization as described by Minakata et al.86 In this article electrophilic cyclization is 
achieved by use of a chloramine-T–I2 system to produce N-tosylaziridines and N-
tosylheterocycles from the corresponding N-alkenylamides (Scheme 2.88). Similar to the 
Sharpless aziridination,20 formation of an iodinium species II from olefin I is followed by 
nucleophilic ring-opening using nucleophilic chloramine-T, thus forming III. Formation of 
the aziridine IV regenerates the iodine.  
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Scheme 2.88: Proposed pathway for the I2-catalyzed aziridination of olefins using chloramine-T. 
 
Applying this general reaction mechanism to N-alkenylamides, a slightly different mechanism 
was proposed regarding iodine transfer from iodinated chloramine-T to N-alkenylamide I 
(Scheme 2.89).86 Cyclization was assumed to proceed via a three-membered iodonium ion 
III, generated from iodine transfer from the N-iodinated alkenylsulfonamide II. Subsequent 
iodonium ring-opening by the amine induces the formation of the N-heterocycle IV. 
Experiments using different N-protecting groups such as Boc and benzoyl did not generate 
any product, pointing to the importance of the tosylamides acidity to perform the iodination of 
II. 
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Scheme 2.89: Proposed reaction pathway to formation of N-heterocycles. 
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Following the formation of cyclic iodide 504, removal of the halogen, either by use of crown 
ether87(i) or under base conditions,87(ii) would produce the corresponding ene–sulfonamide 506 
(Scheme 2.90). The stability of this enamine requires evaluation, as the terminal olefin might 
move into conjugation, forming a more highly substituted ene–sulfonamide.  Careful 
oxidative cleavage of enamine 506 would give lactam 500.  
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Scheme 2.90: Proposed route towards δ-lactam 500 via enamine 506 using I2-catalyzed cyclization. 
 
Similar studies had already been conducted by Ioannidis69 and Rahn80 in regard to oxidative 
cleavage of the cyclopentene in proximity of the electron rich indolic C2–C3 pi-system 
(Scheme 2.91). 
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Scheme 2.91: Oxidative cleavage of the cyclopentene in proximity of an electron rich indolic C2–C3 pi-system. 
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2.2.2.2.2. Sulfonic Enol-Ether 515 
 
Using a sulfonic enol-ether strategy would apply a similar sequence as for the sulfone-olefin 
yet circumvent the iodine mediated cyclization and subsequent halogen removal reactions. 
Synthesis of sulfonyl enol-ether 515 would give, upon aziridine ring-opening, enol-ether 
tosamide 505 (Scheme 2.92). 
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Scheme 2.92: Aziridine ring-opening mediated by the sulfone-anion of 515. 
 
This sulfonyl enol-ether is produced from the corresponding tosyl ester under Takai reaction 
conditions. The Takai reaction has proven to be a useful tool in converting carbonyl 
compounds into terminal olefins / enol ethers.88 When compared to other classical Ti(IV) 
alkylidene reagents, the Takai reagent has proven to be applicable to a wide range of carbonyl 
compounds.89 In contrast, the titanium reagents developed by Tebbe90 and Grubbs,91 are 
limited to methylenation, while those developed by Petasis92 may only be utilized if there is 
no possibility of β-elimination.  
 
Application of the Takai olefination protocol to ester 516 gave irreproducible results (Scheme 
2.93). Enol-ether 515 was suspected to be unstable, since complete decomposition was 
detected. This route was subsequently abandoned.  
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Scheme 2.93: Takai protocol regarding ester, enol ether conversion. 
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2.2.2.2.3. Tosyl-Alkyne 519 
 
Intramolecular 6-exo-dig cyclization between the sulfonamide and alkyne in 509 was also 
investigated (Scheme 2.94).  
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Scheme 2.94: Proposed route towards δ-lactam 500 via 6-exo-dig cyclization. 
 
As stated earlier, according to Baldwin’s rules93 no strong preference exists between 6-exo-
dig and 7-endo-dig cyclization. In the context of the development of regiocontrolled synthesis 
of complex functionalized hetero- and carbocycles, catalytic organometallic chemistry has 
proven to be a powerful tool. Besides Hg, Pd salts and lanthanides,94 the later transition 
metals Pt, Au and Ag95 have shown excellent applicability in the promotion of a variety of 
organic transformations.96 The Lewis acidic nature of these metals promotes the intra- and 
intermolecular attack of a nucleophile by pi-acid activation of unsaturated groups. With regard 
to Pt, Ag and Au, lack of toxicity is a significant advantage. In addition, the high affinity 
towards the pi-system, together with easy removal due to the kinetically labile carbon–metal 
bond allows efficient turnover.97 The proposed mechanism involves initiation of I by hydride 
extraction, forming a cationic palladium-hydride and II (Scheme 2.95). Next, PdH+ 
coordinates to the triple bond of III followed by intramolecular cyclization affording 
vinylpalladium IV. Reductive elimination of IV delivers the Pd(0) species back into the cycle 
and forms the enamine V.98   
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Scheme 2.95: Proposed palladium-mediated catalytic cycle. 
 
When comparing commonly used metal-based catalysts to rare lanthanides (La), a different 
mechanism is proposed (Scheme 2.96).94 Liberation of the active catalyst by complexation of 
the lanthanide complex to the alkynol I, thus forming II, is followed by insertion of the 
alkyne triple bond into La–O III. Subsequent La–C protonolysis reforms the lanthanide-
alkynol complex II and generates the methylene-containing heterocycle V.  
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Scheme 2.96: Proposed lanthanide catalytic cycle. 
 
While the large majority of articles concerning cyclic enamines describe 5-exo-dig and 6-
endo-dig cyclizations, the analogous 6-exo-dig reactions are rare. Rutjes et al.99 reported the 
use of palladium catalysts to trigger tosamide 6-exo-dig cyclization, albeit in low yield (7%). 
Application of the latter to corresponding alcohols gave slightly higher yields (24 – 32%), 
presumably due to the higher nucleophilicity of the oxanion compared to the electron-
deficient tosamide. A higher yield of enamine (58%) was obtained by Luo,100 in a process in 
which intramolecular aminopalladation was followed by cross-coupling.  
 
Following literature procedures, 3-butyn-1-ol 517 was chlorinated using SOCl2 and 
subsequently TMS protected to give silyl protected alkyne 518 in good yield (Scheme 
2.97).101 Substituting the halogen for a tosyl moiety via substitution gave the tosyl nucleophile 
519.102 
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Scheme 2.97: a) i) EtMgBr, TMSCl, THF, rt, 1.5 h; ii) SOCl2, pyridine, ∆, 7 h, 65%; b) Anh. Na  p-
toluenesulfinate, anh. NaI, DMF, 80 oC, 12 h, 40 oC, 12 h, 62%. 
  
TMS protection was deemed important in this step due to the acidity of the alkyne (Scheme 
2.98). Initial experiments involving combination of the lithio-anion of sulfone 519 to 
aziridinol 388 returned only starting material. This was disappointing in view of reported 
aziridine ring-opening reactions involving 519-like sulfone-nucleophiles.16 A possible 
explanation was thought to be the dilution used for this reaction, which was 0.24 M, as 
reported by Wenkert,102 in contrast to the more typical values of 0.50–1.0 M used in previous 
studies.15,69,80 This approach was not pursued further due to advances elsewhere. 
N
TsN
HO
+
Ts NNHTsTs
HOTMS
TMS
nBuLi
388 519 509
 
 
Scheme 2.98: Sulfone-nucleophile 519 mediated aziridine ring-opening. 
 
2.2.2.2.4. Tosyl Acetal Hydrolysis  
 
In a recently published article it was reported that acetals could be easily converted into their 
corresponding acids via the aldehydes using CrO2 under mild, aerobic conditions.103 If 
successful, the deprotection and subsequent oxidation of the aldehyde into the ester moiety 
would give 521; ring-closure would then give lactam 500 (Scheme 2.99). 
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Scheme 2.99: Proposed synthesis towards δ-lactam 500. 
 
In order to test the viability of the protocol reported, experiments involving the chromium 
catalyst were carried out using the readily available tosyl acetal. Using various reaction 
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conditions, it was reported that either the methyl ester (when using methanol as solvent), or 
the free acid (in aqueous media) could be obtained.103 In the event, no conversion was 
observed, and pure starting material was recovered (Scheme 2.100).    
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Scheme 2.100: CrO2 mediated acetal conversion. 
 
2.2.2.2.5. Orthoester 525 
 
Following the failure of attempts to oxidize the acetal group in adduct 520 and analogues, it 
was considered that the masked ester 525 might be a suitable alternative. Initial attempts to 
prepare 525 followed the method described by Ghosez.104 Condensation of p-toluenesulfinic 
acid with acrylonitrile gave 526 in an excellent yield (Scheme 2.101). However, conversion of 
the tosyl nitrile into the orthoester via the imine methoxide was not realized, despite being 
reported in the literature. Several attempts to reduce the amount of acid present by base-wash 
to form the orthoester via imidate alcoholysis105 yielded ester 526 exclusively.19,106  
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Scheme 2.101: a) AcOH, ∆, 16 h, 95%; b) i) CH3OH, AcCl, DCM, 5 oC, 45 h; ii) CH3OH, 20 oC, 72 h, 85% 
526. 
 
An alternative route towards the synthesis of the phenylsulfonyl orthoester has been reported 
by Parham et al.107 α,β-Unsaturated sulfide 527 was treated with dichlorocarbene, generated 
from methoxide and ethyl trichloroacetate, to give corresponding dichlorocyclopropane 528 
(Scheme 2.102). 
PhS
PhS
Cl Cl
PhSO2
Cl Cl
PhSO2
O
O
Oa) b) c)
527 528 529 525
 
 
Scheme 2.102: a) Ethyl trichloroacetate, NaOCH3, petrol, 0 oC → rt, 16 h, 60%; b) AcOH, H2O2, 100 oC, 3 h, 
90%; c) NaOCH3, CH3OH, ∆, 2 h, 95%. 
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These reactions generally yield 60% of product due to a side-reaction involving the 
dichlorocarbene and the alcohol formed in these formation reactions (Scheme 2.103).108  
HCCl3 + CCl3 + ROH CCl2
olefin R
R
Cl
ClRO
 
Scheme 2.103: Carbene reaction mechanism. 
 
Although tbutoxide is considered superior to sodium methoxide because of its decreased 
reactivity towards the carbene, no significant yield increase was observed when comparing 
potassium tbutoxide, sodium methoxide and sodium ethoxide. Pivotal to the success of the 
carbene reaction was the use of carefully purified petrol, as olefinic impurities caused 
significant reductions in product purity and ease of isolation.107  
 
Oxidation of 528 involved in situ formation of peracetic acid from peroxide and acetic acid 
and gave 529 as a white solid (Scheme 2.102). Purification of the latter involved base-wash 
and column chromatography in order to remove any traces of phenylsulfonylethene (oxidized 
unreacted starting material) and acetic acid; since the acid caused hydrolysis of the orthoester 
to the corresponding methyl ester. Treatment of 529 with freshly prepared sodium methoxide 
gave 525 in excellent yield.109 
 
Applying our sulfone-stabilized nucleophile methodology to aziridinol 388 gave 526 upon 
mild-acidic work-up, similar to that of the tosylacetal utilization (Scheme 2.104).  
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Scheme 2.104: a) nBuLi, 2.0 equiv. 526, THF, –78 oC, 30 min, then addition of 388, –78 oC → rt, 16 h, 90%. 
 
It was found subsequently that if left standing, hydroxyester 527 was converted into lactone 
528. Treatment of 527 with TFA gave a similar result (Scheme 2.105).110  
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Scheme 2.105: a) TFA, DCM, rt, 5 min, 65%. 
 
Having prepared 527, protection of the alcohol was important, since it was anticipated that 
any attempt at cyclization would lead to the formation of lactone rather than lactam products. 
Attempted formation of β-ketoester 528 by treatment of 527 with sodium acetate and diketene 
was unsuccessful (Scheme 2.106).111 This is probably due to the presence of the amine which 
could interfere in this reaction. Starting material decomposition was observed.   
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Scheme 2.106: Attempted β-ketoester formation. 
 
It was found subsequently that hydroxyl protection was necessary prior to cyclization. This 
was achieved using standard silylating conditions to give 529 in high yield (Scheme 2.107). 
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Scheme 2.107: a) TBSCl, imidazole, DMF, rt, 30 min, 91%. 
 
Thermal as well as Lewis acid conditions were investigated to promote the cyclization. Scott 
et al.112 reported the use of thermal reaction conditions to facilitate intramolecular δ-lactam 
formation from the corresponding secondary amine and ester moieties. Exposing 529 to high 
temperatures (refluxing toluene) did not result in any product formation, and starting material 
was recovered cleanly.  
In an article by Dake,113 deprotection of a Boc-N-tosyl substrate was followed by treatment 
with trimethylaluminium (TMA) at room temperature which provided an effective route to δ-
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lactams. Initial experiments at room temperature did not generate the product and only 
starting material was obtained. When increasing the reaction temperature to 80 oC 
exceptionally clean conversion of 529 into 530 was observed (Scheme 2.108).  
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Scheme 2.108: a) TMA, toluene, rt → 80 oC, 3 h, 99%. 
 
In this cyclization reaction, the TMA-species binds to the amide, forming an aluminium-
amide complex similar to that reported for Weinreb amide formation using TMA. This 
complex increases the nucleophilicity of the amide, resulting in cyclization through an 
addition–elimination process.114 In a later step TMA also activates the sulfone which is 
removed to give unsaturated lactam 530, presumably via an E1cB mechanism. 
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2.2.2.3. Towards (±)-Alstonerine 
 
Removal of the TBS group was achieved using standard conditions.15 Installation of the β-
ketoester through the use of potassium acetate and diketene111 (the acetate forming an 
activated β-keto anhydride) at elevated temperatures gave β-ketoester lactam 531 (Scheme 
2.109). 
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Scheme 2.109: a) HOAc : H2O : THF (3 : 1 : 1), rt, 16 h, 99%; b) KOAc, diketene, THF, ∆, 1 h, 93%. 
 
Following successful installation of the β-ketoester, treatment of 531 with DBU would trigger 
a Michael-type addition of the in situ formed enolate to the vinylogous lactam forming the 
final ring structure of alstonerine. This reaction gave a pure conversion of 531 to 532 in which 
532 exhibits a singlet proton at 14 ppm due to intramolecular hydrogen bonding within the 
enol tautomer (Scheme 2.110). 
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Scheme 2.110: a) DBU, THF, rt, 6 h, 91%. 
 
With all ring-systems now incorporated we hoped to simultaneously perform a Pictet–
Spengler cyclization and reduce the β-ketolactone into the vinylogous carbonate. DIBAL was 
chosen to perform this ambitious sequence of reactions (Scheme 2.111).  
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Scheme 2.111: Global reduction. 
 
The global reduction step was followed by an acid quench which gave a mixture of 2 
products, 533 and 534. The acid quench (containing 6 M HCl) was too acidic therefore 
removing the alcohol in the aminol intermediate resulting in THPyr 533 formation (Scheme 
2.112). 533 Could easily be converted into 534 by treatment with a catalytic amount of TFA. 
This minor issue was circumvented by the addition of catalytic TFA at the end of the DIBAL 
reduction, reaction providing 534 as a single product.  
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Scheme 2.112: a) i) DIBAL, THF, 1 h, –78 oC; ii) 6M HCl (cat.), rt, 15% 533, 75% 534. 
 
DIBAL, Superhydride and L-Selectride all failed to effect conversion of 532 into alstonerine 
36 and 534 was obtained. Subsequent attempts to further reduce 534 using the aforementioned 
reagents failed and pure 534 was recovered. A modification would involve conversion of the 
N-Ts lactam into the N-Me lactam prior to the global reduction step, thus obtaining the correct 
piperidine structure needed and obviating the need for subsequent deprotection–protection. It 
was hoped also that such conversion would provide a more reactive substrate for vinylogous 
carbonate reduction. Rahn had already examined the sulfonamide detosylation, using sodium 
naphthalide followed by reductive amination with formaldehyde, in which the N-Me 
piperidine was obtained in moderate yield.80 Lactam desulfonylation by use of a mild 
reduction step employing samarium diiodide115 was unsuccessful. A final attempt to access 
alstonerine 36, bis-methylation116 to gain 535 (of both N-piperidine as well as enolic OH) was 
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attempted, after which it was hoped that global reduction would yield the natural product. 
Extensive decomposition during the dimethylation reaction towards 535 was observed 
(Scheme 2.113). However, NMR analysis revealed the absence of the enolic hydroxy and 
tosyl moiety and the presence of two new methyl functionalities. 
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Scheme 2.113: a) i) Na napthalide, THF, –78 oC, 1 h; ii) CH3I, rt, 30 min.   
 
Kocienski previously reported116 such a transformation involving conversion of β-ketolactone 
536 into enol ether 537 followed by reduction using DIBAL to provide 538 (Scheme 2.114). 
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Scheme 2.114: Koscienski approach to the formation of vinylogous ester 538. 
 
A last attempt towards DIBAL induced global reduction of 535 to obtain alstonerine 36 was 
attempted yet proved unsuccessful (Scheme 2.115).    
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Scheme 2.115: Attempted global reduction of 535. 
 
Despite this setback a new strategy towards the total synthesis of (±)-alstonerine has been 
developed and is presented in this thesis. As such, optimalization of the final global reduction 
steps is required in order to successfully conclude the total synthesis of (±)-alstonerine.
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2.3.  Cytisine 
 
2.3.1.  Current Progress Towards (–)-Cytisine 
 
Key to the viability of the cytisine project was the regioselective opening of the aziridinol by 
the tosyl acetal anion nucleophile (Scheme 2.116). Lithium-chelation control was expected to 
assist the nucleophile towards attack at the more substituted end (539).16,17 In addition to the 
application of the aziridine ring-opening mediated by sulfone-anions, synthesis and chemical 
manipulation of THPyrs would be a major component in the synthesis of this natural product. 
The latter has been thoroughly investigated within the Craig group for the last decade, 
initiated by the work of Williams.117  
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Scheme 2.116: Regioselective aziridine ring-opening. 
 
Retrosynthetic analysis of (–)-cytisine 70 reveals a disconnection between the N-pyridone and 
the piperidine side chain (Figure 2.12). Construction of the tricycle would involve 
deprotection of the pyridone amine 540 followed by displacement of the OR-moiety to 
intramolecularly construct the bridged tricyclic structure within 70, followed by detosylation 
of the piperidine. Debenzylation of the pyridone, probably by use of hydrogenation, would 
simultaneously deprotect the latter and saturate the double bond within the THPyr of 542. 
Further analysis of the fused pyridone and THPyr reveals a Suzuki or Stille coupling reaction, 
not unlike that used by O’Neil and co-workers118 in order to form the C3–C6 bond.  
 
Iodination of THPyr119 would provide the Suzuki nucleophile 542 from 543 using NIS, while 
using the O’Neil protocol would provide the electrophile 541. Access to 542 follows from 
Lewis acid treatment of 544.37  
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As stated earlier, the key step involved the sulfone-anion mediated ring-opening of azridinol 
545, which it was hoped would result in the regioselective opening of the latter at the more 
substituted end, providing 544.  
 
The tosyl diacetal nucleophile 40613 would be prepared in two steps from tolylsulfinic acid 
and acrolein, while the aziridinol 545 would be prepared either as a racemate from 2-propen-
1-ol (one step) via Sharpless aziridination,20 or in enantiomerically pure from L-serine (six 
steps).120  
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Figure 2.12: Retrosynthesis of cytisine 70. 
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2.3.2.1. Tosyl Acetal 406 
 
Acetal 406 (Scheme 2.117) was prepared using a standard procedure developed in our 
group,13 which included the use of p-toluene sulfinic acid sodium salt and acrolein in an 
acidic THF / H2O solution (1 : 1). The resulting 3-tosylpropanal 546 was subjected to a 
catalytic amount of tosic acid in methanol in the presence of trimethyl orthoformate to give 
acetal 406 in 83% yield. 
 
O OTs
OTs
O
a)S O- Na+
O
+
b)
546 406
 
Scheme 2.117: a) HOAc, THF / H2O, rt, 16 h, 99%; b) p-TsOH, CH3OH, trimethyl orthoformate, 50 °C, 16 h, 
83%. 
 
2.3.2.2. Enantiomerically Pure Aziridinol 545 
 
L-Serine was chosen as the starting material for the synthesis of the enantiomerically pure 
aziridinol 545 (Scheme 2.118). Following the Bergmeier synthesis route120(ii) towards 545, the 
initial step involved the SOCl2 mediated esterification of serine to provide the corresponding 
methyl ester as a HCl salt 547. Neutralization followed by treatment with tosyl chloride gave 
tosyl ester 548. Protection of the alcohol as a silyl ether gave fully protected L-serine 549. 
Reduction of the ester moiety by use of LiBH4, either prepared from NaBH4 and LiCl or used 
as commercially available reagent, furnished amino alcohol 550. Application of Mitsunobu 
condensation reaction conditions resulted in aziridine silyl-ether 551. TBAF desilylation gave 
545 in six steps with an overall yield of 44% as described by Bergmeier.120(ii) 
 Results and Discussion 
 
  183 
O
O
NHTs
OH O
O
NHTs
OTBS
HO
NHTs
OTBS
TsN
TBSO
TsN
HO
O
O
NH3+ Cl-
OH
b) c)
d) e) f)
HO
O
NH3+ Cl-
OH
L-Serine 547 548 549
550 551 545
a)
 
Scheme 2.118: a) SOCl2, CH3OH, ∆, 4 h, 99%; b) TsCl, TEA, DCM, 0 °C, 16 h, 85%; c) TBSCl, Imidazole, 
DCM, rt, 16 h, 97%; d) LiBH4, THF, rt, 16 h, 80%; e) DIAD, PPh3, THF, 0 °C → rt, 16 h, 97%; f) TBAF, THF, 
0 °C, 1 h, 90%. 
 
2.3.2.3. Racemic Aziridinol 545 
 
An alternative route towards racemic aziridinol 545 was investigated, thus circumventing the 
six-step approach towards the enantiomerically pure material. Utilization of the Sharpless 
aziridination20 would provide a quick and steady supply of the latter to screen the aziridine 
ring-opening experiments.  
 
Applying the Sharpless aziridination protocol to 1-propenol would produce the corresponding 
racemic azirdin-1-ol in a single step (Scheme 2.119). Treatment of 1-propenol with PTAB 
and chloramine-T gave racemic aziridinol 545 and diamine 552. This phenomenon occurs due 
to the electrophilicity of the newly formed aziridinol, which in the presence of nucleophilic 
TsNCl-, results in the ring-opening of aziridinol 545.20    
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Scheme 2.119: a) Chloramine-T, PTAB, CH3CN, rt, 16 h, 52%; 40% diamine. 
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2.3.2.4. Aziridine Ring-Opening 
 
Nucleophilic sulfone-anion mediated ring-opening reactions of 406 were attempted using the 
standard nBuLi treatment,117 in which product 553 was obtained (Scheme 2.120). No 
significant changes were observed when applying different methods of addition. NMR data 
obtained from product 553 proved inconclusive in ascertaining the precise regioselective 
outcome. 
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Scheme 2.120: a) nBuLi, THF, –78 °C → rt, 3 h, 95%.  
 
TBS-protection of the alcohol-moiety had previously facilitated the separation of 
diastereomers, as in the case of racemic vinyl aziridine precursor described by Carballares.13 
This same method improved separation significantly, NMR data obtained showed a 3 : 1 ratio 
between both diastereomers 554 (Scheme 2.121). The regioselectivity observed showed a 
total preference towards opening at the least hindered end.  
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Scheme 2.121: a) DMAP, TEA, TBSCl, DCM, 1.5 h, rt, 91%. 
 
BF3 treatment provided corresponding silyl-protected THPyr 555 which showed no sign of a 
branched structure further adding proof to the regioselective outcome of the previous aziridine 
ring-opening reaction (Scheme 2.122).  
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Scheme 2.122: a) BF3·Et2O, DCM, 30 min, –78 oC  –20 oC, 59%. 
 
Due to the regioselective outcome observed during aziridine ring-opening, no further attempts 
were made towards the total synthesis of cytisine using the route described.  
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2.4.  Conclusion and Future Work 
 
2.4.1.  (±)-Suaveoline 
 
Our endeavours into the nucleophilic aziridine ring-opening reaction using sulfone-stabilized 
anions, have led to the synthesis of cis / trans-vinyl aziridine 419 in 8 steps from L-tryptophan 
due to observed inreactivity of the corresponding hydroxy-aziridine 388 (Scheme 2.123). No 
pure cis-vinyl aziridine was obtained in a sufficient yield and reactions continued using the 
diastereomeric mixture of 419. 
Ts
N
TsN
NNHTsTs
+
419 402 434
nBuLi
 
Scheme 2.123: Sulfone-mediated aziridine ring-opening. 
 
Of the three nucleophiles evaluated for nucleophilic aziridine ring-opening, the secondary 
sulfone-stabilized anion of 402 was most able to successfully ring-open vinyl aziridine 419 to 
give the diolefin 434 (Scheme 2.124). In other cases complex mixtures of products were 
obtained. Failed α-tosyl alkylations, reported by Lewis,1 led to investigations towards the 
synthesis of pyridine-N-oxide; this strategy would enable the functionalization at the C4 
position in suaveoline. Similar cases have been reported in literature regarding the insertion of 
cyanide at pyridine C4.121 
NNHTsTs
RCM
NNHTsTs
434 435 436
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N
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Scheme 2.124: Proposed pyridine-N-oxide formation. 
 
Hydrolyzing this cyanide moiety to the ester-functionality would, as described on page 111, 
provide a handle for chain homologation and subsequent Pictet–Spengler bicyclization. 
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2.4.2. (±)-Alstonerine 
 
Following the successful optimization of epoxide 385 ring-opening by N-methylindole and 
subsequent synthesis of indole aziridinol 388, a range of sulfone-nucleophiles were tested 
each involving a different strategy towards the synthesis of δ-lactam 500. Formation of tosyl 
orthoester 526 proved to be the most successful approach and as such was carried through 
towards the total synthesis of (±)-alstonerine (Scheme 2.125).  
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Scheme 2.125: Nucleophilic ring-opening of aziridine 388 using the lithio-anion of 526. 
 
Application of TMA to the corresponding silyl-ether of 527 facilitated formation of δ-lactam 
530 via E1cB (Scheme 2.126). Michael-type addition of the β-ketoester at the vinyl moiety of 
the δ-lactam C4 position also progressed at a very high yield. Investigations into global 
reduction of both carbonyl moieties in 532 did not lead to alstonerine formation. Pictet–
Spengler cyclization was observed, forming the piperidine pentacyclic system while not 
affecting the lactone ring, showing the ease of this cyclization to occur.  
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Scheme 2.126: Synthesis of 532. 
 
A last attempt towards reduction of the lactone carbonyl involved methylation of the enolate 
together with conversion of the N-tosyl protecting group into N-methyl 535 (Scheme 2.127). 
Global reduction was unsuccessful and due to the lack of material and time, no further 
optimization of this conversion could be carried out.  
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Scheme 2.127: Attempted global reduction of 535. 
 
With the successful completion of the total synthesis of (±)-alstonerine 36 just two steps 
away, a more efficient dimethylation reaction to give 535, and a method for its reduction 
requires further investigation. Recent articles have described the conversion of lactones into 
transposed vinyloguous esters in high yield, applying DIBAL reduction on methyl enolate 
lactones.116  
 
2.4.3.  (–)-Cytisine 
 
Aziridine 545 could be prepared either enantiomerically pure in six steps or in its racemic 
form utilizing Sharpless aziridination of propene-1-ol in a single step. The ring-opening 
reaction using tosyl acetal 406 only furnished unwanted regioselective product 552 (Scheme 
2.128). Our attempt to regioselectively ring-open 545 by use of the aforementioned lithio-
oxygen chelation control proved to be unsuccessful, and as such this project has been 
abandoned.  
OTs
O TsN
HO OTs
OTsHN
nBuLi
+
406 545 552
HO
 
 
Scheme 2.128: Synthesis of 552.
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3.  Experimental 
 
All experiments were performed under a nitrogen atmosphere unless stated otherwise, with 
standard laboratory techniques used when handling water-sensitive reagents. 
Solvents and reagents: Solvents were distilled under nitrogen prior to use; MeCN and 
CH2Cl2 from calcium hydride, toluene from sodium, Et2O, THF and DME from sodium-
benzophenone ketyl, MeOH from magnesium turnings and iodine, DCE from calcium 
chloride water using a Stuart Merit Water Still W4000.  Petrol refers to the fraction of light 
petroleum ether that boils at 40–60 oC.  All solvents were dry reagent grade unless otherwise 
stated.  All chemical reagents used were commercially available from Fischer and Sigma 
Aldrich.  nBuLi (2.5 M in hexanes) was titrated prior to each use using diphenyl acetic acid. 
Melting points: Determined on Stuart Scientific SMP1 melting point apparatus. 
Infrared Spectroscopy: Spectra were recorded by a PerkinElmer Spectrum 100 series FT-IR 
Spectrometer. 
Optical rotation: Measured on an Optical Activity Ltd. Instrument. 
Microwave: Performed in a Biotage Initiator upgraded to version 2.5 and cooled using 
compressed air (4 bar). 
NMR spectroscopy: 1H NMR recorded on Bruker Ultra-Shield AV400 and DRX-400 at 400 
MHz. 13C NMR recorded on Bruker Ultra-Shield AV400 and DRX-400 at 100 MHz.  
Chemical shifts are in parts per million (ppm) and are referenced relative to the residual 
proton-containing solvent (CDCl3; 1H NMR = 7.27 ppm, 13C = 77.0 ppm, CD3OD; 1H NMR 
4.87, 3.31 ppm, 13C = 49.1 ppm).   
Mass Spectroscopy (CI, ESI): Low and high resolution mass spectra recorded on Micromass 
Autospec Premier spectrometer.  
Elemental Analysis: Performed by Dr. Stephen Boyer at the microanalytical laboratory, 
London Metropolitan University. 
Chromatography: Thin layer chromatography (TLC) performed on aluminium-backed 0.2 
mm Merck 60 F254 plates with visualisation effected with ultraviolet light, potassium 
permanganate or vanillin.  Flash chromatography with BDH (40–63 µm) silica gel performed 
according to the method employed by Still.1   
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3.1.  (±)-Suaveoline  
 
Cis-4-[(tbutyldimethylsylil)oxy]-but-2-en-1-ol 383 
 
OH
HO
OTBS
HO
381 383
 
 
To a suspension of NaH (2.80 g, 70.0 mmol, 1.0 equiv.) in THF (140 ml) at rt was added cis-
but-2-ene-1,4-diol 381 (6.20 g, 5.80 mL, 70.0 mmol, 1.0 equiv.) and the mixture stirred for 16 
h. TBDMSCl (10.4 g, 69.3 mmol, 1.0 equiv.) was then added and vigorous stirring continued 
for 45 min. The reaction mixture was poured onto Et2O (500 mL) and the resulting solution 
washed with 10% aqueous K2CO3 (2 x 200 mL) and brine (200 mL), dried (Na2SO4), filtered 
and concentrated under reduced pressure. Column chromatography (10% → 50% EtOAc–
petrol) gave 383 as a pale yellow oil (13.9 g, 98%).  
 
Rf = 0.15 (40% Et2O–petrol); νmax (film) 3400, 2929, 2961, 2857, 1474, 1465, 1253, 1082, 
1029, 833, 774 cm–1; δH (400 MHz, CDCl3) 5.68 (2H, m, CH2CH=CHCH2), 4.26 (2H, d, J 5.0 
Hz, CH2OH), 4.20 (2H, d, J 5.5 Hz, CH2OTBS), 2.46 (1H, broad s, OH), 0.91 (9H, s, 
(CH3)3C), 0.09 (6H, s, (CH3)2Si); δC (100 MHz, CDCl3) 131.2 (CH=CHCH2OH), 130.1 
(CH=CHCH2OTBS), 59.4 (CH2OH), 58.4 (CH2OTBS), 25.8 (3 x CH3C), –5.3 (2 x CH2Si); 
M/z (CI) 220 [M+NH4]+, 203 [M+H]+, 170, 153, 132 (Found [M+H]+, 203.1465. C10H22SiO2 
requires [M+H]+, 203.1467).  
 
The data are in agreement with the reported compound.2   
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Cis-((2R,3S)-3-((tbutyldimethylsilyloxy)methyl)-1-tosylaziridin-2-yl)methanol 384 
 
OTBS
HO
TsNOTBS
HO
383 384
 
 
To a mixture of olefin 383 (9.50 g, 47.0 mmol, 1.0 equiv.) and anhydrous chloramine T (12.8 
g, 56.4 mmol, 1.2 equiv.) in CH3CN (240 mL) at rt was added PTAB (1.80 g, 4.70 mmol, 10 
mol %). The reaction mixture was stirred at rt for 48 h, partially concentrated under reduced 
pressure and filtered through a pad of silica (washing with Et2O). Concentration of the filtrate 
under reduced pressure and column chromatography (25% → 50% EtOAc–petrol) gave 384 
as a pale yellow oil (15.7 g, 90%). 
 
Rf = 0.25 (66% petrol–EtOAc); νmax (film) 3500, 2933, 2861, 1601, 1466, 1324, 1264, 1159, 
1089, 948, 834, 669 cm–1; δH (400 MHz, CDCl3) 7.83 (2H, d, J 8.0 Hz, ortho-Ts), 7.35 (2H, 
d, J 8.5 Hz, meta-Ts), 3.88 (3H, dd, J 6.0, 11.5 Hz, NCHCH2OH), 3.76 (1H, dd, J 6.5, 13.0 
Hz, NCHCH2OTBS), 3.69 (2H, m, NCHCH2OH), 3.10 (2H, m, NCHCH2OTBS) 2.45 (3H, s, 
TsCH3), 2.33 (1H, t, J 6.5, OH), 0.82 (9H, s, (CH3)3C), 0.04 (6H, s, (CH3)2Si); δC (100 MHz, 
CDCl3) 145.0 (SO2C), 134.5 (CH3CTs), 130 (ortho-Ts), 128 (meta-Ts), 60.5 (CH2OH), 59.5 
(CH2OTBS), 44.0 (CCH2OH), 43.5 (CCH2OTBS), 26.0 ((CH3)3), 21.5 (TsCH3), 18.0 
((CH3)3C), –5.5 ((CH3)2Si). M/z (CI) 389, 372 [M+H]+, 218, 189, 174 (Found [M+H]+ 
371.1431, C17H29NO4SSi requires [M+H]+ 371.1587). (Found: C, 55.00; H, 7.79; N, 3.79. 
C17H29NO4SSi requires C, 54.95; H, 7.87; N, 3.77%). 
 
The data are in agreement with the reported compound.2   
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N-((R)-2-(tButyldimethylsilyloxy)-1-((S)-oxiran-2-yl)ethyl)-4-methylbenzenesulfonamide 
385 
 
O
TsHN
OTBS
HO
TsN
TBSO
384 385
 
 
To a 60% w/t suspension of NaH in mineral oil (7.30 g, 183 mmol, 4.0 equiv.) in THF (360 
mL) at 0 oC was dropwise added a solution of aziridine 384 (17.0 g, 45.7 mmol, 1.0 equiv.) in 
THF (140 mL). The reaction mixture was stirred for 3 h at 0 oC after which it was cooled to 
–78 oC and saturated aqueous NH4Cl (100 mL) was added dropwise. After warming to rt, the 
aqueous layer was extracted with Et2O (3 x 100 mL), and the combined organic layers dried 
(Na2SO4), filtered and concentrated under reduced pressure to yield compound 385 as a 
colorless oil (15.8 g, 93%). 
 
Rf = 0.75 (50% petrol–EtOAc); νmax (film) 2929, 2860, 1600, 1475, 1336, 1255, 1163, 1092, 
899, 836, 814 cm–1; δh (400 MHz, CDCl3) 7.77 (2H, d, J 8.5 Hz, ortho-Ts), 7.32 (2H, d, J 8.0 
Hz, meta-Ts), 4.73 (1H, d, J 8.0 Hz, NHTs), 3.59 (1H, m, NHCH), 3.52 (2H, m, CH2OTBS), 
3.17 (1H, dd, J 2.5, 6.5, CHOCH3), 2.69 (1H, dd, J 3.0, 4.5 Hz, CHAHBOCH), 2.57 (1H, dd, J 
3.0, 5.0 Hz, CHAHBOCH), 2.44 (3H, s, TsCH3), 0.86 (9H, s, (CH3)3C), 0.00 (6H, s, (CH3)2Si); 
δC (100 MHz, CDCl3) 143.5 (SO2C), 138.0 (CH3CTs), 129.7 (ortho-Ts), 127.0 (meta-Ts), 
63.2 (CH2OTBS), 53.7 (NHCH), 51.1 (NHCHCHO), 43.8 (CH2OCH), 25.8 ((CH3)3), 18.2 
(TsCH3), 14.1 ((CH3)3C), –5.9 ((CH3)2Si); M/z (CI) 389 [M+NH4]+, 372, 314, 218, 174, 116, 
108, 91 (Found: [M+H]+, 372.1667. C17H29NO4SSi requires [M+H]+, 372.1587) (Found: C, 
55.02; H, 7.91; N, 3.77. C17H29NO4SSi  requires C, 54.95; H, 7.87; N, 3.77%). 
 
The data are in agreement with the reported compound.2   
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N-((2R,3R)-1-(tButyldimethylsilyloxy)-3-hydroxy-4-(1-methyl-1H-indol-3-yl)butan-2-yl)-
4-methylbenzenesulfonamide 386 
 
O
TsHN
NOH
TsHN
TBSOTBSO
385 386
 
Classic Approach 
 
To a suspension of epoxide 385 (17.0 g, 45.7 mmol, 1.0 equiv.), N-methylindole (23.4 ml, 
183 mmol, 4.0 equiv.) and anhydrous NaHCO3 (15.5 g, 183 mmol, 4.0 equiv.) in DCM (30 
mL) at –78 oC was dropwise added BF3·Et2O (5.80 ml, 45.7 mmol, 1.0 equiv.). The reaction 
mixture was stirred at this temperature for 3 h. H2O (60 mL) was added and the solution 
allowed to heat up to rt. The aqueous layer was extracted using Et2O (3 x 200 mL) and the 
combined organic layers were dried (Na2SO4), filtered and concentrated under reduced 
pressure. Column chromatography (25% → 50% EtOAc–petrol) gave compound 386 as a 
pale yellow oil (22.8 g, 95%). 
 
Microwave Application 
 
Epoxide 385 (900 mg, 2.40 mmol, 1.0 equiv.), N-methylindole (383 µl, 3.00 mmol, 1.3 
equiv.) and ZnCl2 (100 mg, 1.20 mmol, 0.5 equiv.) were dissolved in DCM (5 mL) and heated 
2 x 30 min at 80 oC using the microwave. The reaction mixture was poured into H2O (30 mL) 
and extracted using DCM (3 x 20 mL). The combined organic layers were dried (Mg2SO4), 
filtered and concentrated under reduced pressure. Chromatography (25% → 50% EtOAc–
petrol) gave compound 386 as a pale yellow oil (1.12 g, 92%). 
 
Rf = 0.33 (66% petrol–EtOAc); νmax (film) 3507, 3288, 2954, 2929, 2857, 1616, 1473, 1327, 
1157, 1092, 1073, 838, 734 cm–1;  
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δH (400 MHz, CDCl3) 7.83 (2H, d, J 8.5 Hz, ortho-Ts), 7.51 (1H, d, J 8.0 Hz, C-9), 7.30 (3H, 
m, meta-Ts + C-12), 7.23 (1H, t, J 7.5 Hz, C-11), 7.10 (1H, t, J 7.5 Hz, C-10), 6.67 (1H, s, C-
2), 5.32 (1H, d, J 9.0 Hz, NH), 4.24 (1H, t, J 6.5 Hz, CHOH), 3.73 (3H, s, NCH3), 3.68 (1H, 
dd, J 5.0, 10.5 Hz, CHAHBOTBS), 3.63 (1H, dd, J 5.0, 10.5 Hz, CHAHBOTBS), 3.39 (1H, m, 
CHN), 2.94 (1H, s, OH),  2.77 (2H, m, CH2C), 2.45 (3H, s, TsCH3) 0.88 (9H, s, (CH3)3C), -
0.01 (6H, s, (CH3)2Si); δC (100 MHz, CDCl3) 143.4 (SO2C), 138.7 (CH3CTs), 137.1 (C-13), 
129.9 (ortho-Ts), 128.0 (C-2), 127.7 (C-8), 127.3 (meta-Ts), 121.8 (C-11), 119.0 (C-10), 
119.0 (C-9), 110.0 (C-7), 109.3 (C-12), 72.1 (CHOH), 65.7 (CH2OTBS), 55.4 (CHN), 32.6 
(NCH3), 29.5 (CH2C), 25.8 ((CH3)3Si), 21.5 (TsCH3), 18.1 (SiC), -5.65 ((CH3)2Si) M/z (CI) 
520 [M+NH4]+, 503 [M+H]+, 349, 189, 174, 165, 148, 132 (Found [M+H]+, 503.2322. 
C26H32N2O4SSi requires [M+H]+, 503.2415). 
 
The data are in agreement with the reported compound.2   
 
3-(((2S,3S)-3-((tButyldimethylsilyloxy)methyl)-1-tosylaziridin-2-yl)methyl)-1-methyl-1H-
indole 387 
 
N
TsN
N
HO
TsHN
TBSO TBSO
386 387
 
 
To a solution of aminoalcohol 386 (6.00 g, 12.0 mmol, 1.0 equiv.) and PPh3 (3.80 g, 18.0 
mmol, 1.2 equiv.) in THF (130 mL) at rt was added DIAD (3.60 mL, 18.0 mmol, 1.5 equiv.) 
dropwise over 15 min. The reaction mixture was stirred at rt for 1 h and concentrated under 
reduced pressure. Chromatography (10% → 40% EtOAc–petrol) gave compound 387 as a 
pale yellow oil (5.00 g, 86%). 
 
Rf = 0.87 (50% petrol–EtOAc); νmax (film) 2953, 2929, 2884, 1725, 1598, 1472, 1326, 1160, 
1122, 838 cm–1;  
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δH (400 MHz, CDCl3) 7.64 (2H, d, J 8.0 Hz, ortho-Ts), 7.48 (1H, d, J 8.0 Hz, C-9), 7.25 (2H, 
m, C-11 + C-12), 7.12 (2H, d, J 8.0 Hz, meta-Ts), 7.12-7.06 (1H, m, C-10), 6.85 (1H, s, C-2), 
3.90 (1H, dd, J 11.0, 5.5 Hz, CHAHBOTBS), 3.78 (1H, dd, J 11.0, 6.5 Hz, CHAHBOTBS), 
3.68 (3H, s, NCH3), 3.18 (1H, m, CHCH2OTBS), 3.11 (1H, m, CHCH2C), 2.99 (1H, dd, J 
15.5, 5.5 Hz, CHAHBC), 2.89 (1H, dd, J 15.5, 7.5 Hz, CHAHBC), 2.40 (3H, s, TsCH3), 0.88 
(9H, s, C(CH3)3), 0.04 (6H, s, (CH3)2Si); δC (100 MHz, CDCl3) 144.1 (SO2C), 136.6 (C-13), 
129.4 (ortho-TsCH), 128.1 (meta-TsCH), 127.7 (C-8), 127.0 (C-2), 121.8 (C-11), 119.1 (C-
10), 118.8 (C-9), 109.9 (C-7), 109.2 (C-12), 60.4 (CH2OTBS), 44.9 (CHCH2OTBS), 44.8 
(CHCH2C), 32.7 (NCH3), 26.0 (C(CH3)3, 22.9 (CH2C), 21.6 (TsCH3), –5.2 (Si(CH3)2); M/z 
(CI) 485 [M+H]+, 331, 214, 189, 174, 144, 132 (Found: [M+H]+, 485.2309.  C26H37N2O3SSi 
requires [M+H]+, 485.2294.). 
 
The data are in agreement with the reported compound.2   
 
((2S,3S)-3-((1-Methyl-1H-indol-3-yl)methyl)-1-tosylaziridin-2-yl)methanol 388 
 
N
TsN
N
TsN
TBSO HO
387 388
 
 
To a solution of aziridine 387 (5.00 g, 10.3 mmol, 1.0 equiv.) in THF (25 mL) at 0 oC was 
added a 1 M solution of TBAF in THF (11.3 mL, 11.3 mmol, 1.1 equiv.). The reaction 
mixture was stirred at 0 oC for 15 min. Saturated aqueous NH4Cl (47 mL) was added and the 
aqueous layer was extracted with DCM (3 x 100 mL). The combined organic layers were 
dried (Na2SO4), filtered and concentrated under reduced pressure. Chromatography (50% → 
100% EtOAc–petrol) gave compound 388 as a pale yellow oil (3.00 g, 80%). 
 
Rf = 0.20 (50% petrol–EtOAc); νmax (film) 3508, 3364, 2932, 1808, 1783, 1598, 1325, 1184, 
1091, 739 cm–1;  
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δH (400 MHz, CDCl3) 7.63 (2H, d, J 8.0 Hz, ortho-Ts), 7.48 (1H, d, J 8.0 Hz, C-9), 7.29-7.21 
(2H, m, C-11 + C-12), 7.12 (2H, d, J 8.0, meta-Ts), 7.09 (1H, m C-10), 6.78 (1H, s, C-2), 3.89 
(2H, m CH2OH), 3.67 (3H, s, NCH3), 3.21 (1H, q, J 7.0 Hz, CHCH2C), 3.16 (1H, app. q, J 6.5 
Hz, CHCH2OH), 2.99 (1H, dd, J 15.5, 6.0 Hz, CHAHBC), 2.94 (1H, dd, J 15.5, 7.5 Hz, 
CHAHBC), 2.41 (3H, s, TsCH3), 1.59 (1H, s, OH); δC (100 MHz, CDCl3) 144.4 (SO2C), 137.0 
(CH3CTs), 134.7 (C-13), 129.5 (ortho-Ts), 128.1 (meta-Ts), 127.5 (C-8), 126.8 (C-2), 122.0 
(C-11), 119.3 (C-10), 118.7 (C-9), 110.2 (C-7), 109.3 (C-12), 59.6 (CH2OH), 45.6 
(CHCH2C), 44.6 (CHCH2OH), 32.8 (NCH3), 23.1 (CH2C), 21.9 (TsCH3); M/z (CI) 372 
[M+H]+, 217, 144 (Found: [M+H]+, 371.1677.  C20H22N2O3S requires [M+H]+, 371.1351.). 
 
The data are in agreement with the reported compound.2   
  
3-Methoxy-3-oxopropanoic acid 396 
 
O O
O O HO O
O O
395 396
 
 
A solution of Meldrum’s acid 395 (3.0 g, 21.1 mmol, 1.0 equiv.) in methanol (1.0 mL) was 
heated to 80 oC and stirred over 16 h. Evaporation of the residual acetone gave methyl 
malonate 396 (2.3 g, 92%). νmax (film) 3515, 2960, 1713, 1440, 1328, 1154, 1015 cm–1; δH 
(400 MHz, CDCl3) 10.9 (1H, s, CO2H), 3.71 (3H, s, OCH3), 3.43 (2H, s, CH2); δC (100 MHz, 
CDCl3) 171.8 (CO2H) 167.1 (CO2CH3), 52.8 (CO2CH3), 10.8 (CH2); M/z (CI) 136 [M+NH4]+ 
(Found: [M+H]+, 136.0611.  C4H6O4 requires [M+NH4]+, 136.0266). 
 
The data are in agreement with the reported compound.3   
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(E)-Methyl pent-2-enyl malonate 397 
 
HO O
O O
O O
O O
396 397
 
 
To a solution of methyl malonate 396 (2.21 g, 18.7 mmol, 1.0 equiv.) and trans-2-penten-1-ol 
(1.87 mL, 18.7 mmol, 1.0 equiv.) in DCM (50 mL), were added at 0 oC, DCC (3.90 g, 18.7 
mmol, 1.0 equiv.) and DMAP (0.23 g, 18.7 mmol, 0.1 equiv.). After stirring 16 h at rt, the 
mixture was filtered through Celite (DCM washing). The filtrate was washed with brine (50 
mL), dried (Na2SO4) and concentrated under reduced pressure. Chromatography (25% → 
50% EtOAc–petrol) gave compound 397 as a pale yellow oil (2.46g, 65%).  
 
νmax (film) 2962, 1733, 1332, 1199, 1146, 971 cm-1; δH (400 MHz, CDCl3) 5.84 (1H, dt, J 15, 
6.5 Hz, CH=CHCH2O), 5.55 (1H, dt, J 15, 6.5 Hz,  CH=CHCH2O), 4.59 (2H, m, CH2O), 3.75 
(3H, s, CH3O), 3.39 (2H, s, COCH2CO), 2.12–2.01 (2H, m, CH3CH2), 1.00 (3H, t, J 7.5 Hz, 
CH3CH2); δC (100 MHz, CDCl3) 167 (C=O), 166.3 (C=O), 138.7 (CH=CHCH2O), 122.1 
(CH=CHCH2O), 66.3 (CH2O), 52.4 (CH3O), 41.3 (COCH2CO), 25.2 (CH3CH2), 13.0 
(CH3CH2); M/z (CI) 236, 218, 204 [M+NH4]+, 136 (Found: [M+NH4]+, 204.1231. C9H14O4 
requires [M+NH4]+, 204.0892). 
 
The data are in agreement with the reported compound.3,4   
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Methyl (2-pentenyl) (toluene-4-sulfonyl) malonate 398 
 
O O
O O
O O
O O
Ts
397 398
 
 
To a solution of 397 (6.80 g, 36.6 mmol, 2.0 equiv.) in DMSO (19 mL) was added at rt, very 
slowly, potassium tbutoxide (4.10 g, 36.6 mmol, 2.0 equiv.). The reaction was then stirred for 
15 min prior to addition of tosyl fluoride (3.20 g, 18.3 mmol, 1.0 equiv.). After stirring for 16 
h the mixture was poured onto 10% aqueous HCl (50 mL), extracted with Et2O (2 x 50 mL) 
and the combined organic layers were washed with brine (2 x 50 mL), dried (Na2SO4) and 
concentrated under reduced pressure. Chromatography (0% → 50% EtOAc–petrol) gave 
compound 398 as a pale yellow oil (7.90 g, 64%).  
 
Rf = 0.55 (25% EtOAc–petrol); νmax (film) 2925, 1742, 1436, 1336, 1266, 732 cm-1; δH (400 
MHz, CDCl3) 7.84 (2H, d, J 8.0 Hz, ortho-Ts), 7.34 (2H, d, J 8.0 Hz, meta-Ts), 5.81 (1H, td, 
J 6.5, 15.0 Hz, OCH2CH=CH), 5.47 (1H, app. ttd, J 1.5, 6.5, 15.0 Hz, CH=CH-CH2), 4.96 
(1H, s, CHTs), 4.58 (2H, d, J 6.5 Hz, OCH2), 3.77 (3H, s, OCH3), 2.44 (3H, s, CH3Ts), 2.05 
(2H, quint, J 7.5 Hz, CH2CH3), 0.98 (3H, t, J 7.5 Hz, CH2CH3);  δC (100 MHz, CDCl3) 161.5, 
160.7 (2 x CO), 146.0 (SO2C), 139.6 (CH=CHCH2O), 134.2 (CCH3), 130.1 (ortho-Ts), 129.4 
(meta-Ts), 121.3 (CH=CHCH2O), 74.4 (CHTs), 67.7 (CH2O), 53.6 (CH3O), 25.2 (CH3CH2), 
14.1 (CH3CH2); M/z (CI) 358 [M+NH4]+, 246, 204, 136, 52 (Found: [M+NH4]+, 358.1319. 
C16H20O6 requires [M+NH4]+, 358.0981). 
 
The data are in agreement with the reported compound.3,4   
 
Experimental 
 
202 
Methyl 3-ethyl-2-tosylpent-4-enoate 399 
 
O O
O O
Ts Ts CO2CH3
398 399
1 : 1
 
 
To a solution of 398 (2.80 g, 8.50 mmol, 1 equiv.) in DCM (28 mL) were added 
simultaneously, at rt, TBDMSOTf (4.11 ml, 17.9 mmol, 2.1 equiv.) and DBU (2.68 mL, 118 
mmol, 2.1 equiv.). After 30 min of stirring, the reaction mixture was concentrated under 
reduced pressure. Chromatography (0% → 25% EtOAc–petrol) gave compound 399 as a 
colorless oil (1.61 g, 64%, 1 : 1 dr). 
 
Deprotonation / carboxylation method 
 
Ts CO2CH3
399
1 : 1
Ts
402
 
 
To a solution of 402 (500 mg, 1.90 mmol, 1.0 equiv.) in THF (25 mL) at –78 oC was added 
2.5 M nBuLi (2.0 mL, 4.6 mmol, 2.4 equiv.) and the solution stirred for 30 min. The orange 
solution was allowed to heat up to –50 oC and methylchloroformate (210 µL, 2.70 mmol, 1.4 
equiv.) was added dropwise. After stirring at –50 oC for 1 h, the mixture was allowed to heat 
up to rt and quenched using saturated aqueous NH4Cl (75 mL). The aqueous layer was 
extracted using EtOAc (3 x 100 mL) and the combined organic layers were dried (MgSO4), 
concentrated under reduced pressure and purified using column chromatography (75% petrol–
EtOAc). 399 Was obtained in 486 mg as a colorless oil, 81% yield. 
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Rf = 0.74 (25% EtOAc–petrol); νmax (film) 2925, 1740, 1597, 1323, 1139, 1083, 814 cm-1; δH 
(400 MHz, CDCl3) 7.78 (2H, d, J 8.0 Hz, ortho-Ts major), 7.77 (2H, d, J 8.0 Hz, ortho-Ts 
minor) 7.35 (2H, d, J 8.0 Hz, meta-Ts major), 7.34 (2H, d, J 8.0 Hz, meta-Ts minor) 5.58 (1H, 
m, CH=CH2), 5.10 (2H, m, CH=CH2), 4.03 (1H, d, J 9.0 Hz, CH-Ts minor), 4.01 (1H, d, J 9.0 
Hz, CHTs major), 3.66 (3H, s, OCH3 minor), 3.52 (3H, s, OCH3 major),  2.80 (1H, qd, J 4.0, 
9.0 Hz, CH-CH=CH2 major), 2.70 (1H, qd, J 4.0, 9.0 Hz, CHCH=CH2 minor), 2.48 (3H, s, 
CH3-Ts major), 2.46 (3H, s, CH3-Ts minor), 1.45 (2H, m, CH2CH3 major), 1.25 (2H, m, 
CH2CH3 minor), 0.87 (3H, t, J 7.5 Hz, CH2CH3 major), 0.81 (3H, t, J 7.5 Hz, CH2CH3 
minor);  δC (100 MHz, CDCl3) 166.4 (CO major), 166.0 (CO minor), 145.3 (SO2C), 136.3 
(CH2=CHCH minor), 136.0 (CH2=CHCH major), 134.1 (CCH3), 129.6 (ortho-Ts), 129.4 
(meta-Ts), 118.8 (CH2=CHCH major), 118.6 (CH2=CHCH minor), 75.1 (CHTs, major), 74.5 
(CHTs minor), 52.7 (OCH3 minor), 52.4 (OCH3 major), 44.7 (CH2=CHCH major), 44.5 
(CH2=CHCH minor), 25.1 (CH2CH3 minor), 21.7 (CH2CH3 major), 11.1 (CH2CH3 major), 
10.9 (CH2CH3 major); M/z (CI) 314 [M+NH4]+ (Found [M+NH4]+, 314.1429. C15H20O4 
requires [M+NH4]+, 314.1426). 
 
The data are in agreement with the reported compound.3,4   
 
Pent-2-enyl 2-tosylacetate 401 
 
OH
O
O
Ts
400 401
 
 
To a solution of tosyl acetic acid (9.00 g, 42.0 mmol, 1.0 equiv.) and 2-penten-1-ol 400 (4.20 
mL, 42.0 mmol, 1.0 equiv.) in DCM (120 mL), were added at 0 oC, DCC (8.70 g, 42.0 mmol, 
1.0 equiv.) and DMAP (0.52 g, 4.20 mmol, 0.1 equiv.). After stirring for 16 h at rt, the 
mixture was filtered through Celite (DCM washing). The filtrate was washed with brine (60 
mL), dried (Na2SO4) and concentrated under reduced pressure. Chromatography (0% → 50% 
EtOAc–petrol) gave compound 401 as a pale yellow oil (10.9 g, 92%). 
 
Rf = 0.50 (25% EtOAc–petrol); νmax (film) 2968, 1738, 1597, 1457, 1400, 1327, 1275, 1150, 
1085, 1018, 967, 813 cm-1;  
Experimental 
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δh (400 MHz, CDCl3) 7.83 (2H, d, J 8.0 Hz, ortho-Ts), 7.37 (2H, d, J 8.0 Hz, meta-Ts), 5.81 
(1H, dt, J 6.5, 15.5 Hz, CH=CHCH2O), 5.45 (1H, dtt, J 1.5, 6.5, 15.5 Hz, CH=CHCH2O), 
4.53 (2H, d, J 6.0 Hz, CH=CHCH2O), 4.11 (2H, s, COCH2Ts), 2.47 (3H, s, CH3Ts), 2.07 (2H, 
m, CH3CH2), 1.00 (3H, t, J 7.0 Hz, CH3CH2); ); δC (100 MHz, CDCl3) 162.3 (CO), 145.4 
(CSO2), 139.4 (CH=CHCH2O), 135.8 (CCH3), 129.8 (ortho-Ts), 128.6 (meta-Ts), 121.6 
(CH=CHCH2O), 67.0 (CH=CHCH2O), 61.1 (CO2CH2Ts), 25.2 (CH3CH2), 13.0 (CH3CH2); 
M/z (CI) 300 [M+NH4]+ (Found [M+NH4]+, 300.1274. C14H18O4S requires [M+NH4]+, 
300.1270).  
 
1-(2-Ethylbut-3-enylsulfonyl)-4-methylbenzene 402 
 
O
O
Ts
Ts
401 402
 
 
To a solution of compound 401 (10.0 g, 35.5 mmol, 1.0 equiv.) in toluene (200 mL) was 
added, at rt, BSA (8.80 ml, 35.5 mmol, 1.0 equiv.) and KOAc (350 mg, 3.55 mmol, 0.1 
equiv.). After stirring for 16 h the reaction mixture was concentrated under reduced pressure. 
Chromatography (10% EtOAc–petrol) afforded compound 402 as a colorless oil (7.69 g, 
91%). 
 
Rf = 0.65 (25% EtOAc–petrol); νmax (film) 2963, 2927, 1598, 1454, 1316, 1301, 1146, 1087, 
817 cm-1; δh (400 MHz, CDCl3) 7.79 (2H, d, J 8.0 Hz, ortho-Ts), 7.33 (2H, d, J 8.0 Hz, meta-
Ts), 5.55 (1H, ddd, J 8.5, 10.5, 17.0, CH=CH2), 5.01 (2H, m, CH=CH2), 3.13 (2H, d, J 6.5 
Hz, CH2-Ts), 2.55 (1H, m, CH=CHCH), 2.46 (3H, s, CH3-Ts), 1.63 (2H, m, CH2CH3 major), 
1.39 (2H, m, CH2CH3 minor), 0.85 (3H, t, J 7.5 Hz, CH2CH3); δC (100 MHz, CDCl3) 144.5 
(SO2C), 138.9 (CH2=CHCH), 137.1 (CCH3), 129.8 (ortho-Ts), 128.0 (meta-Ts), 116.4 
(CH2=CHCH), 60.6 (CH2Ts), 40.1 (CH2=CHCH), 27.3 (CH2CH3 minor), 21.6 (CH2CH3 
major), 10.9 (CH2CH3); M/z (CI) 256 [M+NH4]+, 239 [M+H]+ (Found: [M+NH4]+, 256.1374. 
C13H18O2S requires [M+NH4]+, 256.1372) (Found: C, 65.60; H, 7.57. C13H18O2S requires C, 
65.51; H, 7.61%).  
 
Experimental 
 
205 
(2S,3S)-3-((1-Methyl-1H-indol-3-yl)methyl)-1-tosylaziridine-2-carbaldehyde 418 
 
N
TsN
N
TsN
HO O
388 418
 
 
A solution of aziridinol 388 (230 mg, 0.62 mmol, 1.0 equiv.) and IBX (174 mg, 0.62 mmol, 
1.0 equiv.) in DMSO (6 mL) was stirred at rt for 16 h. The solution was partitioned between 
H2O (15 mL) and EtOAc (15 mL) and the aqueous layer extracted using EtOAc (3 x 10 mL). 
Combined organic layers were washed with brine (2 x 10 mL), dried (Na2SO4) and 
concentrated under reduced pressure. Crude aldehyde 418 was used immediately (172 mg, 
75%).  
 
1-((2S,3S)-3-((1-Methyl-1H-indol-3-yl)methyl)-1-tosylaziridin-2-yl)-2-
(phenylsulfonyl)ethyl acetate 420 
N
TsN
AcO S O
O
N
TsN
O
418 420
 
 
To a solution of methyl p-tolyl sulfone (4.52 mg, 29.0 mmol, 1.2 equiv.) in THF (125 mL) at 
–78 oC was added 1.95 M nBuLi (16 mL, 31 mmol, 1.3 equiv.) and stirred for 30 min. 
Aldehyde 418 (9.0 g, 24 mmol, 1.0 equiv.) was added in THF (100 + 25 mL) at –78 oC via 
cannula. The mixture was stirred for 3 h while heating up –40 oC. Acetic anhydride (6.0 mL, 
62 mmol, 2.6 equiv.) was added and the mixture stirred for 15 min at rt, poured onto saturated 
aqueous NaHCO3 (200 mL) and extracted using DCM (2 x 200 mL). The combined organic 
Experimental 
 
206 
layers were washed with H2O (200 mL), dried (MgSO4) and concentrated under reduced 
pressure. Column chromatography (66% → 50% petrol–EtOAc) yielded 420 as a yellow foam 
(10.1 g, 74%).  
 
Rf = 0.40 (66% Et2O–petrol); m.p. = 88 oC; νmax (film) 3494, 2980, 1747, 1614, 1598, 1470, 
1447, 1373, 1321, 1305, 1224, 1151, 1087, 735 cm-1; δh (400 MHz, CDCl3) 7.95 (2H, d, J 7.5 
Hz, ortho-Ts), 7.63 (2H, m, ortho-Ts), 7.40 (2H, d, J 8.5 Hz, C-9), 7.21 (2H, d, J 3.5 Hz, C-
12), 7.04 (1H, dd, J 4.0, 8.0 Hz, C-11), 6.99 (2H, d, J 8.0 Hz, C-10), 6.61 (1H, s, C-2), 5.29 
(1H, td, J 4.0, 8.0 Hz, CHOAc), 3.63 (2H, m, CH2SO2Ph), 3.61 (3H, s, NCH3), 3.15 (1H, m, 
CHOAcCHNTs), 3.09 (2H, m, CH2CHNTs), 2.72 (1H, dd, J 9.0, 15.0 Hz, CH2CHNTs), 2.39 
(3H, s, CH3Ts), 1.91 (3H, s, CH3CO2); δC (100 MHz, CDCl3) 169.4 (C=O),  144.4 (CSO2), 
139.6 (CSO2), 136.7 (CH3CTs), 133.3 (para-PhSO2), 129.8 (C-13), 129.4 (ortho-Ts), 129.1 
(ortho-PhSO2), 128.4 (meta-Ts), 127.9 (C-8), 127.8 (meta-PhSO2), 126.9 (C-2), 121.4 (C-11), 
118.9 (C-10), 118.6 (C-9), 109.6 (C-12), 109.0 (C-7), 65.0 (CHOAc), 57.7 (CH2SO2Ph), 47.7 
(CHCHOAc), 43.1 (CH2CHNTs), 32.5 (NCH3), 22.9 (CH2CNTs), 21.7 (TsCH3), 20.6 
(CO2CH3). M/z (ESI) 605.1260, 589.1454 [M+Na]+, 567.1639 [M+H]+, 196.0197 (Found: 
[M+H]+, 567.1639. C29H30N2O6S2 requires [M+H]+, 567.1545) (Found: C, 61.37; H, 5.21; N, 
4.89. C29H30N2O6S2 requires C, 61.46; H, 5.34; N, 4.94%).  
 
Experimental 
 
207 
1-((2S,3S)-3-((1-Methyl-1H-indol-3-yl)methyl)-1-tosylaziridin-2-yl)-2-
(phenylsulfonyl)ethyl benzoate 421 
N
TsN
BzO S O
O
N
TsN
O
418 421
 
 
To a solution of methyl p-tolyl sulfone (114 mg, 0.73 mmol, 1.2 equiv.) in THF (3 mL) at –78 
oC was added 2.5 M nBuLi (317 µL, 0.79 mmol, 1.2 equiv.) and stirred for 30 min. Aldehyde 
418 (225 mg, 0.61 mmol, 1.0 equiv.) was added in THF (3 + 2 mL) at –78 oC via cannula. 
The mixture was stirred for 2 h while heating up to rt. Benzoyl chloride (90.0 µL, 0.79 mmol, 
1.3 equiv.) was added and the mixture stirred for 1 h at rt, poured on saturated aqueous 
NaHCO3 (100 mL), extracted using DCM (2 x 100 mL). The combined organic layers were 
washed with H2O (100 mL), dried (MgSO4) and concentrated under reduced pressure. 
Chromatography (66% → 50% petrol–EtOAc) yielded 421 as a yellow gum (269 mg, 70%).  
 
Rf = 0.40 (66% Et2O–petrol); νmax (film) 3062, 2927, 1724, 1614, 1599, 1472, 1447, 1376, 
1304, 1264, 1148, 1087, 1069, 956, 740 cm-1; δh (400 MHz, CDCl3) 7.96 (2H, d, J 7.5 Hz, 
ortho-Ts), 7.75 (2H, d, J 8.0 Hz, meta-Ts), 7.58 (3H, m, C-9), 7.45–7.36 (4H, m, C-12), 7.17 
(3H, m, C-11), 7.00 (2H, d, J 8.0 Hz, C-10), 6.58 (1H, s, C-2), 5.52 (1H, dt, J 2.5, 8.5 Hz, 
CHOBz), 3.83 (2H, m, CH2SO2Ph), 3.49 (3H, s, NCH3), 3.23–3.20 (3H, m, CHOBzCHNTs + 
CH2CHNTs), 2.86 (1H, dd, J 9.0, 15.0 Hz, CH2CHNTs), 2.40 (3H, s, CH3Ts);  δC (100 MHz, 
CDCl3) 164.5 (CO), 164.2 (CO), 144.4 (CSO2), 139.6 (CSO2), 136.7 (CH3C-Ts), 133.7 
(CCO), 133.6 (para-PhSO2), 133.5 (para-Bz), 129.8 (C-13), 129.4 (ortho-Ts), 129.3 (ortho-
PhSO2), 129.1 (ortho-Bz), 128.3 (meta-Ts), 128.0 (C-8), 127.9 (meta-PhSO2), 127.8 (ortho-
Bz), 127.4 (meta-Bz), 126.9 (C-2), 121.5 (C-11), 118.9 (C-10), 118.7 (C-9), 109.7 (C-7), 
108.9 (C-12), 65.9 (CHOBz), 58.0 (CH2SO2Ph), 47.9 (CHCHOBz), 43.3 (CH2CHNTs), 32.3 
(NCH3), 23.0 (CH2CNTs), 21.8 (CH3Ts); M/z (ESI) 196.0166, 629.1779 [M+H]+, 651.1599 
[M+Na]+
 
(Found: [M+H]+, 629.1779. C34H32N2O6S2 requires [M+H]+, 629.1702). 
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(S)-4-Methyl-N-(1-(1-methyl-1H-indol-3-yl)pent-3-en-2-yl)benzenesulfonamide 422 
 
N
TsN
BzO S O
O
N
TsHN
421 422
 
 
To a flame-dried flask containing Sm0 (218 mg, 1.44 mmol, 9.0 equiv.) was slowly added 
diodoethane (360 mg, 1.28 mmol, 8.0 equiv.) in THF (15 mL) at 0 oC. After stirring at rt for 2 
h, the aziridine benzoyl ester 421 (100 mg, 0.16 mmol, 1.0 equiv.) was added in THF (2 mL) 
together with DMPU (483 µL, 4.00 mmol, 25.0 equiv.) and stirred for 45 min at rt. The 
solution was concentrated under reduced pressure and dissolved using EtOAc (50 mL), the 
organic layer was washed with 1 M HCl (2 x 20 mL), H2O (2 x 20 mL), saturated aqueous 
Na2S2O3 (2 x 20 mL), H2O (2 x 20 mL), brine (2 x 20 mL), dried (MgSO4) and concentrated 
under reduced pressure. Chromatography (25% EtOAc–petrol) gave the amino olefin 422 as a 
yellow gum (23 mg, 40%).  
 
Rf = 0.65 (50% EtOAc–petrol); δh (400 MHz, CDCl3) 7.51 (2H, d, J 8.5 Hz, ortho-Ts), 7.35 
(1H, d, J 8.0 Hz, C-9), 7.28 (1H, d, J 8.0 Hz, C-12), 7.23 (1H, dd, J C-11), 7.11 (2H, d, J 8.0 
Hz, meta-Ts), 7.06 (1H, dd, J 4.0, 11.0 Hz, C-10), 6.82 (1H, s, C-2), 5.51 (1H, dt, J 6.5, 13.0 
Hz, CHCHCH3), 5.31 (1H, ddd, J 1.5, 7.0, 15.0 Hz, CHCHCH3), 4.46 (1H, d, J 6.0 Hz, 
NHTs), 3.99 (1H, m, CHNHTs), 3.74 (3H, s, NCH3), 2.96 (1H, dd, J 5.5, 14.0 Hz, 
CHAHBCHNHTs), 2.86 (1H, dd, J 7.0, 14.0 Hz, CHAHBCHNHTs), 2.38 (3H, s, CH3Ts), 1.57 
(3H, d, J 6.0 Hz, CHCH3);  δC (100 MHz, CDCl3) 142.8 (CCH3), 137.4 (C-13), 137.0 (CSO2), 
131.1 (CHCHCH3), 129.2 (meta-Ts), 128.6 (C-2), 127.8 (C-8), 127.4 (CHCHCH3), 127.1 
(ortho-Ts), 121.7 (C-11), 119.1 (C-10), 1191.0 (C-9), 109.0 (C-12), 108.9 (C-7), 55.8 
(CHNHTs), 32.6 (NCH3), 32.8 (CH2CHNHTs), 21.5 CH3Ts), 17.6 (CH3). 
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(S)-2-Amino-3-(1-methyl-1H-indol-3-yl)propanoic acid 427 
 
N
H
H2N
O
HO
N
H2N
O
HO
427
 
 
To a solution of sodium (1.20 g, 50.0 mmol, 2.0 equiv.) in liquid ammonia (~200 mL) at –78 
oC in a three-neck flask equipped with a dry ice condenser was added FeCl3 (cat.). The 
solution was stirred for 1 h while the colour changed from deep blue to dark grey. In the dark 
L-tryptophan (5.00 g, 25.0 mmol, 1.0 equiv.) was added in one portion. After 15 min CH3I 
(2.00 mL, 27.5 mmol, 1.1 equiv.) was added dropwise via a syringe and the solution stirred 
for 1 h at –78 oC. After evaporation of the ammonia, the residue was dissolved in H2O (20 
mL, 65 oC) and filtered hot. Precipitation occurred while adjusting the pH of the filtrate to 5 
by dropwise addition of HOAc (conc.) at 65 oC. After cooling to rt, the precipitate was filtered 
and washed (70% EtOH–H2O). Recrystallization (70% EtOH–H2O) gave 427 as a white solid 
(5.10 g, 91%).  
 
Rf = 0.40 (100% CH3OH); νmax (film), 3010, 1663, 1589, 1409, 1350, 1280, 728 cm-1;  δH (400 
MHz, CD3COOD) 7.65 (1H, d, J 8.0 Hz, CH-9), 7.32 (1H, d, J 8.0 Hz, C-12), 7.22 (1H, t, J 
7.5 Hz, C-11), 7.14 (1H, s, C-2), 7.10 (1H, t, J 7.5 Hz, C-10), 4.37 (1H, br s, NH2CH), 3.74 
(3H, s, NCH3), 3.53 (1H, dd, J 6.0, 14.5 Hz, CHAHBCHNH2), 3.40 (1H, dd, J 6.0, 14.5 Hz, 
CHAHBCHNH2); C (100 MHz, CDCl3) 177.0 (CO), 137.2 (C-13), 129.0 (C-8), 127.7 (C-2), 
121.7 (C-11), 119.2 (C-9), 118.6 (C-10), 109.2 (C-12), 106.2 (C-7), 57.4 (CHNH2), 31.8 
(CH3N), 26.0 (CH2CHNH); M/z  (ESI) 219, 202 [M+H]+.  
 
The data are in agreement with the reported compound.5   
 
 
Experimental 
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(S)-1-Methoxy-3-(1-methyl-1H-indol-3-yl)-1-oxopropan-2-aminium chloride 428 
 
N
H2N
O
HO
427
N
-Cl+H3N
O
O
428
 
 
To a solution of 427 (4.00 g, 18.3 mmol, 1.0 equiv.) in CH3OH (50 mL) at 0 oC was added 
thionyl chloride (2.00 mL, 27.5 mmol, 1.5 equiv.) dropwise. The solution was refluxed for 2 
h, cooled to rt, and concentrated under reduced pressure. Azeotropic removal of H2O using 
toluene provided 428 as a white solid (4.9 g, 99%).  
 
Rf = 0.32 (20% CH3OH–EtOAc); νmax (film), 2840, 1747, 1506, 1474, 1448, 1327, 1232, 739 
cm-1; δH (400 MHz, D2O) 7.46 (1H, d, J 8.0 Hz, CH-9), 7.36(1H, d, J 8.0 Hz, CH-12), 7.20 
(1H, t, J 7.5 Hz, CH-11), 7.09 (1H, t, J 7.5 Hz, CH-10), 7.06 (1H, s, CH-2), 4.31 (1H, t, J 6.0 
Hz, NH2CH), 3.69 (3H, s, NCH3), 3.64 (3H, s, OCH3), 3.31 (2H, m, CH2CHNH2); δC (100 
MHz, CDCl3) 170.3 (CO), 136.9 (C-13), 129.6 (C-12), 126.8 (C-8), 122.0 (C-2), 119.4 (C-
11), 118.2 (C-9), 110.1 (C-10), 104.8 (C-7), 53.5 (CHNH2), 53.3 (OCH3), 32.1 (NCH3), 25.5 
(CH2CHNH2); M/z (ESI) 216, 233 [M+H]+.  
 
The data are in agreement with the reported compound.5   
 
 
Experimental 
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(S)-Methyl 3-(1-methyl-1H-indol-3-yl)-2-(4-methylphenylsulfonamido)propanoate 426 
 
N
-Cl+H3N
O
O
428
N
TsHN
O
O
426
 
 
To a suspension of 428 (1.70 g, 6.3 mmol, 1.0 equiv.), DMAP (160 mg, 1.30 mmol, 0.2 
equiv.) and TsCl (1.30 g, 6.90 mmol, 1.1 equiv.) in DCM (13 mL) at 0 oC was added TEA 
(1.80 mL, 14.0 mmol, 2.2 equiv.). After 30 min at 0 oC, the mixture was allowed to warm up 
to rt for 16 h. The mixture was partitioned between DCM (125 mL) and H2O (100 mL). The 
aqueous layer was extracted using DCM (3 x 50 mL) and the combined organic layers were 
washed with saturated aqueous NaHCO3 (50 mL), H2O (50 mL), brine (50 mL), dried 
(MgSO4). Concentration under reduced pressure and chromatography (50% petrol–EtOAc) 
gave 426 as a white solid (1.9 g, 80% yield).  
 
Rf = 0.37 (50% EtOAc–petrol); νmax (film), 3399, 3293, 2952, 1741, 1432, 1332, 1160, 1091, 
814, 743, 667 cm-1;
 
δH (400 MHz, CDCl3) 7.63 (2H, d, J 8.5 Hz, ortho-Ts), 7.43 (1H, d, J 8.0 
Hz, C-9), 7.28 (1H, d, J 8.0 Hz, C-12), 7.21 (2H, m, meta-Ts + C-11), 7.08 (1H, dd, J 4.0, 
11.0 Hz, C-10), 6.90 (1H, s, C-2), 5.15 (1H, d, J 9.0 Hz, NHTs), 4.26 (1H, dt, J 5.5, 9.0 Hz, 
CHNHTs), 3.74 (3H, s, NCH3), 3.47 (3H, s, OCH3), 3.25 (2H, d, J 5.5 Hz, CH2CHNHTs), 
2.39 (3H, s, CH3Ts); δC (100 MHz, CDCl3) 171.6 (CO), 143.4 (CCH3), 136.8 (C-13), 136.6 
(CSO2), 129.5 (meta-Ts), 128.1 (C-2), 127.7 (C-8), 127.1 (ortho-Ts), 121.7 (C-11), 119.2 (C-
10), 118.6 (C-9), 109.3 (C-12), 107.3 (C-7), 56.0 (CHNHTs), 52.4 (OCH3), 32.7 (NCH3), 
29.2 (CH2CHNHTs), 21.5 (CH3Ts); M/z (ESI) 450, 436, 425, 409, 395, 387 [M+H]+, 373. 
 
The data are in agreement with the reported compound.5   
 
 
Experimental 
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(S)-N-(1-Hydroxy-3-(1-methyl-1H-indol-3-yl)propan-2-yl)-4-methylbenzenesulfonamide 
429 
 
N
TsHN
O
N
TsHN
O
426 429
HO
 
 
To a solution of LiAlH4 (296 mg, 7.80 mmol, 2.0 equiv.) in THF (8.0 mL) at 0 oC was added 
426 (1.50 g, 3.90 mmol, 1.0 equiv.) in THF (30 mL). After stirring at 0 oC for 1 h, the 
suspension was slowly heated to rt over 16 h and quenched using Rochelle’s salt until 
evaporation of gas ended. Filtration through a Celite plug was followed by washing the 
residue with EtOAc. The organic layer was separated, dried (MgSO4) and concentrated under 
reduced pressure. Chromatography (50% EtOAc–petrol) gave 429 as a yellow gum (1.30 g, 
94%).  
 
Rf = 0.40 (100% EtOAc); νmax (film), 3530, 3280, 2924, 1600, 1471, 1320, 1250, 1090, 1040, 
880, 739 cm-1;
  
δH (400 MHz, CDCl3) 7.50 (2H, d, J 8.0 Hz, ortho-Ts), 7.28–7.19 (3H, m, C-9 
+ C-12 + C-11), 7.07 (2H, d, J 8.0 Hz, meta-Ts), 6.99 (1H, dd, J 4.0, 11.0 Hz, C-10), 6.78 
(1H, s, C-2), 5.00 (1H, m, NHTs), 3.73 (1H, m, CHAHBOH), 3.70 (3H, s, NCH3), 3.62 (1H, 
m, CHAHBOH), 3.50 (1H, m, CHNHTs), 2.95 (1H, dd, J 6.5, 14.5 Hz, CHAHBCHNHTs), 2.83 
(1H, dd, J 7.5, 14.5 Hz, CHAHBCHNHTs), 2.37 (3H, s, CH3Ts); δC (100 MHz, CDCl3) 143.2 
(CCH3), 137.1 (C-13), 136.4 (CSO2), 129.4 (meta-Ts), 128.6 (C-2), 127.7 (C-8), 126.8 (ortho-
Ts), 121.7 (C-11), 119.2 (C-10), 118.6 (C-9), 109.2 (C-12), 108.9 (C-7), 64.7 (CH2OH), 55.6 
(CHNHTs), 32.6 (NCH3), 27.3 (CH2CHNHTs), 21.6 (CH3Ts); M/z (ESI) 359 [M+H]+.  
 
The data are in agreement with the reported compound.5   
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(S)-4-Methyl-N-(1-(1-methyl-1H-indol-3-yl)-3-oxopropan-2-yl)benzenesulfonamide 425  
 
N
TsHN
O
N
TsHN
O
O
426 425
 
Procedure A 
 
To a solution of 426 (100 mg, 0.26 mmol, 1.0 equiv.) in THF (2 mL) at –78 oC was added 1.2 
M DIBAL (0.43 mL, 0.52 mmol, 2.0 equiv.) and stirred at –78 oC for 30 min. Quenching the 
reaction using Rochelle’s salt (~5 mL) was followed by addition of EtOAc (10 mL). The 
aqueous layer was extracted using EtOAc (3 x 5 mL), the combined organic layers were 
washed with brine (2 x 10 mL), dried (MgSO4) and concentrated under reduced pressure. 
Crude aldehyde 425 was used immediately (91 mg, 98%).  
 
N
TsHN
N
TsHN
O
HO
429 425
 
 
Procedure B 
 
A solution of 429 (370 mg, 1.00 mmol, 1.0 equiv.) and IBX (310 mg, 1.10 mmol, 1.1 equiv.) 
in DMSO (6 mL) was stirred at rt for 16 h. The solution was partitioned between H2O (10 
mL) and EtOAc (10 mL) and the aqueous layer extracted using EtOAc (3 x 10 mL). 
Combined organic layers were washed with brine (2 x 10 mL), dried (MgSO4) and 
concentrated under reduced pressure. Crude aldehyde 425 was used immediately (300 mg, 
81%).  
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N-((2S,3S)-3-Hydroxy-1-(1-methyl-1H-indol-3-yl)pent-4-en-2-yl)-4-
methylbenzenesulfonamide 424 
 
N
TsHN
O
N
TsHN
OH
425 424
 
Procedure A 
 
To a solution of Ph3PCH3Br (1.40 g, 4.00 mmol, 4.0 equiv.) in THF (20 mL) at 0 oC was 
added 1.66 M nBuLi (2.40 mL, 4.00 mmol, 4.0 equiv.). After stirring for 1 h at rt, the solution 
was cooled to 0 oC and (CH3)3SiCH2I (594 µL, 4.00 mmol, 4.0 equiv.) was dropwise added. 
Stirring at rt for 1 h was followed by addition of 1.66M nBuLi (2.40 mL, 4.00 mmol, 4.0 
equiv.) at –78 oC. The solution was stirred at –78 oC for 1 h after which aldehyde 425 (370 
mg, 1.00 mmol, 1.0 equiv.) in THF (20 mL) was added and the solution allowed to warm to rt 
over 16 h. Quenching the mixture using saturated aqueous NH4Cl (30 mL) was followed by 
addition of EtOAc (30 mL). The layers were partitioned and the aqueous layer was extracted 
using EtOAc (3 x 40 mL), the combined organic layers were dried (MgSO4) and concentrated 
under reduced pressure. The crude silylether was dissolved in THF (10 mL) at 0 oC and 1M 
TBAF (1.40 mL, 1.40 mmol, 1.4 equiv.) was added. After stirring for 30 min at 0 oC, the 
suspension was allowed to rt and diluted by addition of H2O (10 mL). The aqueous layer was 
extracted using EtOAc (3 x 10 mL) and the combined organic layers were washed with brine 
(15 mL), dried (MgSO4) and concentrated under reduced pressure. Chromatography gave 424 
as a colorless gum (100 mg, 33% (2 steps)). 
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Procedure B 
 
To a solution of aldehyde 425 (0.50 g, 4.20 mmol, 1.0 equiv.) in THF (6 mL) at –78 oC was 
added 1.0 M vinyl Grignard (5.60 mL, 5.60 mmol, 4.0 equiv.) dropwise. After 10 min stirring 
at –78 oC, the solution was allowed to warm up to rt over 2 h. The reaction was quenched 
using saturated aqueous NH4Cl (20 mL) and DCM (40 mL) was added. After partitioning the 
layers, the aqueous layer was extracted with DCM (3 x 40 mL). The combined organic layers 
were washed with brine (70 mL), dried (MgSO4) and concentrated under reduced pressure. 
Flash chromatography (50% EtOAc–petrol) gave 424 as a colorless gum (150 mg, 41% (2 
steps)). 
 
N
TsHN
O
N
TsHN
O
N
TsHN
OH
O
426 425 424
 
 
Procedure C 
 
To a solution of 426 (200 mg, 0.52 mmol, 1.0 equiv.) in DCM (1.0 mL) at –78 oC was added 
1.0 M DIBAL (1.10 mL, 1.10 mmol, 2.0 equiv.). After stirring for 1 h at –78 oC, 1.0 M vinyl 
Grignard (1.56 mL, 1.56 mmol, 3.0 equiv.) was added and the solution allowed to warm up 
slowly to rt over 4 h. Quench with saturated aqueous NH4Cl (5 mL) was followed by dilution 
using EtOAc (5 mL), partitioning the layers was followed by extraction of the aqueous layer 
using EtOAc (3 x 5 mL), the combined organic layers were dried (MgSO4), and concentrated 
under reduced pressure. Chromatography (50% EtOAc–petrol) gave 424 as a colorless gum 
(100mg, 51%) as well as alcohol 429 as a yellow gum (71mg, 41% (2 steps)). 
 
N
TsHN
O
N
TsHN
OH
431 424
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Procedure D 
 
To a mixture of vinyl ketone 431 (60 mg, 0.17 mmol, 1.0 equiv.) and CeCl3·7H2O (63 mg, 
0.17 mmol, 1.0 equiv.) in CH3OH (2.5 mL) at rt was added NaBH4 (6.0 mg, 0.17 mmol, 1.0 
equiv.) and stirred for 10 min. The mixture was partitioned between saturated aqueous NH4Cl 
(10 mL) and EtOAc (10 mL) and the aqueous layers extracted with EtOAc ( 3 x 5 mL). The 
combined organic layers were dried (MgSO4) and concentrated under reduced pressure. 
Chromatography (50% EtOAc–petrol) gave 424 as a colorless gum (58 mg, 95%).  
 
Rf = 0.35 (50% EtOAc–petrol); νmax (film), 3489, 3288, 2925, 1710, 1598, 1473, 1424, 1377, 
1326, 1155, 1092, 812, 740, 666 cm-1; δH (400 MHz, CDCl3) 7.55 (2H, d, J 8.0 Hz, ortho-Ts), 
7.46 (1H, m, C-9), 7.23 (2H, m, C-12 + C-11), 7.08 (2H, m, meta-Ts + C-10), 6.79 (1H, s, C-
2), 5.73 (1H, ddd, J 5.5, 10.5, 17.0 Hz, CH=CH2), 5.26 (1H, d, J 17.0 Hz, CH=CHAHB), 5.11 
(1H, d, J 10.5 Hz, CH=CHAHB), 4.99 (1H, d, J 7.5 Hz, NHTs), 4.23 (1H, m, CHOH), 3.69 
(3H, s, NCH3), 3.52 (1H, m, CHNHTs), 3.12 (1H, dd, J 7.5, 14.5 Hz, CHAHBCHNHTs), 2.82 
(1H, dd, J 6.5, 14.5 Hz, CHAHBCHNHTs), 2.37 (3H, s, CH3Ts); δC (100 MHz, CDCl3) 142.9 
(CCH3), 137.5 (CH=CH2), 137.3 (C-13), 136.9 (CSO2), 129.2 (meta-Ts), 127.7 (C-2), 127.6 
(C-8), 126.9 (ortho-Ts), 121.7 (C-11), 119.1 (C-10), 118.8 (C-9), 116.8 (CH=CH2), 109.6 (C-
7), 109.2 (C-12), 72.6 (CHOH), 58.1 (CHNHTs), 32.6 (NCH3), 27.6 (CH2CHNHTs), 21.1 
(CH3Ts); M/z (CI) 144, 385 [M+H]+, 402 [M+NH4]+, 429, 528 (Found: [M+H]+, 385.1581. 
C21H24N2O3S requires [M+H]+, 385.1508).  
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(S)-3-(1-Methyl-1H-indol-3-yl)-2-(4-methylphenylsulfonamido)propanoic acid 432 
 
N
TsHN
O
O
N
TsHN
O
HO
426 432
 
 
A solution of 426 (0.60 g, 1.70 mmol, 1.0 equiv.) and LiOH (80.0 mg, 1.90 mmol, 1.1 equiv.) 
in 1:1 DME–H2O (2 + 2 mL) at rt was stirred for 16 h. Adjusting the pH to 4 using 10% citric 
acid was followed by extraction of the aqueous layer using EtOAc (3 x 20 mL). The 
combined organic layers were dried (MgSO4) and concentrated under reduced pressure to 
provide crude acid 432 as a yellow oil (550 mg, 95%).  
 
(S)-N-Methoxy-N-methyl-3-(1-methyl-1H-indol-3-yl)-2-(4-
methylphenylsulfonamido)propanamide 430 
 
N
TsHN
N
TsHN
OO
HO N
O
432 430
 
 
To a solution of 432 (550 mg, 1.60 mmol, 1.0 equiv.) and DMAP (20.0 mg, 0.16 mmol, 0.1 
equiv.) in DCM (10 mL) at rt was added TEA (0.63 mL, 4.80 mmol, 3.0 equiv.). DIC (0.25 
mL, 1.60 mmol, 1.0 equiv.) was added dropwise and the solution stirred for 16 h at rt. The 
mixture was extracted with 10% aqueous HCl (3 x 10 mL) and the organic layer was 
subsequently washed with saturated aqueous NaHCO3, dried (MgSO4) and concentrated under 
reduced pressure. Chromatography (50% EtOAc–petrol) gave Weinreb amide 430 as a yellow 
gum (620 mg, 95%). 
 
Rf = 0.30 (50% EtOAc–petrol); νmax (film), 3248, 2937, 1655, 1474, 1377, 1328, 1157, 1092, 
987, 741 cm-1;  
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δH (400 MHz, CDCl3) 7.53 (2H, d, J 8.0 Hz, ortho-Ts), 7.39 (1H, d, J 8.5 Hz, C-9), 7.21 (2H, 
m, C-12 + C-11), 7.09 (2H, d, J 8.0 Hz, meta-Ts), 7.05 (1H, dt, J 1.5, 8.5 Hz, C-10), 6.83 (1H, 
s, C-2), 5.59 (1H, d, J 7.0 Hz, NHTs), 4.15 (1H, m, CHNHTs), 3.66 (3H, s, NCH3 Indole), 
3.36 (3H, s, NCH3 Weinreb amide), 3.19 (1H, dd, J 6.0, 15.0 Hz, CHAHBCHNHTs), 3.08 (1H, 
dd, 7.0, 15.0 Hz, CHAHBCHNHTs), 2.49 (3H,s , OCH3), 2.34 (3H, s, CH3Ts); δC (100 MHz, 
CDCl3) 207.8 (CO), 143.4 (CCH3), 136.9 (CSO2), 136.4 (C-13), 129.4 (meta-Ts), 128.2 (C-
2), 127.9 (C-8), 126.9 (ortho-Ts), 121.8 (C-11), 119.2 (C-10), 118.5 (C-9), 109.3 (C-12), 
107.5 (C-7), 61.6 (CHNHTs), 59.8 (NCH3 Weinreb amide), 44.8 (OCH3), 32.6 (NCH3), 28.1 
(CH2CHNHTs), 21.5 (CH3Ts); M/z (CI) 433 [M+NH4]+, 416 [M+H]+ (Found: [M+H]+, 
416.1641. C21H25N3O4S requires [M+H]+, 416.1566) (Found: C, 60.70; H, 6.06; N, 10.11. 
C21H25N3O4S requires C, 60.66; H, 5.98; N, 10.15%).  
 
(S)-4-Methyl-N-(1-(1-methyl-1H-indol-3-yl)-3-oxopent-4-en-2-yl)benzenesulfonamide 
431 
 
N
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O
N
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O
N
O
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To a solution of Weinreb amide 430 (307 mg, 0.76 mmol, 1.0 equiv.) in THF (4 mL) at rt was 
added 1 M vinyl Grignard in THF (3.00 mL, 3.04 mmol, 4.0 equiv.). After stirring at rt for 16 
h, the solution was quenched using saturated aqueous NH4Cl (10 mL) and EtOAc (10 mL) 
was added. The aqueous layer was extracted with EtOAc (3 x 10 mL) and the combined 
organic layers were washed with brine (15 mL), dried (MgSO4) and concentrated under 
reduced pressure. Chromatography (50% EtOAc–petrol) gave vinyl ketone 431 as a yellow 
gum (255 mg, 95%). 
  
Rf = 0.51 (50% EtOAc–petrol); νmax (film), 3292, 2926, 1701, 1612, 1701, 1473, 1403, 1376, 
1331, 1158, 1091, 989, 740 cm-1;  
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δH (400 MHz, CDCl3) 7.57 (2H, d, J 8.0 Hz, ortho-Ts), 7.40 (1H, d, J 8.5 Hz, C-9), 7.26 (1H, 
dd, J 1.0, 8.5 Hz, C-12), 7.22 (1H, dd, J 1.0, 8.5 Hz, C-11), 7.15 (2H, d, J 8.0 Hz, meta-Ts), 
7.06 (1H, dt, J 1.0, 8.0 Hz, C-10), 6.82 (1H, s, C-2), 6.42 (1H, dd, J 10.5, 17.5 Hz, CH=CH2), 
6.22 (1H, dd, J 1.0, 17.5 Hz, CH=CHAHB), 5.78 (1H, dd, J 1.0, 10.5 Hz, CH=CHAHB), 5.39 
(1H, d, J 7.5 Hz, NHTs), 4.49 (1H, dd, J 6.0, 13.5 Hz, CHNHTs), 3.72 (3H, s, CH3N), 3.23 
(1H, dd, J 6.0, 15.0 Hz, CHAHBCHNHTs), 3.13 (1H, dd, J 6.0, 15.0 Hz, CHAHBCHNHTs), 
2.38 (3H, s, CH3Ts); δC (100 MHz, CDCl3) 197.2 (CO), 143.4 (CCH3), 136.9 (CSO2), 136.6 
(C-13), 132.3 (CH=CH2), 130.3 (CH=CH2), 129.5 (meta-Ts), 128.0 (C-2), 127.6 (C-8), 126.0 
(ortho-Ts), 121.8 (C-11), 119.2 (C-10), 118.7 (C-9), 109.3 (C-12), 107.3 (C-7), 59.7 
(CHNHTs), 32.7 (NCH3), 28.9 (CH2CHNHTs), 21.5 (CH3Ts); M/z (ESI) 446.1525, 421.0988, 
405.1249 [M+Na]+, 383.1422 [M+H]+, 196.0171 (Found: [M+H]+, 383.1422. C21H22N2O3S 
requires [M+H]+, 383.1351). 
 
(S)-1-Methyl-3-((1-tosyl-3-vinylaziridin-2-yl)methyl)-1H-indole 419 
 
N
TsN
N
TsHN
OH
424 419
 
 
To a solution of 424 (280 mg, 0.78 mmol, 1.0 equiv.) and PPh3 (262 mg, 1.0 mmol, 1.2 
equiv.) in THF (8 mL) at rt was dropwise added, in the dark, DIAD (232 µL, 1.17 mmol, 1.5 
equiv.). After stirring at rt for 1.5 h the solution was concentrated under reduced pressure 
followed by column chromatography (66% petrol–EtOAc) gave 419 as a yellow gum (251 
mg, 96%). 
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Wittig Reaction to provide 419 
 
N
TsN
N
TsN
O
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To a solution of PPh3CH3Br (343 mg, 0.95 mmol, 1.2 equiv.) in THF (11 mL) at –20 oC was 
added KHMDS (1.92 mL, 0.95 mmol, 1.2 equiv.). After stirring at –20 oC for 15 min, the 
solution was heated to rt and stirred for 10 min, cooled to –20 oC and aldehyde 418 (289 mg, 
0.80 mmol, 1.0 equiv.) in THF (11 mL) was added. The solution was stirred for 30 min at –20 
oC, poured on brine (100 mL) and extracted using Et2O (3 x 100 mL). The combined organic 
layers were dried (MgSO4), concentrated under reduced pressure and purified using column 
chromatography (66% petrol–EtOAc) to give 419 (36 mg, 12%).  
 
Rf = 0.81 (50% EtOAc–petrol); νmax (film), 3301, 3055, 2935, 1716, 1598, 1475, 1437, 1376, 
1323, 1265, 1154, 1013, 734 cm-1; δH (400 MHz, CDCl3) 7.64 (2H, d, J 8.0 Hz, ortho-Ts), 
7.49 (1H, d, J 8.5 Hz, C-9), 7.28–7.20 (2H, m, C-12 + C11), 7.09 (2H, d, J 8.0 Hz, meta-Ts), 
7.05 (1H, dt, J 1.0, 8.0 Hz, C-10), 6.77 (1H, s, C-2), 5.83 (1H, ddd, J 7.0, 10.5, 17.5 Hz, 
CH=CH2), 5.55 (1H, dd, J 8.0, 17.0 Hz, CH=CHAHB), 5.42 (1H, dd, J 1.0, 10.5 Hz, 
CH=CHAHB), 3.67 (3H, s, NCH3), 3.52 (1H, app t, J 7.5 Hz, NTsCHCH=CH2), 3.25 (1H, dd, 
J .7.5, 13.5 Hz, CH2CHNTs), 2.93 (1H, dd, J 6.0, 15.0 Hz, CHAHBCHNTs), 2.87 (1H, dd, J 
6.0, 15.0 Hz, CHAHBCHNHTs), 2.41 (3H, s, CH3Ts); δC (100 MHz, CDCl3) 143.9 (CCH3), 
136.8 (CSO2), 134.9 (C-13), 129.9 (CH=CH2), 129.2 (meta-Ts), 127.5 (ortho-Ts), 127.4 (C-
8), 126.7 (C-2), 121.6 (CH2=CH), 121.6 (C-11), 118.9 (C-10), 118.7 (C-9), 110.0 (C-7),109.0 
(C-12), 46.2 (CH2CHNTs), 45.3 (NTsCHCHCH2), 32.6 (NCH3), 22.8 (CH2CNTs), 21.7 
(TsCH3); M/z (CI) 441, 423, 385 [M+NH4]+, 367 [M+H]+, 189 (Found: [M+H]+, 367.1484. 
C21H22N2O2S requires [M+H]+, 367.1402). 
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4-Methyl-N-((2S)-1-(1-methyl-1H-indol-3-yl)-3-(phenylsulfonylmethyl)pent-4-en-2-
yl)benzenesulfonamide 433 
 
N
TsN
NNHTsS
+
S O
O
O
O
432419 433
 
 
To a solution of sulfone 432 (150.0 mg, 0.90 mmol, 3.0 equiv.) in THF (1.0 mL) was added 
2.5 M nBuLi (588 µL, 1.35 mmol, 4.5 equiv.) at –40 oC,. After 30 min, aziridine 419 (100 mg, 
0.30 mmol, 1.0 equiv.) in THF (0.5 mL) was added at –40 oC dropwise and stirred for 16 h 
while heating up to rt. The solution was quenched using saturated aqueous NH4Cl (15 mL) 
and the aqueous layer was extracted with EtOAc (3 x 15 mL). The combined organic layers 
were dried (MgSO4) and concentrated under reduced pressure. Column chromatography (33% 
EtOAc–petrol) gave 433 as a yellow gum (133 mg, 90%).  
 
Rf = 0.30 (33% EtOAc–petrol); νmax (film), 3298, 2924, 2854, 1735, 1704, 1598, 1467, 1424, 
1376, 1304, 1249, 1147, 1084, 925, 738 cm-1; δH (400 MHz, CDCl3) 7.92 (2H, d, J 7.5 Hz, 
ortho-Ts), 7.78 (1H, app. d, J 8.0 Hz, para-PhSO2), 7.64 (2H, m, ortho-PhSO2), 7.47 (2H, t, J 
8.0 Hz, meta-PhSO2), 7.35 (1H, d, J 7.5 Hz, C-9), 7.21 (1H, d, J 3.5 Hz, C-12), 7.02 (3H, m, 
meta-Ts + C-11), 6.95 (1H, m, C-10), 6.69 (1H, s, C-2), 5.80 (1H, m, CH=CH2), 5.23 (1H, d, 
J 10.0 Hz, CH=CHAHB), 5.15 (1H, d, J 17.0 Hz, CH=CHAHB), 4.63 (1H, d, J 7.5 Hz, NHTs), 
3.72 (1H, m, CHNHTs), 3.68 (3H, s, NCH3), 3.50 (1H, dd, J 6.0, 14.5 Hz, CHAHBCHNHTs), 
3.19 (1H, dd, J 6.5, 14.5 Hz, CHAHBCHNHTs), 3.11 (1H, m, CHCH=CH2), 2.98 (1H, dd, J 
4.5, 14.0 Hz, CHAHBSO2Ph), 2.65 (1H, dd, J 8.5, 14.5 Hz, CHAHBSO2Ph), 2.34 (3H, s, 
CH3Ts); δC (100 MHz, CDCl3) 142.3 (CSO2), 139.5 (CSO2), 136.8 (CCH3), 135.5 (CH=CH2), 
133.7 (C-13), 133.3 (para-PhSO2), 129.3 (meta-Ts), 129.1 (meta-PhSO2), 127.7 (ortho-Ts), 
127.6 (meta-PhSO2), 126.9 (C-8), 126.6 (C-2), 121.7 (CH2=CH), 120.3 (C-11), 119.2 (C-10), 
118.5 (C-9), 109.1 (C-12), 108.2 (C-7), 57.4 (CH2CHNHTs), 56.0 (CHNHTs), 42.1 
(CHCH=CH2), 32.6 (NCH3), 26.6 (CH2SO2Ph), 21.8 (TsCH3); M/z (ESI) 586.1797, 
561.1319, 545.1528 [M+Na]+, 523.1721 [M+H]+, 363.0991, 196.0160 (Found: [M+H]+, 
523.1721. C28H30N2O4S2 requires [M+H]+ 523.1647). 
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N-((2S)-5-Ethyl-1-(1-methyl-1H-indol-3-yl)-4-tosyl-3-vinylhept-6-en-2-yl)-4-
methylbenzenesulfonamide 434 
 
Ts
N
TsN
NNHTsTs
+
419 402 434
 
 
To a solution of sulfone 402 (266 mg, 0.78 mmol, 3.0 equiv.) in THF (100 µL) was added 2.5 
M nBuLi (480 µL, 1.04 mmol, 4.0 equiv.) at –40 oC. After 30 min, aziridine 419 (100 mg, 
0.26 mmol, 1.0 equiv.) in THF (190 µL) was added at –40 oC dropwise and stirred for 16 h 
while heating up to rt. The solution was quenched using saturated aqueous NH4Cl (5 mL) and 
the aqueous layer was extracted with EtOAc (3 x 5 mL). The combined organic layers were 
dried (MgSO4) and concentrated under reduced pressure. Column chromatography (80% 
Et2O–petrol) gave 434 as a yellow gum (187 mg, 94%).  
 
Rf = 0.50 (80% Et2O–petrol); νmax (film), 3060, 3025, 2948, 2926, 2874, 2853, 1590, 1490, 
1454, 1370, 1140, 1086, 968, 910, 810 cm-1; δH (400 MHz, CDCl3) 7.81 (2H, J 8.0 Hz, ortho-
Ts), 7.75 (2H, d, J 8.0 Hz, ortho-Ts), 7.71 (1H, dd, J 3.0, 8.5 Hz, ArH), 7.45 (1H, d, J 8.0 Hz, 
ArH), 7.34 (2H, d, J 8.0 Hz, meta-Ts), 7.24 (3H, m, meta-Ts + ArH), 7.11–7.07 (2H, m, ArH) 
6.74 (1H, s, NCH), 6.16 (1H, dt, J 10.0, 17.0 Hz, CH=CH2), 5.87 (1H, dt, J 7.0, 17.0 Hz, 
CH=CH2’), 5.78 (1H, d, J 7.0 Hz, NHTs), 5.46 (1H, m, CH=CHAHB), 5.24 (1H, m, 
CH=CHAHB), 4.99 (1H, m, CH=CHAHB’), 4.69 (1H, m, CH=CHAHB’), 3.82 (1H, m, 
CHNHTs), 3.72 (3H, s, NCH3), 3.45 (1H, m, CHTs’), 3.42 (1H, m, CHTs), 2.97–2.83 (3H, m, 
CH2CHNHTs + CHCH=CH2), 2.45 (3H, s, CH3Ts), 2.43 (3H, s, CH3Ts’), 2.07 (1H, m, 
CHCH=CH2’), 0.65 (2H, m, CH2CH3), 0.32 (3H, t, J 7.5 Hz, CH2CH3); δC (100 MHz, CDCl3) 
144.5, 143.3, 137.9, 137.2, 137.0, 136.5, 132.0, 129.7, 129.5, 129.3, 128.7, 128.6, 128.5, 
127.4, 127.2, 122.4, 121.8, 118.9, 116.6, 109.9, 109.2, 67.9, 58.4, 46.6, 44.7, 44.0, 32.6, 29.3, 
22.8, 21.6, 12.4, 11.3; M/z (ESI) 1232, 628, 627 [M+Na]+, 605 [M+H]+ (Found: [M+H]+, 
605.2505. C34H40N2O4S2 requires [M+H]+ 605.2429). 
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 3.2.  (±)-Alstonerine  
PhSO2 Br+
PhSO2 PhSO2
+
432 512 513 514
 
 
To a solution of LDA (prepared from diisopropylamine (1.80 mL, 14.0 mmol, 2.2 equiv.) and 
2.5 M nBuLi (3.20 mL, 7.00 mmol, 1.1 equiv.)) in THF (6 mL) at –78 oC was added a solution 
of methylphenylsulfone 432 (1.00 g, 6.40 mmol, 1.0 equiv.) in THF (3 mL). After stirring for 
1 h at –78 oC, allyl bromide 512 (0.61 mL, 7.00 mmol, 1.1 equiv.) was added and the solution 
heated to rt. The reaction mixture was quenched using saturated aqueous NH4Cl (20 mL) and 
extracted with EtOAc (3 x 30 mL), the combined organic layers were washed with brine (50 
mL), dried (Na2SO4) and concentrated under reduced pressure. Chromatography (20% Et2O–
petrol) afforded compound 514 as a colorless oil (610 mg, 48%) together with the 
bissubstituted adduct 513 (472 mg, 31%) and starting material 432 (218 mg, 22%). 
 
(But-3-enylsulfonyl)benzene 514 
 
PhSO2
514
 
 
Rf = 0.51 (33% EtOAc–petrol); νmax (film) 1642, 1446, 1305, 1233, 1142, 1085, 919 cm-1; δH 
(400 MHz, CDCl3) 7.95 (2H, d, J 7.5 Hz, ortho-Ar), 7.70 (1H, t, J 7.5 Hz, para-Ar), 7.61 
(2H, t, J 7.5 Hz, meta-Ar),  5.75 (1H, ddt, J 6.5, 10, 17.0 Hz, CH=CH2); 5.08 (2H, t, J 8.0 Hz, 
CH=CH2), 3.19 (2H, t, J 8.0 Hz, SO2CH2), 2.49 (2H, m, SO2CH2CH2); δC (100 MHz, CDCl3) 
139.0 (SO2C), 133.8 (CH2=CH), 129.3 (ortho-Ar + para-Ar), 128.1 (meta-Ar), 117.2 
(CH2=CHCH), 55.4 (SO2CH2), 26.9 (SO2CH2CH2); M/z (CI) 214 [M+NH4]+, 197 [M+H]+.  
 
The data are in agreement with the reported compound.6   
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(Hepta-1,6-dien-4-ylsulfonyl)benzene 513 
 
PhSO2
513
 
Rf = 0.65 (33% EtOAc–petrol); νmax (film) 1641, 1446, 1303, 1143, 1084, 917 cm-1; δh (400 
MHz, CDCl3) 7.79 (2H, d, J 8.0 Hz, ortho-Ts), 7.33 (2H, d, J 8.0 Hz, meta-Ts), 5.55 (1H, 
ddd, J 8.5, 10.5, 17.0, CH=CH2), 5.01 (2H, m, CH=CH2), 3.13 (2H, d, J 6.5 Hz, CH2-Ts), 
2.55 (1H, m, CH=CHCH), 2.46 (3H, s, CH3-Ts), 1.63 (2H, m, CH2CH3 major), 1.39 (2H, m, 
CH2CH3 minor), 0.85 (3H, t, J 7.5 Hz, CH2CH3); δC (100 MHz, CDCl3) 137.9 (SO2C), 133.7 
(CH2=CH), 129.3 (ortho-Ar + para-Ar), 128.9 (meta-Ar), 117.2 (CH2=CHCH), 63.7 
(SO2CH), 31.7 (SO2CH2CH2); M/z (CI) 254 [M+NH4]+, 237 [M+H]+. 
 
The data are in agreement with the reported compound.6   
 
(4-Chlorobut-1-ynyl)trimethylsilane 518 
 
HO Cl
TMS
517 518
 
 
To a solution of EtMgBr (43.0 mL, 160 mmol, 2.5 equiv.) in THF (38 mL) was added 4-
hydroxy-1-butyn 517 (5.00 mL, 64.0 mmol, 1.0 equiv.) at rt. After stirring for 20 min at rt, 
TMSCl (20.0 mL, 160 mmol, 2.5 equiv) in THF (38 mL) was added and stirred for 1.5 h. The 
solution was quenched with aqueous NH4Cl (11.4 g in 44 mL H2O), separated and the organic 
layer concentrated to ~38 mL. To the solution was added aqueous NH4Cl (11.4 g in 44 mL 
water) and stirred at rt for 16 h. The aqueous mixture was extracted with Et2O (3 x 50 mL), 
dried (MgSO4) and concentrated. The liquid obtained was redissolved in SOCl2 (15 mL) and 
pyridine (0.8 mL) and refluxed for 7 h. After cooling the solution to rt, the resulting mixture 
was poured into ice / H2O and extracted using Et2O (3 x 100 mL), the combined organic 
layers were washed with 10 M HCl (2 x 100 mL), dried (MgSO4) and concentrated under 
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reduced pressure. Distillation (62 oC, 10 mmHg) gave 518 as a colorless liquid (6.66 g, 65% 
yield). 
 
νmax (film) 2961, 2179, 1250, 1004, 838 cm-1; δH (400 MHz, CDCl3) 3.60 (2H, t, J 7.5, 
ClCH2CH2), 2.69 (2H, t, J 7.5, ClCH2CH2), 0.17 (9H, s, (CH3)3Si); δC (100 MHz, CDCl3) 
102.3 (CCSi(CH3)3), 87.0 (CCSi(CH3)3), 41.9 (ClCH2CH2), 24.2 (ClCH2CH2), -0.06 
(Si(CH3)3); M/z (CI) Unable to ascertain mass, compound not detected.  
 
The data are in agreement with the reported compound.7   
 
Trimethyl(4-tosylbut-1-ynyl)silane 519 
 
Cl
TMS
Ts
TMS
518 519
 
 
 A mixture of 518 (0.30 g, 1.90 mmol, 1.0 equiv), anhydrous NaI (285 mg, 1.90 mmol, 1.0 
equiv.) and anhydrous sodium p-toluenesulfinate (406 mg, 2.28 mmol, 1.2 equiv.) in DMF (2 
mL) was heated to 80 oC and stirred for 12 h, after which it was cooled to 40 oC and stirred at 
this temperature for 12 h. The solution was cooled to rt and diluted with H2O (10 mL). The 
aqueous layer was extracted with Et2O (3 x 10 mL), dried (MgSO4) and concentrated under 
reduced pressure resulting in a yellow solid. Recrystilization from 50% petrol–Et2O gave 519 
as a colorless oil (330 mg, 62% yield). 
 
νmax (film) 2958, 2173, 1281, 1135, 759 cm-1; δH (400 MHz, CDCl3) 7.80 (2H, d, J 8.0 Hz, 
ortho-Ts), 7.38 (2H, d, J 8.0 Hz, meta-Ts), 3.30 (2H, t, J 8.0 Hz, TsCH2), 2.47 (3H, s, 
CH3Ts), 2.66 (2H, J 8.0 Hz, TsCH2CH2), 0.10 (9H, s, (CH3)3Si); δC (100 MHz, CDCl3) 145.0 
(CSO2), 135.6 (CH3C), 130.0 (ortho-Ts), 128.3 (meta-Ts), 101.4 (TMSCC), 87.1 (TMSCC), 
54.8 (TsCH2), 21.7 (CH3Ts), 14.7 (TsCH2CH2), 0.10 ((CH3)3Si); M/z (CI) 298 [M+NH4]+, 
281 [M+H]+ (Found: [M+NH4]+, 298.1292. C14H20O2SSi requires [M+NH4]+, 298.1297.). 
 
The data are in agreement with the reported compound.8   
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3-Tosylpropanenitrile 524 
 
pTolSO2Na + CN
Ts
CN
523 524
 
 
A solution of acrylonitrile 523 (4.0 mL, 60.0 mmol, 1.0 equiv.), p-toluenesulfinic acid (11.6 g, 
65.0 mmol, 1.1 equiv.) and HOAc (4 mL) was heated to reflux for 16 h. After cooling down 
to rt, the mixture was extracted with DCM (3 x 30 mL) and the combined organic layers 
washed with saturated aqueous NaHCO3 (3 x 30 mL), H2O (3 x 30 mL) and brine (3 x 30 
mL). The combined organic layers were dried (MgSO4) and concentrated under reduced 
pressure to provide 524 (11.9 g, 95%). 
 
Rf = 0.31 (50% EtOAc–petrol); m.p. = 94 oC (lit.9 m.p. 94–95 oC); νmax (film) 2991, 2927, 
2248, 1791, 1596, 1422, 1302, 1139, 1084 cm-1; δH (400 MHz, CDCl3) 7.82 (2H, d, J 8.0 Hz, 
ortho-Ts), 7.43 (2H, d, J 8.0 Hz, meta-Ts), 3.38 (2H, t, J 7.5 Hz, TsCH2CH2), 2.82 (2H, t, J 
7.5 Hz, CH=CH2), 2.49 (3H, s, CH3Ts); δC (100 MHz, CDCl3) 146.0 (SO2C), 134.5 (CCH3), 
130.4 (ortho-Ts), 128.3 (meta-Ts), 116.0 (CN), 51.2 (TsCH2CH2), 21.7 (CH3Ts), 12.1 
(TsCH2CH2); M/z (CI) 254 [M+NH4]+ (Found: [M+NH4]+, 227.0852. C10H11NO2S requires 
[M+NH4]+, 227.0854.). 
 
The data are in agreement with the reported compound.9   
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(2,2-Dichlorocyclopropyl)(phenyl)sulfane 528 
 
PhS
PhS
Cl Cl
527 528
 
 
To a solution of NaOMe (0.47 g, 8.70 mmol, 1.5 equiv.) in petrol (5.5 mL) was added 
phenylvinylsulfide 527 (0.50 mL, 5.80 mmol, 1.0 equiv.) at 0 oC. Ethyl trichloroacetate (0.89 
mL, 6.40 mmol, 1.1 equiv.) was added dropwise over 30 min and the solution was stirred for 
6 h at 0 oC. After heating to rt for 16 h, water (3 mL) was added and the organic layer 
separated. The aqueous layer was extracted using DCM (3 x 10 mL), dried (MgSO4) and 
concentrated under reduced pressure. Distillation (95 oC, 1 mmHg) gave 528 as a pale yellow 
oil (76.0 mg, 60%). 
 
νmax (film) 3085, 3009, 1584, 1480, 1440, 1092, 1053, 737 cm-1; δH (400 MHz, CDCl3) 7.40 
(3H, m, ortho-, para-Ar), 7.27 (2H, m, meta-Ar), 2.98 (1H, dd, J 7.5, 10.5 Hz, PhSCH), 2.07 
(1H, dd, J 7.5, 10.5 Hz, PhSCHCHAHB), 1.57 (1H, dd, J 6.5, 8.5 Hz, PhSCHCHAHB);  δC (100 
MHz, CDCl3) 135.4 (CS), 129.2 (ortho-Ar), 127.6 (meta-Ar), 126.3 (para-Ar), 61.9 (CCl2), 
32.7 (PhSCH), 27.4 (PHSCHCH2; M/z (CI) 218 [M+H]+, 183, 147 (Found: [M+H]+, 
218.0228. C9H8Cl2S requires [M+H]+, 218.9720.). 
 
The data are in agreement with the reported compound.10   
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(2,2-Dichlorocyclopropylsulfonyl)benzene 529 
 
PhS
Cl Cl
PhSO2
Cl Cl
528 529
 
 
A solution of 528 (160 mg, 0.75 mmol, 1.0 equiv.) and 30% wt H2O2 (320 µL) in HOAc (1.1 
mL) was heated to 100 oC for 3 h. After cooling to rt, water (10 mL) was added and the 
aqueous layer extracted with Et2O (3 x 10 mL). The combined organic layers were dried 
(MgSO4) and concentrated under reduced pressure to give a white solid. Chromatography 
(30% Et2O–petrol) gave 529 as a white solid (662 mg, 90%).    
 
Rf = 0.40 (66% Et2O–petrol); m.p. = 88 oC  (lit.11 m.p. 87–88 oC); νmax (film) 3112, 3033, 
1446, 1322, 1214, 1158, 1087, 723 cm-1; δH (400 MHz, CDCl3) 8.04 (2H, dd, J 1.0, 8.0 Hz, 
ortho-Ar), 7.75 (1H, dd, J 1.0, 8.0 Hz, para-Ar), 7.65 (2H, dd, J 1.0, 8.0 Hz, meta-Ar), 3.32 
(1H, dd, J 7.5, 10.0 Hz, PhSCH), 2.47 (1H, t, J 7.5 Hz, PhSCHCHAHb), 2.20 (1H, dd, J 7.5, 
10.0 Hz, PhSCHCHAHB);  δC (100 MHz, CDCl3) 139.6 (CS), 134.3 ((para-Ar),129.5 (ortho-
Ar), 128.0 (meta-Ar), 55.4 (CCl2), 47.9 (PhSCH), 26.3 (PHSCHCH2; M/z (CI) 268 [M+NH4]+ 
(Found: [M+NH4]+, 267.9970. C9H8Cl2O2S requires [M+NH4]+, 267.9966.). 
 
The data are in agreement with the reported compound.11   
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(3,3,3-Trimethoxypropylsulfonyl)benzene 525 
 
PhSO2
Cl Cl
PhSO2
O
O
O
529 525
 
 
To a solution of NaOMe (110 mg, 2.04 mmol, 3.0 equiv.) in methanol (2 mL) was added 529 
(167 mg, 0.68 mmol, 1.0 equiv.) in methanol (2 mL) and heated to reflux for 2 h. After 
cooling down to rt, the solution was poured into water (13 mL) and the aqueous layer 
extracted using Et2O (3 x 15 mL). The combined organic layers were dried (MgSO4) and 
concentrated under reduced pressure to give 525 as a colorless oil (172 mg, 95%). 
 
 νmax (film) 2947, 2840, 1446, 1284, 1240, 1143, 1076, 100 cm-1; δh (400 MHz, CDCl3) 7.94 
(2H, d, J 8.0 Hz, ortho-Ar), 7.68 (1H, m, para-Ar), 7.59 (2H, m, meta-Ar), 3.19 (9H, s, 
(CH3O)3), 3.14 (2H, dt, J 4.5, 9.0 Hz, PhSO2CH2) 2.18 (2H, dt, J 4.5, 9.0 Hz, 
PhSO2CH2CH2); δC (100 MHz, CDCl3) 139.0 (CSO2), 139.0 (para-Ar), 129.4 (ortho-Ar), 
127.9 (meta-Ar), 114.3 (C(CH3O)3), 51.3 (PhSO2CH2), 49.6 ((OCH3)3), 23.9 
(PhSO2CH2CH2); M/z (CI) 292 [M+NH4]+, 243, 214, 105 [(M-OCH3)+H]+  (Found: 
[M+NH4]+, 292.1219. C12H18O5S requires [M+NH4]+, 292.1219.) (Found: C, 52.63; H, 6.68; 
C12H18O2S requires C, 52.54; H, 6.61%).  
 
The data are in agreement with the reported compound.11   
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Methyl 3-(phenylsulfonyl)propanoate 525 
 
PhSO2
Cl Cl
PhSO2
O
O
529 525
 
 
νmax (film) 2955, 1736, 1586, 1586, 1447, 1439, 1308, 1251, 1148, 1132, 1086, 1071, 732, 
689 cm-1;
 
δH (400 MHz, CDCl3) 7.92 (2H, m, ortho-Ar), 7.69 (1H, J 1.0, 9.0 Hz, para-Ar), 
7.58 (2H, dd, J 5.0, 9.0 Hz, meta-Ar), 3.64 (3H, s, OCH3), 3.44 (2H, t, J 8.0 Hz, PhSO2CH2), 
2.79 (2H, t, J 8.0 Hz, PhSO2CH2CH2); δC (100 MHz, CDCl3) 170.4 (CO), 138.4 (CSO2), 
134.1 (para-Ar), 129.5 (ortho-Ar), 128.2 (meta-Ar), 52.3 (PhSO2CH2), 51.5 (OCH3), 27.6 
(PhSO2CH2CH2); M/z (CI) 246 [M+NH4]+, 229 [M+H]+. 
 
The data are in agreement with the reported compound.12   
 
N-((2S,3R)-3-(Hydroxymethyl)-1-(1-methyl-1H-indol-3-yl)-4-(phenylsulfonyl)hept-6-en-
2-yl)-4-methylbenzenesulfonamide 503 
N
TsN
HO
+
PhSO2 NNHTsPhSO2
HO
388 514 503
 
 
To a solution of sulfone 514 (780 mg, 4.00 mmol, 2.0 equiv.) in THF (2.2 mL) and 2.5 M 
nBuLi (3.0 mL, 6.0 mmol, 3.0 equiv.) at –78 oC was added, after 30 min, aziridine 388 (742 
mg, 2.00 mmol, 1.0 equiv.) in THF (2.2 mL). After stirring for 16 h while heating up to rt, the 
solution was quenched using brine (40 mL) and the aqueous layer was extracted with EtOAc 
(3 x 50 mL). The combined organic layers were dried (MgSO4) and concentrated under 
reduced pressure. Column chromatography (33% EtOAc–petrol) gave 503 as a pale yellow oil 
(663 mg, 60%).  
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Rf = 060 (66% EtOAc–petrol); νmax (film) 3401, 2932, 1808, 1783, 1642, 1598, 1325, 1184, 
1091, 919, 739 cm-1; δh (400 MHz, Aceton D6) 8.05 (2H, d, J 8.0 Hz, ortho-Ts), 7.93 (2H, d, J 
8.0 Hz, ortho-Ts’), 7.79 (2H, m, C-9 + ArH), 7.69 (3H, m, meta-Ts + C-10), 7.62 (2H, m, 
meta-Ts’), 7.46 (3H, 3 x ArH), 7.29 (2H,m , 2 x ArH), 7.24 (3H, m, 3 x ArH), 7.13 (2H, m, 2 
x ArH), 7.01 (2H, m, 2 x ArH), 6.95 (3H, m, 3 x ArH), 6.93 (1H, s, C-2), 6.83 (1H, s, C-2’), 
6.52 (1H, d, J 7.0 Hz, NHTs), 6.23 (1H, d, J 7.0 Hz, NHTs’), 5.76 (1H, m, CH=CH2), 5.42 
(1H, m, CH=CH2), 5.04 (1H, dd, J 1.5, 17.0 Hz, CHACHB=CH), 4.94 (1H, dd, J 1.5, 17.0 Hz, 
CHACHB=CH’), 4.85 (1H, dd, J 1.0, 10.5 Hz, CHACHB=CH’), 4.83 (1H, dd, J 1.5, 10.5 Hz, 
CHACHB=CH), 4.31 (1H, m, CHNHTs), 4.11 (1H, m, CHNHTs’), 4.03-3.94 (1H, m, 
CHSO2Ph’), 3.85 (1H, m, CHSO2Ph), 3.68 (3H, s, NCH3), 3.63 (3H, s, NCH3’), 3.23 (1H, dd, 
J 5.5, 14.5 Hz, CHAHBCHNHTs), 3.01 (1H, dd, J 4.0, 14.5 Hz, CHAHBCHNHTs’), 2.94 (1H, 
dd, J 8.5, 14.5 Hz, CHAHBCHNHTs), 2.76 (1H, dd, J 8.5, 14.5 Hz, CHAHBCHNHTs’), 2.70-
2.61 (4H, m, CH2CH=CH2 + CH2CH=CH2’), 2.55 (2H, CHCH2OH + CHCH2OH’), 2.55-2.45 
(4H, m, CH2OH + CH2OH’), 2.34 (3H, s, CH3Ts), 2.32 (3H, s, CH3Ts’);  δC (100 MHz, 
CDCl3) 143.0 (CSO2), 138.2 (CH3CTs, 138.0 (CSO2), 137.5, 136.8, 136.7, 134.9, 134.1, 
133.7, 132.6, 129.4, 129.3, 129.2, 128.8, 128.7, 127.7, 127.3, 126.8, 121.8, 119.1, 118.4, 
117.8, 109.2, 108.5, 108.3, 62.8 (CH2OH), 61.6 , 60.4, 60.2, 58.6, 54.3, 52.9, 45.3, 42.6, 33.5, 
32.6, 29.9, 28.6, 28.1, 21.6 (CH3Ts); M/z (CI) 584 [M+NH4]+, 567 [M+H]+, 499, 425, 189, 
174, 160 (Found: [M+H]+, 567.1967. C30H34N2O5S2 requires [M+H]+, 567.1987). 
 
4R,5S)-Methyl 4-(hydroxymethyl)-6-(1-methyl-1H-indol-3-yl)-5-(4-
methylphenylsulfonamido)-3-(phenylsulfonyl)hexanoate 527 
 
N
TsN
HO
+
PhSO2
O
NNHTsPhSO2
HO
OO
O
O
388 526 527
 
 
To a solution of sulfone 526 (108 mg, 0.39 mmol, 1.5 equiv.) in THF (0.5 mL) was added, 
after 30 min, aziridine 388 (100 mg, 0.26 mmol, 1.0 equiv.) in THF (0.6 mL) at –78 oC 
dropwise. After stirring for 16 h while heating up to rt, the solution was quenched using 
saturated aqueous NH4Cl (10 mL) and the aqueous layer was extracted with EtOAc (3 x 15 
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mL). The combined organic layers were dried (MgSO4) and concentrated under reduced 
pressure. Flash chromatography (50% EtOAc–petrol) gave 527 as an off-white solid (140 mg, 
90%).  
 
Rf = 0.35 (66% EtOAc–petrol); m.p. = 90–92 oC; νmax (film) 3301, 2924, 1739, 1601, 1475, 
1427, 1305, 1155, 1090, 1072, 954, 726 cm-1;  δh (400 MHz, CDCl3) 7.94 (2H, d, J 8.0 Hz, 
ortho-Ts), 7.69 (1H, m, C-9), 7.59 (3H, m, meta-Ts + C-12), 7.25 (2H, m, 2 x ArH), 7.20, 
(2H, d, J 7.5 Hz, 2 x ArH) 7.10 (2H, d, J 7.5 Hz, C-11 + ArH), 7.04 (1H, m, C-10), 6.80 (1H, 
s, C-2), 5.84 (1H, d, J 9.0 Hz, NHTs), 4.32 (1H, dt, J 3.0, 6.0 Hz, PhSO2CH), 4.10 (1H, dt, J 
8.5 Hz, TsNHCH), 4.01 (2H, ddd, J 6.5 Hz, CH2OH), 3.64 (3H, s, NMe), 3.42 (3H, s, OMe), 
3.10-2.90 (2H, dd, J 7.0 Hz, CH2CHNHTs), 2.36 (2H, d, J 5.0 Hz, CH2CO2Me), 2.52 (1H, m, 
CHCH2OH), 2.93 (3H, s, CH3Ts);  δC (100 MHz, CDCl3) 170.7 (CO), 142.9 (CSO2), 137.8 
(CSO2), 137.6 (CH3C-Ts), 134.2 (para-PhSO2), 129.8 (C-13), 129.2 (ortho-Ts), 129.3 (ortho-
PhSO2), 129.0 (meta-Ts), 128.8 (ArC), 127.7 (meta-PhSO2), 126.8 (meta-PhSO2), 121.7 
(ArH), 119.1 (ArH), 118.5 (ArH), 109.0 (ArCH), 107.5 (C-7), 60.1 (CH2OH), 59.2 (OCH3), 
53.2 (PhSO2CH), 52.2 (TsNHCH), 46.8 (CHCH2OH), 34.1 (CH2CO2CH3), 32.5 (NCH3), 29.0 
(CH2C), 21.6 (TsCH3); M/z (ESI) 621.1710 [M+Na]+, 589.1450 [M+Na-OCH3]+, 567.1626 
[M-OCH3]+, 479.1616 [M+Na-SO2Ph]+, 457.1797 [M-SO2Ph]+ (Found: [M+H]+, 599.1890. 
C30H34O7S2 requires [M+H]+, 599.1870.) (Found: C, 60.20; H, 5.74; N, 4.64 C30H34O7S2 
requires C, 60.18; H, 5.72; N, 4.68%).  
 
4-Methyl-N-((1S)-2-(1-methyl-1H-indol-3-yl)-1-((3R)-6-oxo-4-
(phenylsulfonyl)tetrahydro-2H-pyran-3-yl)ethyl)benzenesulfonamide 528 
 
NNHTsPhSO2
HO
O
O NNHTs
OO
PhSO2
527 528
 
 
To a solution of 527 (100 mg, 0.17 mmol, 1.0 equiv.) in DCM (1.0 mL) at rt was added TFA 
(1 drop) and the solution stirred for 3 h at rt. The solution was diluted using DCM (10 mL) 
and neutralized by addition of saturated aqueous NaHCO3 (2 x 7 mL). The combined organic 
layers were subsequently washed with brine (7 mL), dried (MgSO4) and concentrated under 
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reduced pressure. Preparative TLC (66% EtOAc–petrol) provided lactone 528 as a gum (61 
mg, 65%).  
 
Rf  = 0.40 (66% EtOAc–petrol); νmax (film) 3301, 2928, 2851, 1759, 1749, 1600, 1447, 1314, 
1155, 1084, 737, 667 cm-1; δh (400 MHz, CDCl3) 7.86 (2H, d, J 8.0 Hz, ortho-Ts), 7.68 (1H, 
m, ArH), 7.55 (2H, t, J 8.5 Hz, ortho-PhSO2), 7.47 (2H, d, J 8.0 Hz, meta-Ts), 7.25 (2H, m, 2 
x ArH), 7.12–7.04 (4H, m, 4 x ArH), 6.74 (1H, s, C-2), 4.76 (1H, d, J 7.5 Hz, NHTs) 4.50 
(1H, dd, J 4.0, 12.5 Hz, CHAHBO)4.33 (1H, dd, J 4.0, 12.5 Hz, CHAHBO), 3.82 (1H, m, 
CHSO2Ph), 3.70 (3H, s, NCH3), 3.64 (1H, m, CHNHTs), 2.99 (1H, dd, J 5.0, 15.0 Hz, 
CHAHBCHNHTs) 2.92 (1H, m, CHNHTsCH), 2.80 (2H, m, CHAHBCO2 + CHAHBCHNHTs), 
2.64 (1H, dd, J 7.0, 15.5 Hz, CHAHBCO2), 2.36 (3H, s, CH3Ts); δC (100 MHz, CDCl3) 168.9 
(CO), 137.0 (CSO2), 136.2 (CSO2), 134.5 (para-PhSO2), 129.6 (ortho-Ts), 129.5 (ortho-
PhSO2), 129.1 (meta-Ts), 127.8 (meta-PhSO2), 126.7 (meta-PhSO2), 122.0 (ArH), 119.6 
(ArH), 118.1 (ArH), 109.4 (ArCH), 107.3 (C-7), 66.5 (CH2O), 56.8 (CH2C=O), 53.7 
(PhSO2CH), 36.6 (CHCH2C=O), 32.9 (NCH3), 29.0 (CH2CHNHTs), 21.9 (TsCH3); M/z (ESI) 
488.1618, 463.1095, 447.1363 [M+Na-SO2Ph]+, 425.1541 [M-SO2Ph]+ (Found [M+H–
SO2Ph]+, 425.1541. C29H30N2O6S2 requires [M+H–SO2Ph]+, 425.1613) (Found: C, 61.96; H, 
5.55; N, 4.81. C29H30N2O6S2 requires C, 62.05; H, 5.55; N, 4.82%).  
 
(4R,5S)-Methyl-4-((tert-butyldimethylsilyloxy)methyl)-6-(1-methyl-1H-indol-3-yl)-5-(4-
methylphenylsulfonamido)-3-(phenylsulfonyl)hexanoate 529 
 
NNHTsPhSO2
HO
O
O NNHTsPhSO2
TBSO
O
O
527 529
 
 
A solution of 527 (30 mg, 50 µmol, 1.0 equiv.), imidazole (5.0 mg, 75 µmol, 1.5 equiv.) and 
TBSCl (11 mg, 75 µmol, 1.5 equiv.) in DMF (0.3 mL) was stirred at rt for 30 min. The 
solution was poured onto H2O / EtOAc (1 : 1, 10 mL) and the organic layer separated. The 
aqueous layer was washed using EtOAc (3 x 5 mL) and the combined organic layers washed 
with 10% citric acid (2 x 10 mL), brine (15 mL), dried (MgSO4) and concentrated under 
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reduced pressure. Preparative TLC (50% EtOAc–petrol) provided 529 as a colorless gum (32 
mg, 91%).  
 
Rf = 0.85 (66% EtOAc–petrol); νmax (film) 3294, 2957, 2928, 2862, 1742, 1472, 1331, 1305, 
1262, 1159, 1089, 838, 777 cm-1; δH (400 MHz, CDCl3) 7.65 (4H, m, ortho-Ts + 2 x ArH), 
7.58 (1H, m, ArH), 7.43 (2H, m, 2 x ArH), 7.29–7.21 (3H, m, 3 x ArH), 7.17 (2H, d, J 8.0 Hz, 
meta-Ts), 7.02 (1H, t, J 7.5 Hz, C-11), 6.84 (1H, s, C-2), 5.93 (1H, d, J 8.0 Hz, NHTs), 4.25 
(1H, td, J 2.0, 8.5 Hz, CHSO2Ph), 3.77 (1H, m, CHNHTs), 3.72 (3H, s, OCH3), 3.68 (1H, m, 
CHAHBOTBS), 3.54 (1H, dd, J 5.5, 10.5 Hz, CHAHBOTBS), 3.47 (3H, s, NCH3), 3.12 (1H, 
dd, J 6.5, 14.5 Hz, CHAHBCHNHTs), 3.00 (1H, dd, J 8.0, 18.0 Hz, CHAHBCO2CH3), 2.89 
(1H, dd, J 6.0, 14.5 Hz, CHAHBCHNHTs), 2.78 (1H, dd, J 3.0, 18.0 Hz, CHAHBCO2CH3), 
2.62 (1H, m, CHCH2OTBS), 2.06 (3H, s, CH3Ts), 0.93 (9H, s, ((CH3)3)C), -0.08 (3H, s, 
CH3Si), -0.09 (3H, s, CH3Si); δC (100 MHz, CDCl3) 171.0 (CO), 138.2 (CSO2), 136.9 
(CSO2), 133.7 (para-PhSO2), 129.4 (ortho-Ts), 129.1 (ortho-PhSO2), 128.8 (meta-Ts), 128.2 
(CH3Ts), 126.8 (meta-PhSO2), 121.6 (ArC), 119.2 (ArC), 118.6 (ArC), 109.2 (ArC), 108.9 
(ArC), 109.2 (ArC), 108.8 (ArC), 64.0 (CH2OTBS), 60.4 (CHSO2Ph), 52.4 (OCH3), 52.0 
(TsNHCH), 42.9 (CHCH2OTBS), 32.7 (NCH3), 30.9 (CH2CO2CH3), 29.7 (CH2CHNHTs), 
25.6 (CH3)3C), 21.0 (CH3Ts), -3.6 ((CH3)2Si); M/z (ESI) 751.2312, 735.2578 [M+Na]+, 
713.2740 [M+H]+, 593.2466
  
(Found [M+H]+, 713.2740. C36H48N2O7S2Si requires [M+H]+ 
713.2672) (Found: C, 61.13; H, 7.00; N, 3.95. C37H50N2O6S2Si requires C, 61.13; H, 6.93; N, 
3.85%).  
 
(5R,6S)-5-((tButyldimethylsilyloxy)methyl)-6-((1-methyl-1H-indol-3-yl)methyl)-1-tosyl-
5,6-dihydropyridin-2(1H)-one 530 
  
NNTs
TBSO
O
NNHTsPhSO2
TBSO
O
O
529 530
 
 
To a solution of 529 (25 mg, 40 µmol, 1.0 equiv.) in toluene (1.0 mL) was added at rt 1M 
AlMe3 (40 µL, 40 µmol, 1.0 equiv.) and the solution stirred at rt for 30 min. The solution was 
heated to 80 oC and stirred for 3 h at this temperature. After cooling down to rt the solution 
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was quenched using saturated aqueous NH4Cl (5 mL) and extracted using EtOAc (3 x 5 mL). 
The combined organic layers were washed with brine (10 mL), dried (MgSO4) and 
concentrated under reduced pressure. Preparative TLC (66% petrol–EtOAc) gave 530 (21 mg, 
99%).  
 
Rf = 0.50 (75% petrol–EtOAc); νmax (film) 3049, 2953, 2928, 2856, 1688, 1471, 1385, 1350, 
1251, 1169, 1251, 1087, 814 cm-1; δH (400 MHz, CDCl3) 8.04 (2H, d, J 8.0 Hz, ortho-Ts), 
7.86 (1H, d, J 7.5Hz, C-9), 7.71 (1H, d, J 8.0 Hz, C-12), 7.59 (1H, t, J 8.0 Hz, C-11), 7.32 
(2H, d, J 8.0 Hz, meta-Ts), 7.17 (1H, t, J 7.5 Hz, C-10), 6.95 (1H, s, C-12), 6.53 (1H, ddd, J 
1.5, 6.0, 8.0 Hz, CH=CHCO), 5.93 (1H, d, J 9.5 Hz, CH=CHCO), 5.23 (1H, dd, J 3.5, 11.5 
Hz, CHNTs), 3.78 (3H, s, NCH3), 3.46 (1H, dd, J 5.5, 10.5 Hz, CHAHBOTBS), 3.35 (1H, m, 
CHAHBCHNTs), 3.29 (1H, m, CHAHBOTBS), 3.19 (1H, m, CHAHBCHNTs), 2.67 (1H, m, 
CHCH2OTBs), 2.45 (3H, s, CH3Ts); δC (100 MHz, CDCl3) 161.6 (C=O lactam), 144.6 
(CSO2), 142.3 (CH=CHCO), 137.0 (CH3CTs), 136.6 (C-13), 129.7 (meta-Ts), 129.0 (ortho-
Ts), 127.9 (C-8), 125.9 (C-2), 125.7 (CH=CHCO), 121.8 (C-11), 119.4 (C-10), 119.0 (C-9), 
109.8 (C-12), 109.2 (C-7), 62.60 (CH2OTBS), 56.6 (CHCH2OTBS), 40.0 (CHNTs), 32.7 
(NCH3), 29.8 (CH2CHNTs), 25.6 ((CH3)3C), 21.7 (CH3Ts), 17.8 ((CH3)3C), -5.75 (CH3Si), -
5.56 (CH3Si); M/z (ESI) 577.1982, 561.2199 [M+Na]+, 539.2383 [M+H]+, 224.0116, 
196.0164
  
(Found [M+H]+, 539.2383. C29H38N2O4SSi requires [M+H]+ 539.2322). 
 
(5R,6S)-5-(Hydroxymethyl)-6-((1-methyl-1H-indol-3-yl)methyl)-1-tosyl-5,6-
dihydropyridin-2(1H)-one 530A 
 
NNTs
TBSO
O
NNTs
HO
O
530 530A
 
 
A solution of 530 (25 mg, 47 µmol, 1.0 equiv.) in 3 : 1 : 1 AcOH : H2O : THF (1.5 mL) was 
stirred at rt for 2 h. The solution was neutralized using saturated aqueous NaHCO3 (5 mL) and 
extracted by EtOAc (3 x 5 mL), the combined organic layers were washed with brine (10 
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mL), dried (MgSO4) and concentrated under reduced pressure. Preparative TLC (66% 
EtOAc–petrol) gave 530A (20 mg, 99%).  
 
Rf = 0.45 (66% EtOAc–petrol); νmax (film) 3434, 2924, 2859, 1689, 1477, 1388, 1347, 1253, 
1168, 1088, 1065, 815, 744 cm-1; δH (400 MHz, CDCl3) 8.01 (2H, d, J 8.0 Hz, ortho-Ts), 7.69 
(1H, d, J 8.0 Hz, C-9), 7.32 (3H, m, meta-Ts + C-12), 7.26 (1H, m, C-11), 7.17 (1H, dt, J 1.0, 
7.5 Hz, C-10), 6.92 (1H, s, C-2), 6.59 (1H, ddd, J 1.5, 6.0, 8.0 Hz, CH=CHCO), 5.97 (1H, d, J 
9.5 Hz, CH=CHCO), 5.18 (1H, dd, J 4.0, 10.0 Hz, CHNTs), 3.77 (3H, s, NCH3), 3.60 (1H, m, 
CHAHBOH), 3.41 (1H, m, CHAHBOH), 3.33 (1H, dd, J 5.0, 14.0 Hz, CHAHBCHNTs), 3.16 
(1H, dd, J 5.0, 10.0 Hz, CHAHBCHNTs), 2.72 (1H, dd, J 6.5, 9.5 Hz, CHCH2OH), 2.44 (3H, 
s, CH3Ts); δC (100 MHz, CDCl3) 161.6 (C=O lactam), 144.7 (CSO2), 142.3 (CH=CHCO), 
137.0 (CH3CTs), 136.4 (C-13), 129.3 (meta-Ts), 129.0 (ortho-Ts), 127.8 (C-8), 125.9 (C-2), 
125.9 (CH=CHCO), 121.9 (C-11), 119.4 (C-10), 118.9 (C-9), 109.5 (C-7), 109.4 (C-12), 62.9 
(CH2OH), 56.9 (CHCH2OH), 39.8 (CHNTs), 32.7 (NCH3), 29.9 (CH2CHNTs), 21.9 (CH3Ts); 
M/z (ESI) 463.1100, 447.1357 [M+Na]+, 425.1530 [M+H]+, 196.0171
 
(Found [M-SO2Ph]+, 
425.1530. C23H24N2O4S1 requires [M+H]+ 425.1457).  
 
((2S,3R)-2-((1-Methyl-1H-indol-3-yl)methyl)-6-oxo-1-tosyl-1,2,3,6-tetrahydropyridin-3-
yl)methyl 3-oxobutanoate 531 
NNTs
HO
O
NNTs
O
O
OO
531530A
 
 
To a solution of 530A (80 mg, 0.19 mmol, 1.0 equiv.) and KOAc (cat.) in THF (1.0 mL) was 
added freshly distilled diketene (21 µL, 0.25 mmol, 1.3 equiv.) in THF (0.5 mL) and the 
solution heated to reflux for 1 h. After cooling to rt, the solution was quenched with H2O (5 
mL) and extracted with EtOAc (3 x 5 mL). The combined organic layers were washed with 
brine (5 mL), dried (MgSO4) and concentrated under reduced pressure. Preparative TLC (66% 
EtOAc–petrol) gave 531 in 90 mg, 93% yield.  
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Rf = 0.70 (66% EtOAc–petrol); νmax (film) 2925, 1855, 2337, 1729, 1640, 1612, 1470, 1344, 
1248, 1161, 1100, 745, 668 cm-1; δH (400 MHz, CDCl3) 8.05 (2H, d, J 8.0 Hz, ortho-Ts), 7.82 
(1H, d, J 8.0 Hz, C-9), 7.35 (3H, m, meta-Ts + C-12), 7.29 (1H, m, C-11), 7.20 (1H, dt, J 1.0, 
7.5 Hz, C-10), 6.90 (1H, s, C-2), 6.52 (1H, ddd, J 1.5, 6.0, 8.0 Hz, CH=CHCO), 6.00 (1H, d, J 
9.5 Hz, CH=CHCO), 5.16 (1H, dd, J 4.0, 10.0 Hz, CHNTs), 4.09 (1H, dd, J 4.5, 11.0 Hz, 
CHAHBO), 3.87 (1H, dd, J 7.5, 11.0 Hz, CHAHBO), 3.79 (3H, s, NCH3), 3.38 (1H, dd, J 4.0, 
13.5 Hz, CHAHBCHNTs), 3.21-3.06 (3H, m, COCH2CO + CHAHBCHNTs), 2.84 (1H, m, 
CHCH2O), 2.46 (3H, s, CH3-Ts), 2.13 (3H, s, COCH3);  δC (100 MHz, CDCl3) 166.6 (C=O 
lactam), 161.2 (C=O), 144.9 (CSO2), 140.0 (CH=CHCO), 137.2 (CH3CTs), 136.3 (C-13), 
129.4 (meta-Ts), 129.1 (ortho-Ts), 127.9 (C-2), 127.4 (C-8), 126.7 (CH=CHCO), 122.0 (C-
11), 119.4 (C-10), 119.1 (C-9), 109.5 (C-12), 109.3 (C-7), 63.6 (CH2CO), 56.9 (CHCH2O), 
49.2 (COCH2CO), 36.3 (CHNTs), 32.8 (NCH3), 30.3 (CH2CHNTs), 21.7 (CH3Ts); M/z (ESI) 
547.1292, 531.1712 [M+Na]+, 509.1735 [M+H]+
 
(Found [M+H]+, 509.1735. C27H28N2O6S 
requires [M+H]+
 
509.1668).  
 
(8S,8aR,Z)-4-(1-Hydroxyethylidene)-8-((1-methyl-1H-indol-3-yl)methyl)-7-
tosyltetrahydro-1H-pyrano[3,4-c]pyridine-3,6(4H,7H)-dione 532 
 
NNTs
O
O
OO
NNTs
O
O
HO
O
531 532
 
 
To a solution of 531 (90.0 mg, 0.18 mmol, 1.0 equiv.) in THF (1.0 mL) was added at rt DBU 
(5.0 µL, 36 µmol, 0.2 equiv.) and the solution stirred for 6 h at rt. The brown / red solution 
was quenched using saturated aqueous NH4Cl (5 mL) and extrated by EtOAc (3 x 5 mL). The 
combined organic layers were washed with brine (10 mL), dried (MgSO4) and concentrated 
under reduced pressure. Preparative TLC (66% EtOAc–petrol) gave 532 as a colorless gum in 
82 mg, 91% yield.  
 
Rf = 0.90 (66% EtOAc–petrol); νmax (film) 3057, 2923, 2854, 1690, 1612, 1597, 1475, 1347, 
1244, 1164, 1086, 907 cm-1;  
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δH (400 MHz, CDCl3) 13.74 (OH), 7.96 (2H, d, J 8.0 Hz, ortho-Ts), 7.74 (1H, d, J 8.0 Hz, C-
9), 7.36 (2H, d, J 8.0 Hz, meta-Ts), 7.30 (2H, m, C-11 + C-12), 7.20 (1H, dt, J 1.0, 7.5 Hz, C-
10), 6.96 (1H, s, C-2), 4.80 (1H, m, CH2CHNTs), 4.23 (1H, ddd, J 1.5, 4.5, 11.5 Hz, 
CHAHBO), 4.06 (1H, app. t, J 11.5 Hz, CHAHBO), 3.81 (3H, s, NCH3), 3.56 (1H, dd, J 3.5, 
14.5 Hz, CHAHBCHNTs), 3.23 (1H, dd, J 3.5, 14.5 Hz, CHAHBCHNTs), 3.14 (1H, 
CHCH2CO), 2.69 (3H, s, CH3Ts), 2.57 (2H, m, CHAHBCO + CHCH2O), 2.30 (3H, s, 
C(OH)CH3), 2.19 (1H, m, CHAHBCO); δC (100 MHz, CDCl3) 177.2 (C=COH), 170.9 (lactam 
C=O), 167.3 (lactone C=O), 145.4 (CH3CTs), 137.1 (CSO2), 135.7 (C-13), 129.4 (ortho-Ts), 
128.2 (meta-Ts), 127.7 (C-8), 122.3 (C-2), 119.8 (C-11), 118.5 (C-10), 109.6 (C-12), 108.3 
(C-7), 66.9 (CH2CO), 57.3 (CHCH2CO), 57.2 (COCHCO), 36.6 (CHNTs), 32.9 (NCH3), 31.7 
(CH2CHNTs), 25.9 (CHCH2CONTs), 21.7 (CH3Ts), 17.9 (CH3COH); M/z (ESI) 572.1885, 
547.1374, 531.1563 [M+Na]+, 509.1741 [M+H]+
  
(Found [M+H]+, 509.1741. C27H28N2O6S 
requires [M+H]+
 
509.1668).  
 
Alstonerine precursor 534 
NNTs
O
O
HO
O
N
Ts
O
OH O
N
532 534
 
 
To a solution of 532 (20 mg, 30 µmol, 1.0 equiv.) in THF (1.0 mL) at –78 oC was added 1.2M 
DIBALH (50 µL, 60 µmol, 2.0 equiv.) and the mixture stirred for 2 h. After reacting for 2 h, 
the mixture was quenched using 6 M HCl (2.0 mL) and heated to rt. The organic layer was 
separated and the aqueous layers extrated using EtOAc (3 x 5mL), the combined organic 
layers were washed with brine (5.0 mL), dried (MgSO4) and concentrated under reduced 
pressure. Preparative TLC (66% petrol–EtOAc) gave 533 (2.7 mg, 15%) and 534 (15.0 mg, 
75%).  
 
Treatment of the DIBAL reaction mixture with TFA (drop) solely provided 534 in 18 mg, 
96%. 
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Rf = 0.35 (66% petrol–EtOAc); δH (400 MHz, CDCl3) 14.06 (1H, s,OH), 7.39 (2H, d, J 8.0 
Hz, ortho-Ts), 7.29 (2H, m, C-9), 7.21 (1H, m, C-11 + C-12), 7.06 (1H, t, J 6.0 Hz, C-10), 
6.84 (2H, d, J 8.0 Hz, meta-Ts), 5.33 (1H, s, CCHNTs), 4.73 (1H, t, J 12.0 Hz, CHAHBO), 
4.43 (1H, dd, J 1.5, 12.0 Hz, CHAHBO), 4.34 (1H, d, J 8.0 Hz, CH2CHNTs), 3.70 (3H, s, 
NCH3), 2.96 (1H, dd, J 8.0, 16.0 Hz, CHAHBCHNTs), 2.76 (1H, m, CCH(NTs)CH2CH), 2.52 
(1H, d, J 16.0 Hz, CHAHBCHNTs), 2.27 (1H, m, CH2CH(NTs)CH), 2.23 (1H, m, 
CCH(NTs)CHAHB), 2.20 (3H, s, CH3Ts), 2.06 (3H, s, C(OH)CH3), 1.77 (1H, dq, J 3.0, 4.0, 
14.0 Hz, CCH(NTs)CHAHB) 
 
(8S,8aR,Z)-4-(1-Hydroxyethylidene)-8-((1-methyl-1H-indol-3-yl)methyl)-7-tosyl-
4,4a,8,8a-tetrahydro-1H-pyrano[3,4-c]pyridin-3(7H)-one 533 
 
NNTs
O
O
HO
O
N
N
Ts
O
OH O
532 533
 
 
Rf = 0.40 (66% petrol–EtOAc); δH (400 MHz, CDCl3) 14.03 (1H, s,OH), 7.84 (1H, d, J 8.0 
Hz, C-9), 7.73 (2H, d, J 8.0 Hz, ortho-Ts), 7.33 (4H, m, meta-Ts + C-11 + C-12), 7.24 (1H, 
dt, J 1.5, 8.0 Hz, C-10), 6.88 (1H, s, C-2), 6.77 (1H, dd, J 1.5, 8.5 Hz, CH=CHNTs), 6.40 
(1H, dt, J 1.5, 8.5 Hz, CH=CHNTs), 4.01 (1H, m, CH2CHNTs), 3.80 (3H, s, NCH3), 3.45 
(1H, m, CHAHBCHNTs), 3.42 (1H, m, CHCH=CHNTs), 3.11 (2H, m, CHCH2O), 3.02 (1H, 
m, CHAHBCHNTs), 2.44 (3H, s, CH3Ts), 2.20 (3H, s, C(OH)CH3), 2.18 (3H, s, C(OH)CH3), 
2.13 (1H, m, CHCH2O) 
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(8S,8aR,Z)-4-(1-Methoxyethylidene)-7-methyl-8-((1-methyl-1H-indol-3-
yl)methyl)tetrahydro-1H-pyrano[3,4-c]pyridine-3,6(4H,7H)-dione 535 
 
NNTs
O
O
HO
O
NN
O
O
O
O
532 535
 
 
A solution of Na (7.50 mg, 0.31 mmol, 8.0 equiv.) and naphthalene (31.0 mg, 0.31 mmol, 8.0 
equiv.) in THF (0.5 mL) was stirred for 45 min at –78 oC. 532 (20.0 mg, 0.04 mmol, 1.0 
equiv.) in THF (0.5 mL) was added to the dark blue sodium naphthalide solution and stirred 
for 1 h at –78 oC. CH3I (7.50 µL, 0.12 mmol, 3.0 equiv.) was added and the solution allowed 
to heat to rt. Saturated aqueous NH4Cl (10 mL) was added and the aqueous layer extracted 
with EtOAc (3 x 10 mL). The combined organic layers were washed with brine (15 mL), 
dried (MgSO4) and concentrated under reduced pressure. Column chromatography (66% 
EtOAc–petrol) gave 535 (3.1 mg, 20%) 
 
Rf  = 0.65 (66% EtOAc–petrol); δH (400 MHz, CDCl3) 3.75 (3H, s, Indole NCH3), 3.47 (3H, s, 
NCH3), 2.99 (3H, s, OCH3). Tosyl-moiety missing in aromatic region (8.0–6.5 ppm), no NH 
peak (6.0–4.0 ppm) detected.    
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3.3.  (–)-Cytisine 
 
3-Tosylpropanal 546 
 
O OTsS O- Na+
O
+
546
 
 
To a solution of p-toluenesulfinic acid sodium salt (10.0 g, 56.1 mmol, 1.0 equiv.) in THF (32 
mL) and H2O (64.5 mL) was dropwise added AcOH (3.21 mL, 56.1 mmol, 1.0 equiv.). The 
solution was cooled to 0 oC and acrolein (7.50 mL, 12.2 mmol, 2.0 equiv.) in THF (32 mL) 
added dropwise to form a white emulsion.  This emulsion was allowed to warm to rt over 16 
h, and diluted with EtOAc (160 mL) and H2O (130 mL).  The aqueous layer was then 
extracted with EtOAc (300 mL), and the combined organic layers washed with NaHCO3 (3 x 
200 mL), brine (200 mL), dried (MgSO4) and concentrated under reduced pressure to give 
546 (11.8 g, 99%) as a colorless gel.  
 
Rf = 0.20 (70% petrol–EtOAc); νmax (film) 3480, 2927, 1723, 1597, 1496, 1408, 1312, 1288, 
1302, 1136, 1086, 1018 cm-1; δH  (400 MHz, CDCl3) 9.76 (1H, s, COH), 7.80 (2H, d, J 8.0 Hz, 
ortho-Ts), 7.39 (2H, d, J 8.0 Hz, meta-Ts), 3.40 (2H, m, TsCH2), 2.97 (2H, m, CH2CHO), 
2.48 (3H, s, CH3Ts); δC (100.6 MHz, CDCl3) 197.0 (C=O), 145.2 (ipso-CH3Ts), 135.7 (ipso-
ArSO2), 130.1 (meta-ArSO2), 128.1 (ortho-ArSO2), 49.2 (TsCH2), 36.7 (CH2CHO), 21.7 
(CH3Ts); M/z (CI) 230 [M+NH4]+, 213 [M+H]+, 189, 174, 130 (Found: [M+NH4]+, 230.0851. 
C10H16NO3S requires: [M+NH4]+, 230.0851).   
 
The data are in agreement with the reported compound.13   
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1-(3,3-Dimethoxypropylsulfonyl)-4-methylbenzene 406 
 
OTs
OTs
O
546 406
 
 
To a solution of 546 (12.8 g, 59.2 mmol, 1.0 equiv.) and p-toluenesulfonic acid (0.30 g, 1.59 
mmol, 2.7 mol %) in methanol (103 mL)
 
was dropwise added trimethylorthoformate (13.0 
mL, 118.5 mmol, 2.0 equiv.) resulting in a pale yellow solution.  The solution was heated to 
50 oC for 16 h, concentrated under reduced pressure, redissolved in Et2O (150 mL), and 
subsequently washed with NaHCO3 (4 x 150 mL), H2O (3 x 150 mL) and brine (1 x 150 mL). 
The combined organic layers were dried (MgSO4) and concentrated under reduced pressure.  
Column chromatography (66% Et2O–petrol) gave 406 (13.9 g, 83%) as a pale yellow solid.  
 
Rf = 0.19 (66% Et2O–petrol); m.p. = 31–33 oC (lit.13 m.p. 32–33 oC); νmax (film) 3505, 3063, 
3029, 2938, 2834, 2083, 2036, 1927, 1636, 1597, 1445, 1404, 1383, 1303, 1288, 1234, 1192, 
1145, 1123, 1073 cm-1; δH  (400 MHz, CDCl3) 7.78 (2H, d, J 8.0 Hz ortho-Ts), 7.35 (2H, d, J 
8.0 Hz, meta-Ts), 4.40 (1H, t, J 5.0 Hz, C(OMe)2H), 3.28 (6H, s, 2 x OCH3), 3.13 (2H, m, 
TsCH2), 2.44 (3H, s, CH3), 1.99 (2H, m, CH2C); δC (100.6 MHz, CDCl3) 144.8 (ipso-CH3Ts), 
136.0 (ipso-ArSO2), 129.9 (meta-ArSO2), 128.0 (ortho-ArSO2), 102.5 (C(OMe)2H), 53.6 
(OCH3), 51.7 (TsCH2), 26.2 (CH2C), 21.6 (CH3Ts); M/z (CI) 276 [M+NH4]+, 244 [M+NH4–
CH3OH]+, 227 [M–OCH3]+, 212 [M+NH4–C2H8O]+ (Found: [M+NH4]+, 276.1279. 
C12H22NO4S requires: [M+NH4]+, 276.1270).  
 
The data are in agreement with the reported compound.13   
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(S)-Methyl 2-amino-3-hydroxypropanoate hydrochloride acid 547  
 
O
O
NH3+ Cl-
OHHO
O
NH3+ Cl-
OH
547
 
 
To a white suspension of L-serine (5.00 g, 47.6 mmol, 1.0 equiv.) in methanol (250 mL) 
stirred at 0 oC was dropwise added SOCl2 (7.63 mL, 104.7 mmol, 2.2 equiv).  The clear 
solution was refluxed at 80 oC for 4 h, cooled to rt and concentrated under reduced pressure.  
Azeotropic removal of H2O by using toluene (2 x 100 mL) gave 547 (7.41 g, 99%) as a white 
solid.   
 
Rf = 0.41 (66% CH2Cl2–MeOH + 1% TEA); m.p. = 163–165 oC (lit.14 m.p. 162–165 oC); 
[α]D23 + 15.1 (c 0.78,  CHCl3); νmax (film) 3395, 2907, 2640, 1965, 1739, 1585, 1503, 1440, 
1250, 1043, 973 cm-1; δH  (400 MHz, CD3OD) 4.17 (1H, t, J 4.0 Hz, NH3+CH), 4.03 (1H, dd, J 
4.5, 12.0 Hz, CH2OH), 3.97 (1H, dd, J 3.5, 12.0 Hz, CH2OH), 3.88 (3H, s, OCH3); δC (100 
MHz, CD3OD) 168.0 (CO), 59.3 (CH2OH), 54.7 (NH3+CH), 52.3 (OCH3); M/z (ESI) 137 
[M+NH4–HCl]+, 120 [M+H–HCl]+ (Found: [M+H–HCl]+, 120.0661. C4H10NO3 requires: 
[M+H–HCl]+, 120.0661).  
 
The data are in agreement with the reported compound.14   
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 (S)-Methyl 3-methyl-2-(4-methylphenylsulfonamido)butanoate 548 
 
O
O
NHTs
OHO
O
NH3+ Cl-
OH
547 548
 
 
To a solution of 547 (7.00 g, 45.0 mmol, 1.0 equiv.) in CH2Cl2 (47.3 mL) at 0 oC was added 
dropwise TEA (12.6 mL, 90.0 mmol, 2.0 equiv.) causing effervescence.  A solution of p-
toluenesulfonyl chloride (8.58 g, 45.0 mmol, 1.0 equiv.) in DCM (47.3 mL) was added 
dropwise and the mixture was stirred for 16 h at 0 oC.  The white precipitate was filtered off 
and the solution concentrated under reduced pressure. The residue was taken up in EtOAc (50 
mL) and washed with saturated aqueous NaHCO3 (2 x 40 mL), 10 % aqueous citric acid (40 
mL), brine (40 mL) and dried (MgSO4). Concentrating the solution under reduced pressure 
gave 548 (10.4 g, 85 %) as a white solid.  
 
Rf  = 0.15 (50% EtOAc–petrol); m.p. = 87–89 oC (lit.14 m.p. 87–89 oC); [α]D23 + 19.1 (c 0.76, -
CHCl3); νmax (film) 3507, 3272, 2940, 1748, 1602, 1436, 1333, 1229, 1162, 1063, 664 cm-1; δH  
(400 MHz, CDCl3) 7.78 (2H, d, J 8.0 Hz ortho-Ts), 7.32 (2H, d, J 8.0 Hz, meta-Ts), 5.83 (1H, 
d, J 8.0 Hz, TsNH), 4.01 (1H, dt, J 4.0, 8.0 Hz, TsNHCH),  3.89 (2H, m,, CH2OH), 3.62 (3H, 
s, OCH3), 2.43 (3H, s, CH3 of Ts); δC (100 MHz, CDCl3) 170.2 (CO), 143.9 (ipso-CH3CTs), 
136.5 (ipso-CSO2), 130.3 (ortho-Ts), 127.2 (meta-Ts), 63.7 (CH2OH), 57.6 (NHTsCH), 52.9 
(OCH3), 21.8 (TsCH3); M/z (CI) 274 [M+H]+, 291 [M+NH4]+.  
 
The data are in agreement with the reported compound.14   
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(S)-Methyl-3-(tbutyldimethylsilyloxy)-2-(4-methylphenylsulfoneamido)propanoate 549 
O
O
NHTs
OH O
O
NHTs
OTBS
548 549
 
 
Imidazole (1.24 g, 18.2 mmol, 2.0 equiv.), 2.11 g of TBSCl (14.0 mmol, 1.5 equiv.) and 548 
(12.5 g, 9.1 mmol, 1 equiv.) were dissolved in DCM (50 mL) and stirred at rt for 16 h. Poured 
on water (100 mL) and extracted with EtOAc (120 mL), dried (MgSO4) and concentrated 
under reduced pressure. Column chromatography (66% → 50% petrol–EtOAc) gave 549 as 
colorless crystals (3.45 g, 97%).  
 
Rf = 0.42 (50% EtOAc–petrol); m.p. = 56–57 oC (lit.14 m.p. 56 oC); [α]D23 + 29.7 (c 0.01, 
CHCl3); νmax (film) 3492, 3270, 2952, 1742, 1599, 1497, 1434, 1329, 1210, 1158, 1125, 1090, 
1062, 1021, 968, 819 cm-1; δH (400 MHz, CDCl3) 7.75 (2H, d, J 8.0 Hz, ortho-Ts), 7.30 (2H, 
d, J 8.0 Hz, meta-Ts), 5.38 (1H, d, J 9.0 Hz, TsNH), 4.04 (1H, dt, J 3.0, 9.0 Hz, TsNHCH), 
3.96 (1H, dd, J 3.0, 10.0 Hz CHAHBOH), 3.78 (1H, dd, J 3.5, 10.0 Hz, CHAHBOH), 3.56 (3H, 
s, OCH3), 2.46 (3H, s, CH3Ts), 0.82 (9H, s, (CH3)3C), 0.02 (3H, s, CH3Si), 0.00 (3H, s, 
CH3Si); δC (100 MHz, CDCl3) 170.1 (CO), 143.5 (ipso-CH3CTs), 137.2 (ipso-CSO2), 129.6 
(ortho-Ts), 127.1 (meta-Ts), 64.5 (CH2OH), 57.6 (TsNHCH), 52.4 (OCH3), 25.6 ((CH3)3C), 
21.5 (TsCH3), -5.6 ((CH3)2Si); M/z (CI) 405 [M+NH4]+, 388 [M+H]+, 330. 
 
The data are in agreement with the reported compound.14   
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(R)-N-(1-(tbutyldimethylsilyloxy)-3-hydroxypropan-2-yl)-4-methylbenzenesulfoneamide 
550 
 
O
O
NHTs
OTBS
549
HO
NHTs
OTBS
550
 
 
To a solution of 549 (3.40 g, 8.80 mmol, 1.0 equiv.) in THF (23 mL) was added 2.0 M LiBH4 
(13.2 mL, 26.4 mmol, 3 equiv.) at 0 oC and stirred for 30 min after which it was heated up to 
rt and reacted for a further 16 h. Dropwise addition of saturated aqueous NH4Cl (7 mL) at 0 
oC resulted in a white solid formation which was filtered off using THF. The filtrate was dried 
(MgSO4) and concentrated under reduced pressure, taken up in EtOAc and washed with 
saturated aqueous NH4Cl, H2O, dried (MgSO4) and concentrated under reduced pressure. 
Column chromatography (30% EtOAc–petrol) gave 550 as a colorless oil (2.49g, 80%).  
 
Rf = 0.31 (30% EtOAc–petrol); [α]D23 + 19.7 (c 0.76, CHCl3); νmax (film) 3408, 1433, 1318, 
1152, 1046, 960, 813, 519 cm-1; δH (400 MHz, CDCl3) 7.78 (2H, d, J 8.0 Hz, ortho-Ts), 7.32 
(2H, d, J 8.0 Hz, meta-Ts), 5.20 (1H, d, J 7.5 Hz, TsNH), 3.71–3.51 (4H, m, CH2OH + 
CH2OTBS), 3.29 (1H, m, TsNHCH), 2.44 (3H, s, CH3Ts), 2.18 (1H, br s, OH), 0.85 (9H, s, 
(CH3)3C), 0.02 (3H, s, CH3Si), 0.00 (3H, s, CH3Si); δC (100 MHz, CDCl3) 143.6 (ipso-
CH3CTs), 137.5 (ipso-CSO2), 129.8 (ortho-Ts), 127.1 (meta-Ts), 63.4 (CH2OH), 62.9 
(CH2OTBS), 55.5 (TsNHCH), 25.8 ((CH3)3C), 21.5 (TsCH3), 18.2 ((CH3)3C), -5.63 
((CH3)2Si); M/z (CI) 377 [M+NH4]+, 360 [M+H]+. 
 
The data are in agreement with the reported compound.14   
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(S)-2-((tButyldimethylsilyloxy)methyl)-1-tosylaziridine 551 
 
HO
NHTs
OTBS
TsN
TBSO
550 551
 
 
To a solution of 550 (2.49 g, 6.90 mmol, 1.0 equiv.) and PPh3 (2.00 g, 7.61 mmol, 1.1 equiv.) 
in THF (44 mL) was added DEAD (1.40 mL, 7.60 mmol, 1.1 equiv.) at rt and stirred for 16 h. 
Concentration of the solution using reduced pressure was followed by column 
chromatography (20% EtOAc–petrol) and provided 551 as an yellow oil (2.43 g, 97%).  
 
Rf = 0.45 (80% petrol–EtOAc); [α]D23 + 40.4 (c 0.72, CHCl3); νmax (film) 3277, 2954, 2929, 
2857, 1599, 1472, 1411, 1331, 1252, 1161, 1093, 980, 939, 832, 776, 663 cm-1; δH (400 MHz, 
CDCl3) 7.85 (2H, d, J 8.0 Hz, ortho-Ts), 7.35 (2H, d, J 8.0 Hz, meta-Ts), 3.72 (1H, dd, J 4.0, 
11.5 Hz, CHAHBOTBS), 3.61 (1H, dd, J 5.5, 11.5 Hz, CHAHBOTBS), 2.95 (1H, ddd, J 4.5, 
7.0, 9.5 Hz, TsNHCH), 2.67 (1H, d, J 7.0 Hz, TsNCHAHB), 2.46 (3H, s, CH3Ts), 2.23(1H, d, 
J 4.5 Hz, TsNCHAHB), 0.83 (9H, s, (CH3)3C), 0.00 (3H, s, CH3Si), -0.02 (3H, s, CH3Si); δC 
(100 MHz, CDCl3) 144.5 (CSO2), 135.1 (CCH3), 129.7 (ortho-Ts), 128.0 (meta-Ts), 62.4 
(CH2OTBS), 40.9 (TsNCH), 30.6 (TsNHCH2), 25.8 ((CH3)3C), 21.7 (CH3Ts), 18.3 
((CH3)3C), -5.5 (CH3Si), -5.47; M/z (CI) 359 [M+NH4]+, 342 [M+H]+, 284.  
 
The data are in agreement with the reported compound.14   
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(S)-(1-Tosylaziridin-2-yl)methanol 545 
 
OH
TsN
HO
545
+ HO
NHTs
NHTs
552
 
 
To a solution of Chloramine-T trihydrate (3.91 g, 14.0 mmol, 0.93 equiv.) and PTAB (2.11 g, 
5.61 mmol, 0.37 equiv.) in CH3CN (60 mL) was added allyl alcohol (1.00 mL, 15.0 mmol, 
1.0 equiv.) and the solution stirred for 2 h at rt. EtOAc was added and the organic layer was 
washed with H2O, brine, dried (MgSO4) and concentrated under reduced pressure. Column 
chromatography (50% EtOAc–petrol) gave 545 as a colorless oil (1.46 g, 52%) and 552 as an 
yellow oil (1.10 g, 40%). 
 
TsN
TBSO
TsN
HO
551 545
 
 
To a solution of TBS-aziridine 551 (22.3 g, 65.0 mmol, 1.0 equiv.) in THF (75 mL) at 0 oC 
was added TBAF (23.0 g, 72.0 mmol, 1.1 equiv.) in THF (75 mL). After 20 min stirring at 0 
oC, the solution was heated to rt and diluted by addition of brine (150 mL) and EtOAc (100 
mL). The organic layer was separated and the aqueous layer extracted using EtOAc (3 x 100 
mL), combined, dried (Na2SO4) and concentrated under reduced pressure. Column 
chromatography (66% → 50% petrol–EtOAc) gave 545 as a colorless oil in a 14.6 g, 90% 
yield.   
 
Rf = 0.30 (50% EtOAc–petrol); νmax (film) 3515, 3287, 2928, 2889, 1598, 1450, 1322, 1290, 
1266, 1155, 1089, 1042, 814, 732 cm-1; δH (400 MHz, CDCl3) 7.82 (2H, d, J 8.0 Hz, ortho-
Ts), 7.35 (2H, d, J 8.0 Hz, meta-Ts), 3.82 (1H, dt, J 3.5, 12.0 Hz, CHAHBOH), 3.54 (1H, dt, J 
5.0, 12.5 Hz, CHAHBOH), 3.01 (1H, m, TsNCH), 2.58 (1H, d, J 7.0 Hz, TsNCHAHB) 2.45 
(3H, s, CH3Ts), 2.30 (1H, d, J 4.5 Hz, TsNCHAHB); δC (100 MHz, CDCl3) 144.9 (CSO2), 
134.4 (CCH3), 129.8 (ortho-Ts), 128.0 (meta-Ts), 60.8 (CH2OH), 40.5 (TsNCH), 31.0 
(TsNCH2), 21.7 (CH3Ts); M/z (CI) 245 [M+NH4]+, 228 [M+H]+.  
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[α]D24 + 31.6 (c 1.23, CHCl3), regarding enantiomerically pure material.14 
 
The data are in agreement with the reported compound.14,15   
 
2,3-Bis[[4-(methylphenyl)sulfonyl]amino]-1-propanol 552 
 
OH
TsN
HO
545
+ HO
NHTs
NHTs
552
 
 
Rf = 0.61 (50% EtOAc–petrol); νmax (film) 3513, 3273, 2927, 1708, 1598, 1494, 1423, 1322, 
1305, 1266, 1154, 1090, 976, 733, 662 cm-1; δH (400 MHz, CDCl3) 7.77 (2H, d, J 8.0 Hz, 
ortho-Ts), 7.69 (2H, d, J 8.0 Hz, ortho-Ts), 7.35-7.29 (4H, m, meta-Ts), 5.60 (1H, d, J 8.0 Hz, 
TsNHCH), 5.43 (1H, t, J 7.5 Hz, TsNHCH2), 3.66 (1H, dd, J 4.0, 11.5 Hz, CHAHBOH), 3.54 
(1H, dd, J 5.0, 11.5 Hz, CHAHBOH), 3.30 (1H, m, TsNHCH), 3.05 (2H, m, TsNHCH2), 2.78 
(1H, br s, OH), 2.44 (6H, s, CH3Ts); δC (100 MHz, CDCl3) 143.8 (CSO2), 136.9 (CCH3), 
136.3 (CCH3), 129.9 (ortho-Ts), 127.1 (meta-Ts), 127.0 (meta-Ts), 61.8 (CH2OH), 53.9 
(TsNHCH), 43.8 (TsNHCH2), 21.6 (CH3Ts); M/z (CI) 263 [M+NH4-Ts]+, 245 [M+H-Ts]+. 
 
The data are in agreement with the reported compound.15   
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(R)-N-(1-Hydroxy-6,6-dimethoxy-4-tosylhexan-2-yl)-4-methylbenzenesulfonamide 553 
 
OTs
O TsN
HO
+
406 545 553
OTs
OTsHN
HO
3   :   1
 
 
To a solution of sulfone 406 (1.24 g, 4.84 mmol, 1.1 equiv.) in THF (20 mL) was added 2.5M 
nBuLi (4.80 mL, 10.6 mmol, 2.4 equiv.) at –78 oC. After 30 min, a solution of 
hydroxyaziridine 545 (1.00 g, 4.41 mmol, 1.0 equiv.) in THF (20 mL) was added and the 
mixture, after stirring at –78 oC for 30 min, slowly heated to rt over 5 h. EtOAc (10 mL) and 
saturated aqueous NH4Cl (20 mL) were added and the aqueous layer extracted with EtOAc (3 
x  10 mL). The combined organic layers were dried (MgSO4) and concentrated under reduced 
pressure. Column chromatography (50% → 33% petrol–EtOAc) gave 553 as a colorless gum 
(2.0 g, 95%, 3 : 1 dr).  
 
Rf = 0.25 (minor), 0.20 (major) (66% EtOAc–petrol); νmax (film) 3515, 3270, 2934, 1597, 
1440, 1300, 1286, 1157, 1128, 1083, 1055, 971, 814 cm-1;  
 
Minor 
 
δH (400 MHz, CDCl3) 7.81 (2H, d, J 8.0 Hz, ortho-TsCH), 7.71 (2H, d, J 8.0 Hz, ortho-TsN), 
7.36 (2H, d, J 8.0 Hz, meta-TsCH), 7.33 (2H, d, J 8.0 Hz, meta-TsN), 5.51 (1H, d, J 7.5 Hz, 
NHTs), 4.42 (1H, t, J 5.0 Hz, (CH3O)2CH), 3.58 (2H, m, CHNHTs + CHAHBOH), 3.46 (1H, 
m, CHAHBOH), 3.27 (3H, s, OCH3), 3.21 (3H, s, OCH3), 3.10 (1H, dd, J 4.0, 9.0 Hz, TsCH), 
2.54 (1H, s, OH), 2.46 (3H, s, CH3-TsCH), 2.44 (3H, s, CH3-TsNH), 2.18 (1H, m, 
CHAHBCHCH2OH), 2.07 (1H, m, (CH3O)2CHCHACHB), 1.83 (1H, m, CHAHBCHCH2OH), 
1.64 (1H, m, (CH3O)2CHCHACHB); δC (100 MHz, CDCl3) 145.2 (CSO2, TsCH), 144.9 
(CSO2, TsN), 137.8 (CH3C, TsCH), 133.3 (CH3C, TsN), 130.0 (ortho-TsCH), 129.8 (ortho-
TsN), 129.2 (meta-TsCH),127.1 (meta-TsN), 102.2 ((CH3O)2CH), 63.8 (NHTsCHCH2OH), 
57.6 (TsCH), 54.5  (CH3O), 53.6 (TsNHCH), 52.9 (CH3O), 32.8 (TsCHCH2CHCH2OH), 30.4 
((CH3O)2CHCH2), 21.6 (2 x CH3Ts);  
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Major 
 
δH (400 MHz, CDCl3) 7.79 (2H, d, J 8.0 Hz, ortho-TsCH), 7.62 (2H, d, J 8.0 Hz, ortho-TsN), 
7.35 (2H, d, J 8.0 Hz, meta-TsCH), 7.33 (2H, d, J 8.0 Hz, meta-TsN), 5.62 (1H, d, J 7.5 Hz, 
NHTs), 4.39 (1H, t, J 5.0 Hz, (CH3O)2CH), 3.51 (1H, m, CHAHBOH), 3.42 (2H, m, CHNHTs 
+ CHAHBOH), 3.26 (6H, s, 2 x OCH3), 3.15 (1H, dd, J 4.0, 9.0 Hz, TsCH), 2.51 (1H, s, OH), 
2.47 (3H, s, CH3-TsCH), 2.45 (3H, s, CH3-TsNH), 2.23 (1H, m, CHAHBCHCH2OH), 1.96 
(1H, m, (CH3O)2CHCHACHB), 1.82 (1H, m, CHAHBCHCH2OH), 1.65 (1H, m, 
(CH3O)2CHCHACHB); δC (100 MHz, CDCl3) 145.0 (CSO2, TsCH), 143.6 (CSO2, TsN), 137.3 
(CH3C, TsCH), 133.3 (CH3C, TsN), 130.0 (ortho-TsCH), 129.8 (ortho-TsN), 128.9 (meta-
TsCH),127.1 (meta-TsN), 102.6 ((CH3O)2CH), 64.1 (NHTsCHCH2OH), 57.6 (TsCH), 54.4  
(CH3O), 53.4 (TsNHCH), 52.9 (CH3O), 32.9 (TsCHCH2CHCH2OH), 30.8 ((CH3O)2CHCH2), 
21.7 (CH3TsCH), 21.0 (CH3TsNH);  
 
M/z (CI) 503 [M+NH4]+, 348, 174 (Found: [M+NH4]+, 503.1873. C22H31NO7S2 requires: 
[M+NH4]+,  503.1886) (Found: C, 54.60; H, 6.57; N, 2.86. C22H31NO7S2 requires C, 54.41; H, 
6.43; N, 2.88%).  
Experimental 
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(R)-N-(1-(tButyldimethylsilyloxy)-6,6-dimethoxy-4-tosylhexan-2-yl)-4-
methylbenzenesulfonamide 554 
 
OTs
OTsHN
OTs
OTsHN
TBSO
3   :   1
553 554
HO
 
 
A mixture of acetal 553 (14.2 g, 29.0 mmol, 1.0 equiv.), DMAP (354 mg, 2.90 mmol, 0.1 
equiv.), TEA (4.81 mL, 35.0 mmol, 1.2 equiv.) and TBSCl (6.70 g, 43.5 mmol, 1.5 equiv.) in 
DCM (140 mL) was stirred for 1.5 h at rt. The solution was diluted with saturated aqueous 
NH4Cl (100 mL) and the aqueous layer was extracted with DCM (2 x 50 mL). The combined 
organic layers were dried (MgSO4) and concentrated under reduced pressure. Column 
chromatography (75% → 66% → 50% petrol–EtOAc) gave 554 as a colorless gum (16.0 g, 
91% yield, 3 : 1 dr).  
 
Rf = 0.90 (minor), 0.85 (major) (66% EtOAc–petrol); νmax (film) 3350, 3054, 2954, 2858, 
1725,1590, 1469, 1422, 1322, 1279, 1163, 1089, 838 cm-1;  
 
Major 
 
δH (400 MHz, CDCl3) 7.77 (2H, d, J 8.0 Hz, ortho-TsCH), 7.71 (2H, d, J 8.0 Hz, ortho-TsN), 
7.33 (2H, d, J 8.0 Hz, meta-TsCH), 7.31 (2H, d, J 8.0 Hz, meta-TsN), 5.12 (1H, d, J 8.5 Hz, 
TsNH), 4.37 (1H, t, J 5.0 Hz, (CH3O)2CH), 3.51 (1H, m, NHTsCH) 3.40 (1H, dd, J 2.0 Hz, 
TBSOCHAHB), 3.36 (1H, m, TsCH), 3.27 (3H, s, OCH3), 3.23 (3H, s, OCH3), 3.16 (1H, m, 
TBSOCHAHB), 2.45 (3H, s, CH3Ts), 2.44 (3H, s, CH3Ts), 2.15 (1H, m, 
CHAHBCHCH2OTBS), 1.96 (1H, m, (CH3O)2CHCHACHB), 1.87 (1H, m, CHAHBCHCH2OH), 
1.68 (1H, m, (CH3O)2CHCHACHB), 0.84 (9H, s, (CH3)3C), 0.00 (3H, s, CH3Si), -0.04 (3H, s, 
CH3Si); δC (100 MHz, CDCl3) 144.7(CSO2, TsCH), 144.4(CSO2, TsN), 137.7 (H3C, TsCH), 
134.4 (CH3C, TsN), 129.8 (ortho-TsCH), 129.7 (ortho-TsN), 128.9 (meta-TsCH),128.7 
(NTsCHCH), 127.0 (meta-TsN), 102.7 ((CH3O)2CH), 64.3 (NHTsCHCH2OTBS), 56.5 
(TsCH), 54.2  (CH3O), 53.8 (TsNHCH), 53.2 (CH3O), 32.6 (TsCHCH2CHCH2OH), 32.3 
Experimental 
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((CH3O)2CHCH2), 25.8 ((CH3)3C), 21.6 (CH3Ts), 21.5 (CH3Ts), 18.2 (CH3)3C), -5.60 
(CH3)Si), -5.67 (CH3)Si);  
 
Minor 
 
δH (400 MHz, CDCl3) 7.75 (2H, d, J 8.0 Hz, ortho-TsCH), 7.70 (2H, d, J 8.0 Hz, ortho-TsN), 
7.33 (2H, d, J 8.0 Hz, meta-TsCH), 7.29 (2H, d, J 8.0 Hz, meta-TsN), 4.92 (1H, d, J 8.5 Hz, 
TsNH), 4.51 (1H, t, J 5.0 Hz, (CH3O)2CH), 3.48 (1H, m, NHTsCH) 3.41 (1H, dd, J 2.0 Hz, 
TBSOCHAHB), 3.34 (1H, m, TsCH), 3.28 (3H, s, OCH3), 3.21 (3H, s, OCH3), 3.13 (1H, m, 
TBSOCHAHB), 2.44 (3H, s, CH3Ts), 2.42 (3H, s, CH3Ts), 2.12 (1H, m, 
CHAHBCHCH2OTBS), 2.02 (1H, m, (CH3O)2CHCHACHB), 1.85 (1H, m, CHAHBCHCH2OH), 
1.75 (1H, m, (CH3O)2CHCHACHB), 0.83 (9H, s, (CH3)3C), -0.04 (3H, s, CH3Si), -0.08 (3H, s, 
CH3Si); δC (100 MHz, CDCl3) 144.5 (CSO2, TsCH), 144.3(CSO2, TsN), 137.6 (H3C, TsCH), 
134.2 (CH3C, TsN), 129.7 (ortho-TsCH), 128.9 (ortho-TsN), 128.5 (meta-TsCH),128.7 
(NTsCHCH), 127.0 (meta-TsN), 102.7 ((CH3O)2CH), 64.3 (NHTsCHCH2OTBS), 56.5 
(TsCH), 54.2  (CH3O), 53.6 (TsNHCH), 53.0 (CH3O), 32.6 (TsCHCH2CHCH2OH), 32.1 
((CH3O)2CHCH2), 25.8 ((CH3)3C), 21.6 (CH3Ts), 21.3 (CH3Ts), 18.2 (CH3)3C), -5.60 
(CH3)Si), -5.67 (CH3)Si);  
 
M/z (CI) 617 [M+NH4]+, 553, 536 (Found: [M+NH4]+, 617.2747, C28H49N2O7S2Si requires: 
[M+NH4]+  617.2750). (Found: C, 56.14; H, 7.62; N, 2.25. C28H49O7S2Si requires C, 56.06; H, 
7.56; N, 2.31%).  
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(S)-2-((tButyldimethylsilyloxy)methyl)-1,4-ditosyl-1,2,3,4-tetrahydropyridine 555  
 
OTs
OTsHN
TBSO
3   :   1
554
N
OTBSTs
Ts
555
 
 
To a solution of acetal 554 (6.30 g, 11.0 mmol, 1.0 equiv.) in DCM (200 mL) at –78 oC was 
added BF3·Et2O (5.30 mL, 45.0 mmol, 4.0 equiv.). The solution was slowly warmed to –20 oC 
and stirred for 30 min. Saturated aqueous NH4Cl (150 mL) was added and the suspension 
heated to rt. The layers were separated and the aqueous layer extracted with DCM (3 x 100 
mL). The combined organic layers were dried (MgSO4) and concentrated under reduced 
pressure. Column chromatography (75% petrol–EtOAc) gave 555 as a pale-yellow solid (3.80 
g, 59%).  
 
Rf = 0.80 (50% petrol–EtOAc); m.p. = 98 oC; νmax (film) 2957, 1720, 1596, 1493, 1445, 1401, 
1343, 1266, 1144, 1087, 1042, 814 cm-1; δH (400 MHz, CDCl3) 7.65 (2H, d, J 8.0 Hz, ortho-
TsCH), 7.54 (2H, d, J 8.0 Hz, ortho-TsN), 7.31 (2H, d, J 8.0 Hz, meta-TsCH), 7.22 (2H, d, J 
8.0 Hz, meta-TsN), 6.91 (1H, dd, J 1.5, 8.5 Hz, NTsCHCH), 5.18 (1H, dt, J 1.5, 8.5 Hz, 
NTsCHCH), 3.87 (1H, m, NTsCHCH2), 3.75–3.65 (2H, m, NTsCHCHAHBOH + TsCH), 3.43 
(1H, dd, J 6.5, 12.5 Hz, NTsCHCHAHBOH), 2.46 (3H, s, CH3-TsCH), 2.42 (3H, s, CH3-
TsNH), 2.21 (1H, dd, J 6.0, 13.0 Hz, NTsCHCH2CHAHBCHTs), 1.17 (1H, td, J 4.5, 16.0 Hz, , 
NTsCHCH2CHAHBCHTs), 0.76 (9H, s, (CH3)3C), 0.00 (3H, s, CH3Si), -0.03 (3H, s, CH3Si); 
δC (100 MHz, CDCl3) 144.8 (CSO2, TsCH), 144.1 (CSO2, TsN), 135.3 (CH3C, TsCH), 133.6 
(CH3C, TsN), 129.9 (ortho-TsCH), 129.6 (ortho-TsN), 129.0 (meta-TsCH),128.7 
(NTsCHCH), 126.7 (meta-TsN), 98.9 (NTSCHCH), 61.8 (NTSCHCH2OH), 55.8 (TsCH), 
52.5 (NTsCHCH2OH), 25.7 ((CH3)3C), 21.6 (2 x CH3Ts + NTsCHCH2CHTs), 17.9((CH3)3C), 
-5.5 ((CH3)2Si); M/z (CI) 553 [M+NH4]+, 536 [M+H]+, 381, 174  (Found: [M+NH4]+, 
553.2210.C26H41N2O5S2Si requires: [M+NH4]+, 553.2226).  
Experimental 
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